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Summary  
 
The comparative study of protein sequences and structures is traditionally used to 
better understand protein fold evolution.  The insights we gain from our evolutionary 
analyses are applied in protein design projects. At the same time, we engineer proteins 
to test evolutionary assumptions; thus, we establish a feedback loop between both 
aspects of protein science. First, we compared Profile Hidden Markov Models, state 
of the art tools for homology detection, that represent all structures that adopt the 
(βα)8-barrel and the flavodoxin-like fold to discover an evolutionary relationship 
between these basic structural forms. Moreover, we located the region of the sequence 
space where both folds are most closely related. Having found this interface, we 
performed remote homologous searches and protein clustering to find sequences with 
intermediate features between the (βα)8-barrel and the flavodoxin-like fold.  
 
We determined the x-ray crystal structure of one of these sequences to learn possible 
scenarios of fold change during the evolution of these ancestral structures. The 
intermediate sequence, named NTM0182, displayed features towards both folds. 
Moreover, and by structurally superimposing the three structures, we found classical 
evidences of homology among the three folds: high sequence identity over long 
aligned fragments. Our approach then starts by using very sensitive novel tools for 
homology detection (probability scores), to find intermediary links that provide 
classical evidences of common ancestry (high sequence identity).  
 
Next, we extended the Profile Hidden Markov Model comparisons to include all folds 
classified as α/β in the Structural Classification of Proteins (SCOP). Our comparisons 
showed that high scoring pairwise alignments are correlated with high local structural 
similarities between different folds. This observation inspired us to look for 
interchangeable sub-domain size protein fragments, related by sequence and structure, 
to build chimeric proteins and mimic protein fold evolution. Our global comparisons 
revealed that both, the flavodoxin-like and the (βα)8-barrel folds were related to 
Periplasmic binding protein-like I proteins. 
 V 
We then employed sequence comparisons, structural superpositions, homology 
modeling and computational assessments to engineer a novel chimeric protein by 
fusing a flavodoxin-like fold protein into a PBP-like scaffold. The chimera turned out 
to be a well-folded protein with native-like properties. Thus, our research allowed us 
to gain evolutionary insights that are applied to protein engineering. In this respect, 
we establish a feedback loop between fold evolution and protein engineering.  We 
finally contribute to an emergent vision where proteins from different folds are 
evolutionary related.  
 
 
 
Zusammenfassung 
 
Die vergleichende Untersuchung von Proteinsequenzen und -strukturen wird 
traditionell dazu genutzt, die Evolution von Proteinfaltungen besser zu verstehen. Die 
Erkenntnisse, die wir aus unseren evolutionären Analysen ziehen, werden wiederum 
in Protein-Design-Projekten angewendet. Gleichzeitig konstruieren wir Proteine, um 
evolutionäre Annahmen zu testen, und schaffen so eine Feedback-Schleife zwischen 
den beiden Aspekten der Proteinforschung. Zunächst verglichen wir Profile von 
Hidden Markov Modellen, eines der modernsten Hilfsmittel zur die Homologie-
Erkennung, welche alle Strukturen der (βα)8-barrel und Flavodoxin–ähnlichen 
Faltung repräsentieren. Dabei entdeckten wir eine evolutionäre Beziehung zwischen 
diesen Grundformen. Darüber hinaus identifizierten wir die Region des 
Sequenzraumes, in dem die beiden Faltungen besonders eng verwandt sind. Nachdem 
wir diese Schnittstelle gefunden hatten, führten wir eine Suche nach entfernt 
homologen Proteinen durch, sowie ein Protein-Clustering, um intermediäre 
Sequenzen zu identifizieren, die gleich weit von beiden Faltungen entfernt sind. 
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Wir bestimmten die Röntgenkristallstruktur von einer dieser Sequenzen, um mehr 
über mögliche Szenarien der Struktur-Veränderung während der Evolution 
ursprünglicher Faltungen zu lernen. Die intermediäre Sequenz, genannt NTM0182 , 
zeigte Charakteristika beider Faltungen. Darüber hinaus, und durch die Überlagerung 
der drei Strukturen, fanden wir klassische Hinweise für Homologie zwischen den drei 
Faltungen: hohe Sequenzidentität über lange Fragmente. Unser Ansatz beginnt also 
mit sehr empfindlichen, neuartigen Werkzeugen für die Homologieerkennung 
(Wahrscheinlichkeitswert), um basierend auf klassischen Homologie-Beweisen (hohe 
Sequenzidentität) intermediäre Strukturen zu finden. 
 
Als nächstes haben wir Vergleiche zwischen allen Faltungen der α/β-Klasse (SCOP) 
durchgeführt. Unsere Untersuchungen zeigten, dass hohe Wertung bei paarweisen 
Alignments mit hohen lokalen strukturellen Ähnlichkeiten zwischen verschiedenen 
Faltungen korreliert. Diese Beobachtung hat uns inspiriert, nach auswechselbaren 
Proteinfragmenten zu suchen, die in Sequenz und Struktur ähnlich sind, und sich 
eignen um chimären Proteine zu bauen und somi die Evolution von Proteinfaltungen 
zu imitieren. Unsere globalen Vergleiche zeigten, daß sowohl die Flavodoxin-
ähnliche als auch die (βα)8-barrel Faltung mit den periplasmatischen Bindeproteinen 
vom Typ I verwandt sind. 
 
Wir haben dann Sequenzvergleiche, Strukturüberlagerungen, Homologie-
Modellierung und computergestützten Berechnungen eingesetzt, um ein neuartiges 
chimäres Protein durch Einbauen eines Flavodoxin-ähnlichen Proteinfragments in ein 
PBP-Gerüst zu konstruieren. Die Chimäre erwies sich als gut gefaltetes Protein mit 
nativ-ähnlichen Eigenschaften. So erlaubt unsere Forschung evolutionäre 
Erkenntnisse, die auf Protein-Engineering angewendet werden können. In diesem 
Zusammenhang stellen wir fest, dass wir eine Rückkopplungsschleife zwischen 
Evolution und Engineering von  Proteinfaltungen etabliert haben. Insgesamt tragen 
wir somit zu einer entstehenden Vorstellung bei, in der Proteine aus verschiedenen 
Faltungen in evolutionärem Zusammenhang stehen. 
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1. Introduction 
 
1.1 Protein diversity and evolution  
 
Nothing in biology makes sense except in the light of evolution (1). Henceforth, we 
study protein evolution to decipher how nature created the structural and functional 
diversity displayed by contemporary proteins. These molecular machines are 
responsible for many biological processes like DNA replication, DNA storage, 
protein synthesis, energy production and signal recognition among others (figure 1).   
 
 
Fig. 1: DNA is replicated in the nucleus. DNA polymerase is shown at the center 
in purple, with a DNA strand entering from the bottom and exiting as two 
strands near the top. The new strands are shown in white. Chromatin fibers are 
shown at either site of the replication fork. (Reproduced with written permission 
from David S. Goodsell) 
  
 2 
The protein structural diversity is strikingly reflected in a diversified functional range. 
For instance, the DNA ligase works in human cells by repairing broken pieces of 
DNA (2). Its structure is very different than the structure of bacteriorhodopsin, the 
biomolecule in charge of pumping protons across biological membranes during 
photosynthesis (3). The functions and structures of these two proteins are different but 
essential for sustaining the life of the cells (figure 2).  
 
 
Fig. 2: Proteins are structurally diverse. The structure of bacteriorhodopsin (left) 
is mainly composed by alpha helices. In contrast, a mixture of alpha helices and 
beta strands constitutes the DNA Ligase (right). 
The function and structure of proteins is defined by their amino acid sequence; 
therefore, it is important to understand the relationship between sequence, structure 
and function (4). It is usually understood that similar sequences will fold into similar 
structures, and one protein sequence will only lead to a single folded native state. The 
previous assumptions on the nature of proteins would then lead to a relatively 
straightforward relationship between sequence and structure. Nevertheless, dissimilar 
protein sequences can also adopt similar structures. The problem of establishing a 
direct correlation between sequence, structure and function represents a major 
challenge in the genomic and metagenomic era of biology when sequencing data is 
produced at an accelerated rate.  
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1.2 Sequence space expansion  
 
To date, the UniProt database contains more than 46 million protein sequences (5),  
including environmental samples, from all kingdoms of life,. Scientists struggle to 
functionally annotate this big amount of biological data. Sequence comparisons are 
frequently used to infer the function of a new sequence. For instance, in the Protein 
Family database (Pfam) we find protein sequences grouped into families (6). Proteins 
in a family are considered to be homologous (share common ancestry) because they 
share significant sequence similarity, similar three-dimensional structures and 
functions. When a new protein sequence is added to the UniProt database, an 
algorithm automatically compares the protein with the families in Pfam to infer its 
probable function. If the new protein shares high sequence identity with a protein 
family of known function, it is very likely that the novel protein will have the same 
activity.  
 
In Pfam we also find groups of proteins that are similar among each other and 
therefore are clustered in a family/group; however, they are not similar to any protein 
sequence with known function. These protein families are denominated Domains of 
Unknown Function (DUF). At the end of 2010, these families represented more than 
20% of the total number of families in Pfam (7).  
 
In certain cases, all the proteins in the family with unknown function display a 
common feature that results in the naming of this group based on a preliminary 
hypothesis of their probable function. For instance, in the Conserved Domain 
Database (CDD) (8), we found a multi-domain protein family named “B12-binding 
domain_like associated with radical SAM domain”. The N-terminal domain of these 
proteins display similarities with B12-binding domains found in numerous enzymes, 
but they lack the signature motif Asp-X-His-X-X-Gly, which is fundamental to bind 
the ligand. The C-terminal domain is similar to Radical S-adenosylmethionine (SAM) 
proteins: these proteins generate radical species by reductive cleavage of SAM 
through an unusual Fe-S cluster (9).  However, the function of this multi-domain 
group of proteins still remains unclear. 
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1.3 Protein structure space classification 
 
A valuable resource frequently used to predict the structure and function of a novel 
protein is the Protein Data Bank (PDB). This database currently comprises almost 
100,000 protein structures. The structures can assist to identify function in different 
ways: looking at the ligands co-crystallized with the proteins, inferring distant 
functional relationships, or by allowing a better definition of the domain boundaries. 
Nonetheless, it is necessary to build an organized picture of the structural and 
evolutionary relationships in the structure space, to more efficiently solve biological 
problems.  
The databases SCOP and CATH emerged as the two main efforts to organize the 
structure space.  SCOP (Structural Classification Of Proteins) sorts proteins into 
classes, folds, superfamilies and families (8) ; while the four major levels in CATH 
(9) are class, architecture, topology, and homology. For our work, we decided to use 
SCOP as the framework because it has been used as the gold standard in similar 
approaches.  
In SCOP, four major classes constitute the top level of classification: 
α, β, α/β and  α+β. These divisions are based on the secondary structure composition 
of the protein structures. Subsequently, we have the fold level:  protein structures that 
belong to the same fold have the same secondary structural elements comparably 
arranged in three dimensions (similar architecture) and display similar order of those 
elements along the path of the protein chain (similar topology). Finally, we find two 
more levels of classification that are based on function and sequence similarity: the 
superfamily and the family level. The superfamily level clusters proteins that share 
few identical residues, but whose structural and functional features imply common 
ancestry. The family level, as we previously discussed, groups proteins that share high 
sequence identity; therefore, common evolutionary origin for proteins classified in the 
same family is the most likely scenario. 
  
 5 
1.4 Evolutionary markers in fold evolution 
Random convergence to highly identical sequences, similar functions and comparable 
structures is very unlikely (10). Therefore, protein families and superfamilies are 
traditionally regarded as homologous groups. In contrast, two proteins may have 
converged to the same structure just by random physicochemical events given the 
small possibilities with which a polypeptide chain is folded. Thus, high sequence 
identity between a pair of proteins is the best indication of common ancestry. It is 
convenient to classify similar protein structures into folds to generate an organized 
view of the structure space and in this way, we discovered that the fold space is 
relatively small, with no more than few thousands of different basic forms (11). This 
observation leads us back to the problem of finding unrelated protein sequences (there 
are millions of protein sequences in the databases) that can adopt similar protein folds 
(a bit more than 1000 folds).  
Is it possible that during the course of evolution, millions of protein sequences have 
diverged from a reduced number of ancestral forms? Or these sequences just converge 
to the reduced number of folded possibilities driven by pure physicochemical forces?  
 
Fig. 3: Two members of the αβ class in SCOP share alternating αβ elements. 
The D-allulose 6-phosphate 3-epimerase from Escherichia coli belongs to the 
(βα)8-barrel fold (PDB; 3CT7, left).  The response regulator CheY from 
Thermotoga maritima belongs to the flavodoxin-like fold (PDB; 1TMY, right). 
Beta strands are colored in yellow while alpha helices are colored in red. 
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Very early it was recognized that divergent evolution is capable of pushing 
homologous proteins to reach disparate sequences and adopt different folds (12). For 
instance, the carboxypeptidase G2 catalytic domain from Pseudomonas sp. has 
structural similarity to the aminopeptidase from Aeromonas proteolytica; the 
similarity shows structurally aligned zinc ligands in the active site (13). However, the 
enzymes fold into different topological isomers. High local similarities in sequence 
and structure between proteins from different folds suggest that modern protein 
domains have evolved from ancient short peptide ancestors (14). These fragments 
have been denominated antecedent domain segments or (ADSs). The ADSs might be 
reflected in repetitive motifs, like the (βα) elements, of the (βα)8-barrel fold (figure 3, 
left) 
Mechanisms of protein fold change during evolution have been investigated, such as 
circular permutations, deletions/insertions/substitutions of whole secondary structural 
elements, and rearrangement of β-sheet topologies. A dramatic example is constituted 
by the structural comparison between bacterial luciferase and non-fluorescent 
flavoprotein (15).   During the course of evolution 90 residues were deleted from the 
luciferase and were replaced by a single β-strand in the flavoprotein (figure 4).   
1.5 Ancient protein folds in Nature  
Figure 4 shows two proteins that adopt one of the most ancient protein folds, the 
(βα)8-barrel. This basic shape is considered among the most ancestral ones by a 
phylogenomic census (16). In this work, the usage and sharing of protein folds, in 
fully sequenced genomes, is employed to generate an evolutionary structured 
representation of the fold space. In this tree-like representation, some SCOP folds 
appear at the very base of the tree: P-loop containing nucleoside triphosphate 
hydrolase, DNA/RNA-binding 3-helical bundle,  (βα)8-barrel, NAD(P)-binding 
Rossmann-fold domain, Ferredoxin-like, Flavodoxin-like, and Ribonuclease H-like 
motif. We focused our work on the (βα)8-barrel and flavodoxin-like folds. By doing 
this, our findings would apply to a broad range of the protein universe because these 
two folds are not only ancient but are also considered superfolds (17).  
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Three layers compose the flavodoxin-like fold: two α-helical layers sandwich a five-
stranded β-sheet (figure 3, right). The proteins that adopt this fold perform diverse 
functions such as chemotaxis, binding of cofactors, signal transduction, and 
enzymatic activity among others (18) (19) (20) (21). Moreover, these proteins have 
been used as models in folding studies (22) (23) and have been ranked as ancient 
architectures as well (24).  Two interesting members of these fold class are involved 
in completely different activities within the cell: CheY and the B12-binding domain 
of the Methionine synthase.   
In bacteria, certain chemical signals trigger autophosphorylation of the CheA histidine 
kinase at a conserved histidine. Subsequently, this phosphohistidine is the substrate 
for CheY that catalyzes its own phosphorylation at a conserved aspartate.  Then 
CheY-P can alter the mechanism in the flagella motor by changing the swimming 
speed or direction (25).  In contrast, vitamin B12 is a common cofactor necessary to 
catalyze a very difficult reaction such as the removal of a methyl group. The B12-
binding domain of the methionine synthase regulates the stability and reactivity of the 
prosthetic group by the protonation of a conserved His-Asp pair (20). These two 
examples illustrate how functionally diverse the flavodoxin-like fold is.  
 
 
Fig. 4: Fold change in the evolution of protein structures. Bacterial luciferase 
(PDB-id: 1LUC, left) and nonfluorescent flavoprotein (PDB-id: 1NFP, right) 
The structural change is highlighted in black. The figure was adapted from (15).  
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The (βα)8-barrel fold is the most common enzyme scaffold in the Protein Data Bank 
(26); a canonical (βα)8-barrel consists of an inner ring of eight parallel β-strands that 
is surrounded by an outer wheel of eight α-helices (figure 4, left). Structural evidence 
exists that certain (βα)8-barrel proteins, like HisF and HisA, show 2-fold symmetry 
and they likely evolved by gene duplication and fusion (27).  Proteins adopting this 
fold vary greatly in size; but 250 residues compose the typical domain. This major 
fold exceeds any other fold in terms of overall number and functional diversity (28). 
The functional diversity displayed by this fold class encouraged scientists to use it as 
scaffold for designing novel enzymes that can, for example, break a carbon-carbon 
bond in a non-natural substrate (29).  
The (βα)8-barrel fold origin and evolution has been a matter of intense debate. It was 
not clear whether the superfamilies that adopt this fold have a common evolutionary 
origin. A decade ago two comprehensive works explored this possibility by a 
combination of sequence and structure based approaches (30) (31). At the time of this 
work 21 from 17 homologous superfamilies were proven to have common ancestry. 
One sensitive tool used for detecting homologous relationships at the superfamily 
level in these works was PSI-BLAST (32).  
1.6 Methods for homology detection  
PSI-BLAST takes BLAST (32) hits and builds a profile that is used to search a 
database. Therefore it is better suited to perform searches when the sequence identity 
of the protein pairs is lower than 30%. Nowadays, even more sensitive sequence-
based tools for homology detection have been developed. For instance, HHsearch 
represent proteins by profile hidden Markov models (HMMs), an extension of 
sequence profiles that additionally trace position-specific amino acid insertion and 
deletion occurrences (33). HHsearch was recently used to explore the folds annotated 
in SCOP20 (sequences with less than 20% identity).  Alva and co-workers (34) 
compared the HMMs of the structures to derive P-values; these values were used to 
cluster, using the clustering algorithm CLANS (35), the folds in a three-dimensional 
map. They showed that many of the superfamilies of one fold cluster together and that 
there appears to be more connectivity in fold space than expected.  
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The development of very sensitive tools for homology detection and their application 
in interesting biological problems, prompted us to reconsider our understanding of 
protein evolution beyond fold boundaries. For our own quest of homology beyond 
fold boundaries, we envisioned different starting points that are complementary.  
The first point was based on an earlier observation that suggested the hypothetical 
homologous relationship between the (βα)8-barrel and flavodoxin-like fold (36).  In a 
subsequent work, by combining sub-domain sized fragments from (βα)8-barrel and 
flavodoxin-like fold structures a well-folded βα-barrel was  built (37). The interface 
between the two folds was optimized by combining homology modeling (38) and 
computational design (39), yielding an eight stranded βα-barrel that still 
retained functional properties (40). 
1.7 Sequence based-comparisons and chimeric protein design 
Based on these works we first compared protein sequences and structures to gather 
experimental and bioinformatic evidence for the homologous relationship between the 
(βα)8-barrel and flavodoxin-like folds. Once we found evidence that these two folds 
are related, two questions arose:  Are there protein sequences with intermediary 
features (evolutionary bridges) between the different folds? And, can we detect other 
homologous folds? 
We answered the first question by identifying a protein intermediate that bears similar 
features towards the (βα)8-barrel and the flavodoxin-like fold. We then determined 
the structure of this intermediate to learn more about the evolutionary path that might 
connect the two super folds. What is more, in our sequence-based comparisons, we 
not only detected homology between the (βα)8-barrel and flavodoxin-like fold. 
Moreover, we also found homologous fragments among many more alpha/beta folds 
Among the other folds that turned out to be related with our starting folds, there was 
an interesting scaffold widely used in experiments of protein engineering (41): the 
Periplasmic binding protein-like I fold (PBP-like I).  
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We chose this scaffold to engineer a novel chimera and mimic how evolution could 
have generated the protein diversity we observe nowadays. The proteins that adopt the 
PBP-like I fold (figure 5) work as chemoreceptors and are very important members of 
transport systems (42). The fold consists of two similar intertwined lobes each 
composed of 3 layers (α/β/α). Each lobe displays a parallel β-sheet of 6 strands with 
order 213456 (8). The fold consists of a single superfamily of proteins.  
The ligand-binding site in the PBP-like I fold is located at the hinge region that 
connects both lobes (43). Upon ligand binding there is a notable conformational 
change. This property has been recognized and exploited by protein engineers to build 
biosensors (41). Along these lines, the ligand specificity determination, in members of 
this fold, has been studied in recent works (44) (45).  Biosensors capable of efficiently 
discriminating between similar ligands are valuable tools. 
 
Fig. 5: The leucine-binding protein is the principal receptor for the leucine 
transport system in E. coli. The fold undergoes conformational change upon 
ligand binding. The open conformation (PDB-id: 1USG), depicted on the left, 
adopts a closed conformation when leucine (black sticks) is bound in the binding 
site, on the right (PDB-id: 1USK).  Beta strands are colored in yellow while 
alpha helices are colored in red. 
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1.8 Origin and aim of my project 
 
The evolution of the (β/α)8-barrel fold has been a matter of intense debate for a long 
time, also among my former scientific advisors. Mimicking enzyme evolution, by 
generating new well-folded (β/α)8-barrels from (β/α)4-half barrels (46), shed new 
light on this exciting topic. In fact, this work drew my scientific interest and was 
pivotal for my decision to work on this project. 
 
The basic idea for my project was initially drafted by a publication that proposed a 
possible evolutionary relationship between the flavodoxin-like and (β/α)8-barrel folds 
(36).  By the time we started discussing my project, another work from our group was 
just published describing the construction of a well-folded (β/α)-barrel by combining 
fragments from flavodoxin-like and (β/α)8-barrel fold structures (37). This 
experiment was a great protein engineering achievement but left opened many 
questions on the evolution of these two super folds. The chimeric (β/α)-barrel was 
designed based solely on structural information. Therefore, neither convergent nor 
divergent evolution could be proposed as the most likely scenario. This is why I 
started an exhaustive sequence based exploration of the sequence space using the 
powerful homology detection tools developed in house. My aim was to detect 
sequence-based evidence for the relationships within and between the two folds and 
to identify and experimentally characterize possible sequence intermediates. Our 
initial findings prompted us to expand the original project by comparing more folds to 
find related fragments that could be combined into novel chimeric constructs. 
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2. Materials and methods 
 
2.1 Materials  
 
Chemicals 
 
Beta mercaptoethanol Brand = Carl ROTH® 
Formula = C2H6OS  
MW = 78.13 g/mol 
Purity = 99% 
Ethanol Brand = Carl ROTH® 
Formula = C2H6O  
MW = 46.07 g/mol 
Purity 99.9% 
Guanidine 
hydrochloride 
Brand = Carl ROTH® 
Formula = CH5N3 * HCL 
MW = 95.53 g/mol 
Purity = 99.5% 
Hydrochloride acid Brand = Carl ROTH® 
Formula = HCL 
WW = 36.46 g/mol 
Purity = 37% 
Imidazole Brand = Carl ROTH® 
Formula = C3H4N2 
MW = 68.08 g/mol 
Purity = 99% 
IPTG Brand = Sigma-Aldrich ®  
Formula = C9H18O5S 
MW = 238.30 g/mol 
Purity = 99% 
PEG  Brand = Carl ROTH® 
Formula = NA 
MW = 380-420 g/mol 
Sodium cacodylate  Brand = Sigma-Aldrich ® 
Formula = (CH3)2AsO2Na · 
3H2O MW = 214.03 g/mol 
Sodium chloride  Brand = Merck Millipore® 
Formula = NaCl 
MW = 58.44 g/mol 
Purity = NA 
Sodium hydroxide Brand = Brand = Carl 
ROTH® 
Formula = NaOH  
MW = 40.01 g/mol 
Purity = 44 – 46% 
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Enzymes 
 
Restriction enzymes 
 NdeI (Thermo scientific) 
XhoI (Thermo scientific) 
DNA-polymerases 
 Taq DNA-polymerase (Thermo scientific 
Q5 DNA-polymerase (NE BioLabs®) 
DNA-ligase   
 T4 DNA-ligase (NE BioLabs®) 
 
Bacterial strains 
 
Top10TM (Invitrogen) 
 Escherichia coli   
mrcA, ∆(mrr-hsdRMS-mcrBC), ∆lacX74, deoR, recA1, araD139∆ 
(ara- leu)7697, galK, rpsL, endA1, nupG 
ArcticExpressTM (Stratagene) 
 Escherichia coli 
 B F-ompT hsdSB (rB−m−B) dcm+ Tetr gal endA I [cpn10 cpn60  
Gentr] 
BL21 (DE3) 
 Escherichia coli 
huA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS λ DE3 = λ 
sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
 
 
 
 
Agarose gel electrophoresis  
TAE-buffer (50x) 2 M Tris pH 8.5, 1 M HCL, acetic acid, 50 mM EDTA 
Agarose gel 
solution 
1% agarose in TAE-buffer 
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Buffers and solutions 
 
Acrylamide gel electrophoresis 
SDS-buffer 25mM Tris, 0.1 % SDS, 200mM Glycine 
SDS-PAGE stacking 
gel buffer 
0.5M Tris-HCl pH 6.8, 0.4% SDS 
SDS-PAGE 
separation gel buffer 
1.5M Tris-HCl pH 8.8, 0.4% SDS 
SDS-PAGE staining 
solution 
0.2% coomassie G250 and R250, 50% ethanol, 10% glacial acid 
SDS-PAGE loading 
buffer (2x) 
10% glycine, 5% β-mercaptoethanol, 2% SDS, 0.01% bromophenol blue, 
1.25M Tris-HCl pH 6.8 
Nickel affinity chromatography 
Buffer-A 50 mM TRIS pH 7.4, 150 mM KCl, 2 mM β-mercaptoethanol 
Buffer-B 50 mM TRIS pH 7.4, 150 mM KCl, 500 mM Imidazole 
2 mM beta mercaptoethanol 
Gel filtration-buffer 
 50 mM TRIS pH 7.4, 300 mM KCl, 2 mM β-mercaptoethanol 
Circular dichroism 
 20 mM Tris pH 7.5 
Refolding  
R1-buffer 50mM Tris pH 7,5, 6 M guanidine hydrochloride, 300 mM KCl 
R2-buffer 50mM Tris pH 7,5, 1 M guanidine hydrochloride, 300 mM KCl 
R3-buffer 50mM Tris pH 7,5, 2 M guanidine hydrochloride, 300 mM KCl 
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Media 
 
     Luria-Bertani Medium 
     LB-medium 10 g peptone from bacteria, 5 g yeast extract, 5 g NaCl, water to  
1 L, autoclaved 
 
Crystallization screenings were acquired from QUIAGEN® 
 
 
Instruments 
   
Centrifuges 
Bench centrifuge Biofuge table centrifuge 5425 (Eppendorf) 
Middle size 
centrifuge 
Centrifuge 5810R (Eppendorf) 
Ultracentrifuge Avanti J-26xPI (Beckmann Coultier) 
Purification columns 
Nickel affinity 
chromatography 
HisTrap HP column, 5 mL Ni Sepharose (GE Healthcare) 
Preparative gel 
filtration 
Superdex S75 GL (GE Healthcare) 320 mL V0 
Superdex S200 GL (GE Healthcare) 320 mL V0 
Analytical gel 
filtration 
Superdex S75 GL (GE Healthcare) 25 mL V0 
Superdex S200 GL (GE Healthcare) 25 mL V0 
Ion exchange 
chromatography 
ResourceTM Q N0.520373 (6mL) 
FPLC instruments 
Affinity 
chromatography and 
analytical gel 
filtration 
Aekta P900 (GE Healthcare) 
 Aekta Prime (GE Healthcare) 
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Instruments for biophysical Characterization 
Circular dichroism J-810 CD-spectrometer (Jasco) 
Fluorescence 
analysis 
FP-6500 fluorescence-spectrometer (Jasco) 
Scales 
Fine scale ALS120-4 (Kern) 
Bench scale 572 (Kern) 
Thermocycler 
  MyCycler ThermocyclerTM (BioRad)  
 T3000 Thermocycler (biometra) 
Others 
Nanodrop ND-1000 Nanodrop (Peqlab ®) 
pH-meter pH211 microprocessor pH meter (Hanna Instruments ®) 
UV-lamp UV fluorescent table model ECX-20M (Peqlab ®) 
Aekta superloop Superloop 50mL (GE Healthcare) 
Dialysis membranes Spectra/Pore® 3.5 kDa with glycerol 
Shaking incubator INOVA® 44 incubator (New Brunswick Scientific) 
Sonicator Bandelin HD 3100 (Sonoplus) 
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2.2 Summary of experimental methods 
 
We experimentally tested 25 proteins in the laboratory. 20 proteins were targeted 
because they showed sequence similarities towards flavodoxin-like and (β/α)8-barrel 
structures. Our primary goal was to characterize the structures of these proteins. For 
NTM0182 we determined the structure by X-ray crystallography.  
Five proteins were different versions of the chimeric construct LBP-CheY. Here, our 
primary aim was to evaluate if the proteins were well folded. Subsequently, we aimed 
to generate an atomic model of the chimera. However, no crystals of enough quality 
to determine the structure could be obtained.  
 
A detailed description of the methods related to NTM0182 is provided in the next 
section. The methods applied to the rest of the proteins are summarized in table 1.  
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Table 1: Proteins experimentally tested in this work. The headers of the columns 
are the methods applied to each protein listed in the first column. The first 19 
proteins are intermediate candidates. The last five proteins are chimeric 
constructs (see section 8.3 from appendix for details). A symbol (✓) indicates 
that the method was successful and a (X) symbol denotes the contrary.  
 
 
 
 
Gene assembly: genes were assembled with overlapping primers 
Purchased plasmid: genes bought from commercial supplier (47) 
PCR: gene was obtained by PCR from genomic DNA 
BL21: expression performed in E. coli strain BL21 (DE3)    
ArticExpress: expression performed in ArticExpress system 
NiAC: nickel affinity chromatography 
SEC: size exclusion chromatography 
IEC: Ionic exchange chromatography 
Refolding: the protein was refolded from inclusion bodies 
Crystallization: A crystallization screening was set up.  
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TM02   ✓ ✓  ✓ ✓   ✓ 
CM01  ✓  ✓ ✓  ✓  ✓  
CM02   ✓ ✓ ✓  ✓  ✓  
SS01   ✓ ✓ ✓    X  
SS02   ✓ ✓ ✓    X  
SS03   ✓ ✓ ✓    X  
PC01  ✓  ✓  ✓     
PC02   ✓ ✓  ✓     
PC03   ✓ ✓  ✓     
PC04   ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
PC05   ✓ ✓  ✓     
PC06   ✓ ✓  ✓     
HI01 ✓   ✓ ✓    X  
CB01 ✓   ✓ ✓  ✓  ✓  
CB02   ✓ ✓ ✓  ✓    
CT01 ✓   ✓  ✓   X  
OB01  ✓  ✓ ✓    X  
OB02   ✓ ✓     X  
SM01   ✓ ✓  ✓    X 
LBP-CheY01   ✓ ✓ ✓ ✓ ✓ ✓ ✓ X 
LBP-CheY02   ✓ ✓  ✓ ✓ ✓ ✓ X 
LBP-CheY03   ✓ ✓  ✓ ✓ ✓ ✓ ✓ 
LBP-CheY04   ✓ ✓  ✓ ✓ ✓ ✓ ✓ 
LBP-CheY05   ✓ ✓  ✓ ✓ ✓ ✓ ✓ 
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2.3 Cloning methods 
 
21 variants of intermediate sequences and 5 versions of the LBP-CheY chimera were 
experimentally tested in this work. All constructs were cloned in the vector pET-21a-
d(+) from Novagen®. The restriction sites used were XhoI (site 158) and NdeI (site 
238). The list of sequences, primers and special remarks about the cloning are 
provided in appendix section 8.3. In the following tables we describe the common 
reactions for PCR amplification, digestion, ligation, colony PCR and sequencing for 
the cloned variants: 
 
Table 2: Polymerase chain reaction mix 
Reagent Volume Final concentration 
Q5® reaction buffer (NE 
BioLabs®) 
10 1x 
dNTPs (Eurogentec®) 1 10 mM 
Forward primer 2 10 mM 
Reverse primer 2 10 m0 
DNA template (plasmid or 
genomic DNA) 
0.5 ~50 ng 
Q5® high-fidelity DNA 
polymerases (NE BioLabs® inc) 
1 2u/µl 
H2O 32 
 
Total volume 50 
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Table 3: Polymerase chain reaction cycles 
Degrees (Celsius) Time Cycles 
95  60 sec. 1 
95 
65 (variable temperature) 
72 
10 sec. 
30 sec. 
20 sec. 
 
30 
72 5 min. 1 
 
Table 4: Digestion of plasmids and PCR products. 
Reagent 
Volume µl Final concentration 
NdeI (Thermo scientific) 100% 
activity 1 1.0 U 
XhoI (Thermo scientific)  
50-100% activity 1 1.0 U 
DNA template 40 ~ 1 µg 
Buffer O (orange) 5 1x 
H2O 3 
 
Total volume 50 
 
The DNA is incubated overnight at 37 °C. 
  
Table 5: DNA ligation reaction. 
Reagent 
Volume µl Final concentration 
T4 ligase (NE BioLabs®) 
1.5 1.5 U 
DNA insert (variable) 
2 (variable) ~ 50 ng.  (variable) 
DNA vector (variable) 10 (variable) ~ 500 ng. (variable) 
T4 ligase buffer (NE 
BioLabs®) 
2 1x 
H2O 4.5 
 
Total volume 20 
 
The DNA is incubated overnight at 4 °C. 
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Table 6: Polymerase Chain Reaction from colony. 
Reagent Volume µl Final concentration 
10 x Taq Pol buffer  2 1x 
dNTPs (Eurogentec®) 2 200µM (each Nucleotide) 
Forward primer 1 1 m 
Reverse primer 1 1 m 
Taq DNA polymerase 2 2u/µl 
H2O 
  
Total volume 20 
 
 
 
Table 7: DNA sequencing reaction 
Reagent Volume µl Final concentration 
DNA plasmid  1 50 ng. 
BDT-Mix 0.5 1x 
Sequencing primer 1 1 m 
Sequencing buffer 2 1x 
H2O 5.5 
 
Total volume 10 
 
 
Gene assembly of intermediate candidates 
Three intermediate candidates were synthetized by assembling alternating primers. 
The method employed in this work is a variation of the methodology outlined in the 
following publication: “ Simplified gene synthesis: A one-step approach to PCR-
based gene construction” (48). Basically, it is necessary to try different 
oligonucleotides concentrations but always adding the external set of primers at much 
higher (10x) concentration than the internal set. By this, we ensure that the full 
product is amplified.  
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Gene purchasing  
Three intermediate candidates were purchased from “Mr. Gene” a company 
specialized in gene synthesis. Mr. Gene was founded in late 2006 and later was 
bought by life technologies® (47). The specialized service was renamed as: 
GeneArt®. The constructs can be optimized for E. coli expression and restriction sites 
are also engineered. Upon digestion it is possible to sub-clone the construct in an 
expression vector.  
 
PCR assembly of LBP-CheY chimeras  
The Leucine Binding Protein, from Escherichia coli, was assembled from genomic 
DNA using the following primers in a standard PCR reaction:  
 
Primers: “FA_fwd” and “FC_K_rev”  
Template: Genomic DNA  
 
The sequence annotated in the NCBI database had a mutation when compared with 
the crystal structure sequence. We cloned the protein following the sequence 
associated with the PDB structure (with the K instead of the T). See appendix section 
8.3 for details. The region from the Response regulator CheY (Thermotoga maritima) 
that was inserted in the LB-CheY chimera was amplified from a plasmid kindly 
donated by Dr. Simone Eisenbeis using the following primers:  
 
Primers: “FB_fwd” and  “FB_rev”  
Template: Plasmid pET21-CheYWT  
 
 
LBP-CheY-01 assembly  
Five reactions were needed to build the chimeric construct: 
Reaction 1:  fragment A (N-terminus region LBP)  
Primers: “FA_fwd” and “FA_rev” 
Template: pET21-LBP 
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Reaction 2:  fragment B (CheY region)  
Primers: “FB_fwd” and “FB_rev”  
Template: pET21-CheYWT  
 
Reaction 3: fragment C (C-terminus region LBP) 
Primers: “FC_fwd” and “FC_K_rev”  
Template:  pET21-LBP 
 
Reaction 4: join fragments A and B.  
Primers: “FA_fwd” and “FB_rev” 
Templates:  fragments A and B 
 
Reaction 5: join fragments AB and C 
Primers: “FA_fwd” and “FC_K_rev” 
Templates: fragments AB and C  
 
 
LBP-CheY-02 assembly 
 
The construction of chimera LBP-Che-02 was identical to the method followed for 
LBP-Che-01 but the fragments (reactions2 and 3) B and C were built using different 
primers to introduce the extra K: 
 
Reaction 2:  fragment B (CheY region)  
Primers: “FB_fwd” and “FB_K_rev”  
Template: pET21-CheYWT  
 
Reaction 3: fragment C (C-terminus region LBP) 
Primers: “FC_K_fwd” and “FC_K_rev”  
Template:  pET21-LBP 
 
 
LBP-CheY-03 assembly 
 
The chimera LBP-Che-03 only had the 6X His Tag removed by PCR:  
 
Primers: “FA_fwd” and “chimera-lbp-chey-c-ter-A344>K” 
Template: pET-LBP-CheY-02 
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LBP-CheY-04 assembly 
 
New primers were used to change the residues at the interfaces of the fragments from 
both folds.  
Reaction 1:  fragment A (N-terminus region LBP)  
Primers: “FA_fwd” and “FA_I_rev” (change this in list of appendix) 
Template: pET-LBP-CheY-02 
 
Reaction 2:  fragment B (CheY region)  
Primers: “F_B_I_fwd” and “F_B_MTV_rev”  
Template: pET-LBP-CheY-03 
 
Reaction 3: fragment C (C-terminus region LBP) 
Primers: “F_C_MTV_fwd” and “FC_K_rev”  
Template:  pET21-LBP 
 
The rest of the reactions are the same than previous versions 
 
LBP-CheY-05 assembly 
 
Three reactions are needed.  
Reaction 1:  fragment A (N-terminus region LBP)  
Primers: “FA_fwd” and “RV_mid-LBPCHEY_version10”  
Template:  pET21-LBP-CheY-03 
 
Reaction 2:  fragment LBP-C 
Primers: “FW_mid-LBPCHEY_version10” and “chimera-lbp-chey-c-ter-A344>K”  
Template:  pET21-LBP-CheY-03 
 
Reaction 3:  join both fragments 
Primers: “FA_fwd” and “chimera-lbp-chey-c-ter-A344>K”  
Template:  Fragment A and LBP-C  
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Gel extraction.  
All digested PCR fragments and vectors were loaded onto an agarose gel 1%. Desired 
bands were cut with a sterile razorblade. The purification was performed according to 
the protocol in QIAquick gel extraction kit of QIAGEN®. Elution volumes ranged 
from 500 ml to 50 ml according to the concentration observed on the gel.   
 
Transformation 
The tubes with competent cells were thaw on ice. We add ~50ng (ligation: 10-15µl) 
of DNA to the cells and let it sit on ice for ~15min. Heat shock the cells for 45sec. 
(ArcticExpressTM cells: 20sec.) at 42°C. Put them back on ice for ~10 min. Add 900 
µL of LB media (no antibiotics) to the cells and incubate them for 1h at 37°C. Plate 
out 100µL on LB-agar plates (ligation: spin down the cells at 4000rpm for 10 min and 
resuspend the pellet in a little bit of supernatant; plate out all the solution).  
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2.4 Heterologous Expression  
 
The protocol outlined here has to be implemented after transformation:  
 
• Pick some colonies from a freshly transformed plate  
• Start an overday culture using Luria-Broth (LB) media (5ml)  
• Start and overnight culture (+AB) 50mL LB  
• The next day inoculate 2L LB (+AB) with the 20mL of O/N-culture 
• Grow at 37°C (this can be also at 20, 25 or 30 °C) until the OD600 is ~0,7 
• Induce the cells by adding isopropyl-β-thiogalactoside  (IPTG) to a final 
concentration of 1 mM 
• Allow growth for 4h at 37°C or longer at lower temperatures (up to 24 hrs. at 
20 °C)  
• Harvest the cells by centrifugation (4000rpm, 15 min, 4°C) 
• Take off the supernatant and resuspend the pellet in 20-50 mL buffer  
• Centrifuge again (4000 rpm, 15 min, 4°C) 
• Resuspend the pellet in 20-50 mL buffer and add protease inhibitors (Protease-
Inhibitor Mix HP, Serva). 
• Sonicate the cell suspension (40% amplitude, 10 min [0.1sec pulse on, 0.9sec 
pulse off] or 5 min [0.2sec pulse on, 0.8sec pulse off])  
• The resulting homogenate should be centrifuged (18000 rpm, 40 min, 4°C). 
• Filter the supernatant homogenate with 0.22 µM filter before proceeding to 
any purification protocol 
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ArcticExpress heterologous expression system 
The overall protocol is similar to the BL21 (DE3) expression but with the following 
differences:  
 
• Transform as previously indicated (but pulse of 20 sec.) the competent cells 
with the protein expression plasmid, using a 37°C cultivation temperature. 
• Pick several transformants and grow overnight cultures in medium containing 
gentamycin and antibiotic for selection of the expression plasmid at 37°C. 
• Grow the cells without antibiotic selection for 3 hours at 30°C. 
• Induce expression of the protein with IPTG at 10–13°C, and continue growth 
after induction at 10–13°C for 24 hours (or more)  
• Analyze protein expression in induced cultures and non-induced controls by 
SDS-PAGE. 
 
Refolding  
 
• Take the pellet after sonication (coming from an expression protocol) and 
resuspend it in 10 mL 6M guanidine hydrochloride (GdHCl) 
• Let it stand for 60 min at 4°C (cold room)  
• Add 10mL 1M GdHCl and mix it by swiveling it gently (this is important)  
• Let it stand for 60 min at 4°C 
• Centrifuge (18000rpm, 60 min, 4°C), afterwards the protein is in the 
supernatant.  
• Take the supernatant and add 2M GdHCl to a final volume of 50mL (a falcon 
tube can be used)  
• Dialyze against 3 x 5L of buffer and continue with further purification steps. 
Diverse additives could be used during the refolding procedure.  
  
 28 
2.5 Purification protocols 
 
Table 8: Buffers employed with the proteins experimentally tested in this work.  
 
Buffer Method Contents Protein variants  
A 
 
NiAC 50 mM TRIS 
pH 7.5 
150 mM KCl 
 2 mM β-
mercaptoethanol  
 
 
50 mM NaCl 
10 mM Tris pH 7.6 
All variants  
(Except LBP-CheY 
variants) 
 
 
 
 
LBP-CheY variants 
 
B NiAC 1 M imidazole 
50 mM TRIS 
pH 7.5 
150 mM KCl 
 2 mM β-
mercaptoethanol  
 
50 mM NaCl 
10 mM Tris pH 7.6 
500 mM Imidazole 
All variants  
(Except LBP-CheY 
variants) 
 
 
 
 
LBP-CheY variants 
 
 
SEC SEC  50 mM TRIS  
300 mM KCl 
pH 7.5 
2 mM β-
mercaptoethanol  
TM01, TM02, 
CM01, CM02 
SM01 
LBP-CheY variants 
 
Sample  CD spectra 20 mM Tris pH 7.5 
10 mM Tris pH 7.4 
TM01 
CM01 
LBP-CheY variants 
Lysis  BL21 (DE3) 
Expression  
AEX expression 
50 mM TRIS  
150 mM KCl 
pH 7.5 
All variants 
Sample  Fluorescence 
spectroscopy (FS) 
20 mM Tris pH 7.5 
100 KCl 
10 mM Tris pH 7.6 
300 mM NaCl 
TM01 
 
 
LBP-CheY variants 
Potassium 
phosphate buffer A 
IEC KP 100 mM  
pH 6.8 
PC04 
Potassium 
phosphate buffer B 
IEC KP 100 mM 
KCl 500 mM  
pH 6.8 
PC04 
SEC SEC KP 100 mM 
KCl 300 mM  
pH 6.8 
PC04 
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Buffer Method Contents Variants  
A NiAC, SEC  10 mM β-
mercaptoethanol  
50 mM HEPES 7.5 
10 mM Cl2Mg 
300 mM KCl 
PC04 
B NiAC 10 mM β-
mercaptoethanol 
50 mM HEPES 7.5 
500 mM Imidazole 
10 mM Cl2Mg 
300 mM KCl 
PC04 
Sample  Light Scattering 50 mM TRIS  
300 mM KCl 
pH 7.5 
TM01 
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NiAC: Nickel Affinity Chromatography 
 
We follow the protocol published elsewhere (49) First we lyse the cells that are 
expressing the tagged protein by sonication on ice or French press. We used different 
lysis buffers for different variants (table 8). Approximately 3–5 mL of loading buffer 
should be used per gram (wet weight) of cells. Keep the lysate as cold as possible to 
minimize protein degradation. 
 
The protein sample was loaded onto a 5 mL nickel column (HisTrap HP Sepharose 
GE Healthcare) previously equilibrated with 50 mL of buffer A. The target protein 
was eluted with an imidazole gradient. We collected the fractions that showed the 
highest concentration of recombinant protein. The samples must be analyzed by SDS-
PAGE.  
 
IEC: Ionic exchange chromatography  
 
We applied a modify version of the protocol outlined elsewhere (50). The protein 
sample should not contain any salt. The sample can be dialyzed against the 
equilibration buffer for the column. The protein sample was then loaded onto a 6 mL 
ResourceTM column via the injection loop. Later, the column is washed with at least 5 
column volumes) of starting buffer or until baseline is reached. The protein is then 
eluted with 10–15 column volumes of a salt gradient.  
 
SEC: Size exclusion chromatography 
 
We used the method described elsewhere (51). The sample has to be pre-purified with 
another method. It is not recommended to inject crude extract into a gel filtration 
column. Importantly, the sample should be dialyzed against gel filtration buffer and it 
must be filtered through a 0.22-µm protein-compatible filter. It is necessary to avoid 
air bubbles that will end up in the top of the column. The sample is loaded via an 
injection loop and eluted with at least one column volume of buffer.  
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2.6 NTM0182 methods 
 
Since we performed a full experimental characterization of NTM0182, that includes 
structure determination, we outline detailed methods related with this variant. 
NTM0182 carries a His6-tag at its C-terminus; it was produced in E. coli BL21 (DE3). 
The cells were grown at 37°C in Luria-Broth supplemented with 100 µg/mL 
ampicillin for maintenance of the plasmid. At an OD600 of 0.6, adding isopropyl-β-
thiogalactoside to a final concentration of 1 mM induced expression, and growth was 
allowed for another 15 h. NTM0182 was mainly found in the soluble fraction of the 
cell extract and purified from this fraction. Cells were harvested by centrifugation, 
washed with 50 mM Tris (pH 7.5), 150 mM KCl, and centrifuged again.  
 
The cells were resuspend in 20 mL of same buffer, and protease inhibitor was added 
in standard 1x concentration (Protease-Inhibitor Mix HP, Serva). The cells were lysed 
by sonication (Branson Sonifier W-250, 6 × 1.0 min, Output 5, 50% pulse, on ice), 
and the resulting homogenate was centrifuged (18000 rpm, 40 min, 4°C). The 
supernatant was filtered and loaded onto a NiNTA column (Amersham Pharmacia) 
equilibrated with 50 mM Tris (pH 7.5), 150 mM KCl. The protein was eluted with an 
increasing concentration of imidazole.  
 
Fractions with the highest content of protein were dialyzed extensively against 50 
mM Tris (pH 7.5), 300 mM KCl and then loaded onto a Superdex 75 HiLoad 26/60 
column (320 mL, Amersham Pharmacia), which was equilibrated with the same 
buffer. Elution was performed at a flow rate of 2.0 mL/min. The protein eluted mainly 
in two well-differentiated peaks, which were collected and treated independently.  
 
Analytical Methods 
Purification of the proteins was evaluated by electrophoresis on 15% polyacrylamide 
gels, using the system of Lämmli (52) and staining with Coomassie blue. Protein 
concentrations were determined by using molar extinction coefficients calculated 
from the amino acid sequence. Analytical gel filtration was performed by using a 
calibrated Superdex 75 10/300 GL column (Amersham Pharmacia) and was coupled 
to a light scattering device for subsequent analysis.  
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Multiangle static laser light-scattering experiments (MALLS) were done online with 
analytical size-exclusion chromatography using miniDAWN TREOS and Optilab rEX 
instruments (Wyatt Technologies) and the associated software (AstraV) for molecular 
weight determination; the method was published elsewhere (53). The protein (0.3 
mg/ml) was eluted at a flow rate of 0.8 ml/min in 50 mM Tris, 300 mM KCl (pH 7.5) 
and the apparent size of the two peaks was analyzed both by size exclusion and 
dynamic light scattering. CD spectra were recorded with a JASCO model J-810 
spectropolarimeter. Fluorescence measurements were carried out with a JASCO FP-
6500 spectrofluorometer. The measurements were performed in 50 mM Tris and 300 
mM KCl (pH 7.5) at room temperature. 
 
Crystallization trials (8 screenings, 96-well plates) were set for both oligomerization 
probes from native NTM0182.  No crystals were obtained for the monomeric 
NTM0182. Small needle-like crystals were obtained with the dimeric NTM1082 and 
further refined by the hanging drop vapor diffusion method at 18°C. Drops contained 
1.5 µl of the protein solution (11.37 mg/mL) mixed with 1.5 µl of 0.1 M HEPES at 
pH 7.5 with 1.2 M ammonium sulfate and 0.3 M NaCl, and were equilibrated against 
500 µl of reservoir buffer. After short transfer into crystallization buffer with 25% 
glycerol, the crystals were flash frozen in liquid nitrogen. Soaking of crystals was 
performed with Potassium tetra-cyano-platinate (II) hydrate [K2Pt(CN)4 • xH2O;  
Mw: 377.36].  Derivative crystals were washed using crystallization buffer with 25% 
glycerol; afterwards the crystals were flash frozen in liquid nitrogen. Data was 
collected at the synchrotron beamline PXII (Swiss Light Source, Villigen PSI) at 
100K, and 0.5 oscillation degrees (images) were recorded on a PILATUS 6M 500-
mm detector. Native and derivative platinum crystals were measured at a wavelength 
of 1.0000 and 1.0698 Å, respectively. Data were indexed, integrated, and scaled with 
XDS and XSCALE and converted with XDSCONV (54)  
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Heavy atom detection in derivative crystals was done using SHELX (55). Two sites 
were unambiguously detected via a SAD protocol (56). The unit cell dimensions 
between the native and two derivative crystals were too big to perform single 
isomorphous replacement.  Heavy atom model refining (on the two detected platinum 
sites), phasing and density modification (using the programs DM and SOLOMON) 
was performed using SHARP (57). We combined the data from the two platinum 
soaked crystals in a single SAD experiment (via the SHARP interface) in order to 
achieve enough phasing power to produce an initial experimental map. After density 
modification and solvent flipping the map showed clear density for α-helices and β-
sheets. An initial model was built using a combination of Phenix (58) (to find helices 
and strands) and Buccaneer (59) (for fast chain tracing) in command line version. Non 
Crystallographic Symmetry (NCS) was used to build six chains into the asymmetric 
unit taking as starting molecule chain A. Model building was performed with the 
program COOT (60).  
 
Initial refinement was done under NCS, Ramachandran, and experimental phase 
restraints with Phenix refine. Intermediate refinement rounds were performed with: 
ZYX coordinates, group B factors (a single b-factor per residue), TLS parameters and 
anomalous groups. Final refinement resulted in Rcryst and Rfree values of 24.6% and 
28.8%, respectively.  
 
2.7 Bioinformatic analysis 
 
Sequence comparisons. 
The sequence based comparisons between the (βα)8-barrel fold structures (SCOP id 
c.1) and flavodoxin-like fold structures (SCOP id c.23) were performed with 
HHsearch (33) The software provides a library of Hidden Markov Models 
representing all the structures in SCOP70 and SCOP95  (Structural Classification of 
Proteins and ASTRAL releases 1.75 and 1.75B (the later from January 2013). We 
extracted all models representing all α/β fold profiles and used them as queries to 
search the entire SCOP95 database of models. Afterwards we filtered the (βα)8-barrel 
and flavodoxin-like fold outputs (890 profiles).   
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The comparisons for all the alpha folds were done with a previous version of SCOP 
(SCOP70). Only the comparisons for (βα)8-barrel fold structures (SCOP id c.1) and 
flavodoxin-like fold structures (SCOP id c.23) were performed using SCOP95.  
 
We used default parameters; however, we did not score secondary structure alignment 
to avoid biases introduced by the highly similar secondary structure content of the  
folds. High probability hits were recorded at three arbitrary cutoffs:  100-80 b) 79.9-
60 c) 59.9-40 
 
Identification of the intermediate sequences 
HHsenser was used to perform remote homologous searches (parameters: Database= 
nr + environmental, Extension of the seed=50, PSI-BLAST E-value threshold=1e-3, 
Minimal coverage PSI-BLAST hits=20, Use clustered database=No, Terminate 
search=5000 sequences found, Prescreen for structural domains=No, using as queries 
the sequences from several flavodoxin-like (e.g. PDB’s: 1I9C, 2YXB, 1TMY) and 
(βα)8-barrel fold structures (e.g. 3IGS, 1THF and 1ZFJ). From each search around 
3500 homologous hits were collected. The hits were merged and fed to the clustering 
program CLANS with which 5000 rounds of clustering were performed. Finally, a 
visual inspection of the cluster map allowed the identification of sequences that link 
clusters from different folds, or that were clearly located between them, at an 
astringent P-value (1.0E-10). 
 
Structural superpositions guided by profile-profile sequence alignments: HHpred 
searches were started with default parameters (web version) using the sequences of 
the aligned structures as queries in order to generate profile-profile pairwise sequence 
alignments among these proteins. The sequence alignments were then used as guides 
to structurally superimpose the three proteins using the software PDBefold (61)  
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Homology modeling and Rosetta relaxation runs of LBP-CheY chimeras 
We submitted the sequence of the chimeric proteins to the HHpred (62) server to 
obtain an alignment and prepare the input file for the Modeller (38) job. We then edit 
the alignment as shown in appendix (8.2 section). We ran modeler in the web server 
to produce the homology model.  
 
This model was used as input for Rosetta relax (63). We also use the PDB structures 
from LBP (1USK and 1USG) and CheY (1TMY) to perform relaxation and get initial 
energies per residue. Per every variant tried in this work we generated 100 structures, 
and averaged the top best in terms of Rosetta energy units. To perform the above 
mentioned protocol we wrote a python script that process the output file “score.sc” 
taking the column that corresponds to the total score per structure.  The total score per 
structure is the total contribution of energy per residue. The script outputs the top five 
models from the run in terms of rosetta energy units. We afterwards averaged the 
energy of the top five structures. The idea is to compare the energy per residue of the 
parental structures and the respective energies in the new chimeric context. Residues 
with unusually high energies might indicate problematic areas that can be visualized. 
This could represent a problematic area that may prevent the protein to reach a native-
like folded conformation.  
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3. Results 
 
3.1 (βα)8-barrel fold evolutionary relationships 
The common evolutionary origin of the (βα)8-barrel fold has been a matter of intense 
debate over the past decades. Our first goal was to generate an updated overview of 
the relationships that could be detected with state of the art tools for homology 
detection. Therefore we performed pairwise profile-profile comparisons using the 
sequences of the structures classified in the Structural Classification Of Proteins 
(SCOP). We worked at the superfamily level of classification given that members of 
the same superfamily are believed to share a common evolutionary origin. There are 
defined 33 homologous superfamilies that adopt the (βα)8-barrel fold. Previously, the 
hypothetical monophyletic origin of the fold has been extensively studied in two 
works (30, 31).  
Now, through profile Hidden Markov Model (HMM) comparisons, we not only 
confirm previous findings, but we also found evidences of common ancestry among 
additional (βα)8-barrel fold superfamilies. The sequence based comparisons between 
the (βα)8-barrel fold structures (SCOP id c.1) and flavodoxin-like fold structures 
(SCOP id c.23) were performed with HHsearch. We used default parameters; 
however, we did not score secondary structure alignments to avoid biases introduced 
by the similar secondary structure content of both folds. Hits were recorded from 100 
to 20 percent HHsearch probability. The score is as Bayesian posterior probability, 
which represents the level of certainty to a potential outcome. This kind of likelihood 
is a different interpretation of the concept of chance and belongs to the category of 
evidential probabilities. The frequentist probability in contrast, defines an event's 
probability as the limit of its relative frequency in a large number of trials. An event 
with Bayesian probability of 0.6 (or 60%) should be interpreted as stating "with 
confidence 60%, this event contains the true outcome", whereas a frequentist 
interpretation would view it as stating "over 100 trials, we should observe event X 
approximately 60 times (64)”.  
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In agreement with previous studies, 30 of 33 SCOP homologous superfamilies 
showed pairwise connections at a better probability of 80 percent; see figures 6, 9 and 
10 for details. The probability graph in figure 6 is not perfectly symmetrical due to the 
intrinsic properties of the HMMs. For any given pairwise profile comparison between 
two superfamilies, the recorded probabilities lie in the range of 20 to 100 percent and 
the hits can be bidirectional or unidirectional. It is intuitively assumed that 80% 
bidirectional probability hits will more likely indicate common ancestry than 20 % 
unidirectional hits.  
 
Fig. 6: Pairwise profile-profile sequence comparison of (βα)8-barrel 
superfamilies. The query superfamilies are listed at the edges using the specific 
superfamily identifiers as labels. The label prefix: c.1 (class α/β and (βα)8-barrel 
-barrel) was omitted for clarity. Each column indicates which other (βα)8-barrel 
fold superfamily from the dataset is detected by HMM-HMM in a probability 
range of 100% to 20% (100-80 dark red highlighted). 
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Let’s look at the connectivity starting from the weakest linked superfamily: the 
Monomethylamine methyltransferase MtmB superfamily (SCOP c.1.25) that only hit 
with 20% probability the Ribulose-phoshate binding barrel superfamily (SCOP c.1.2). 
The connection is not bidirectional, which means that no HMMs representing the 
Ribulose-phosphate binding barrels hit with more than 20% probability any member 
of the Monomethylamine methyltransferase MtmB superfamily. TM1631-like (SCOP 
c.1.32), NAD(P)-linked oxidoreductase (SCOP c.1.7), Malate synthase G (SCOP 
c.1.13), Bacterial luciferase-like, (SCOP c.1.16), cobalamin (vitamin B12)-dependent 
enzymes (SCOP c.1.19), tRNA-guanine transglycosylase (SCOP c.1.20) are weakly 
connected. The rest of the superfamilies were connected multiple times, with the 
phosphate binding superfamilies being the most highly connected cluster (SCOP 
c.1.1-6).  
 
Hence, our data supports a monophyletic origin for most (βα)8-barrel superfamilies. 
Our results were consistent with previous reports. The systematic comparison of the 
data was not trivial. Earlier studies were based on a combination of diverse 
approaches (PSI-BLAST, structural and functional comparisons) in order to evaluate 
the implication of the detected similarities among the (βα)8-barrel superfamilies.  In 
contrast, we only employed HMM-HMM comparisons at superfamily level. Second, 
there are major differences between the database we used in our work (SCOP) and the 
database used by Nagano and coworkers (CATH). An illustrative example of this 
problem is constituted by the structure of the catalytic domain of a thermophilic 
endocellulase (PDB code 1TML); this structure is classified in CATH as  (βα)8-
barrel, while in SCOP it is a 7-stranded β/α barrel. Finally, there are novel (βα)8-
barrel structures in PDB database and these proteins are classified in new 
superfamilies.  
 
The work from (31) is the most inclusive study of this type; therefore, we compared 
our results with their findings. To overcome the problem of using different 
classification schemes, we performed a cross association using the PDB identifiers 
listed in Nagano’s research, see table 9 for details. Our work fully recreates the 
previously observed connections. Overall in our study 30 of the 33 (βα)8-barrel 
superfamilies are connected with more than 80% bidirectional probability, (figure 6).  
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The data shown in our study strongly suggests a common origin for 30 (βα)8-barrel 
superfamilies.  Interestingly, the Aldolase superfamily (c.1.10) is the most highly 
connected hub: it hits 25 of the 33 superfamilies with a probability better than 80 %. 
Moreover, the class I aldolase family is proposed in SCOP as a possible link between 
the aldolase superfamily and the phosphate-binding (βα)8-barrels. The protein 
structures of the Cyclase domain of the imidazoleglycerolphosphate synthase HisF 
and the Phosphoribosylformimino-5-aminoimidazole carboxamide ribotite isomerase 
HisA are classified into this superfamily.  These protein structures are the most cited 
examples for the (βα)8-barrel evolution via duplication and fusion of a (β/α)4 unit.  
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Table 9: Comparison of earlier studies and the current research   
Superfamily as defined in 
(31) 
PDB identifier Previous work SCOP & ASTRAL 
identifier 
Present work 
Alanine racemase (ALR) 1BD0 Connected 
 
c.1.6.1 d1bd0a2 Connected 
Dihydropteroate (DHP) 
synthetase (DHPS) 
1AD4 Connected 
 
c.1.21.1 d1ad4b_ Connected 
 
FMN dependent fluorescent 
proteins 
1FVP Connected 
 
c.1.16.2 d1fvpa_ Connected 
 
Luciferase-like proteins 
LUCL 
1LUC 
1LUC 
Connected 
 
c.1.16.1 d1lucb_ 
c.1.16.1 d1luca_ 
Connected 
 
Seven-stranded 
glycosidases 7CEL 
1TML 
1CB2 
Not connected c.6.1.1 d1tmla_ 
c.6.1.1 d1cb2a_ 
Connected 
Phoshoenolpyruvate (PEP) 
binding enzymes (PEPE) 
1PKM 
1DIK0 
Connected 
 
c.1.12.1 d1pkma2 
c.1.12.2 d1dika 
 
Connected 
Aldolase class I family 
(ALD1) 
1NAL1 
1DHP 
1FBA 
Connected 
 
c.1.10.1 d1nal1_ 
c.1.10.1 d1dhpa_ 
c.1.10.1 d1fbaa_ 
Connected 
 
Glycosidases (GLYC) 
7-1 a-Amylase (AAMY) 
7-2 Endoglucanase (EG) 
7-3 Chitinase (CHTN) 
7-4 Chitobiase (CHOB) 
 
1AVA 1BAG 
1UOK 1CGT 
 
1BYB 1CEO 
1XYZ 1BQC 
1CTN 2HVM 
1QBA 
Connected 
 
 
 
Not connected 
Connected 
Not connected 
c.1.8.1 d1avaa2 
c.1.8.1 d1baga2 
c.1.8.1 d1uoka2 
c.1.8.1 d1cgta4 
c.1.8.1 d1byba_ 
c.1.8.3 d1xyza_ 
c.1.8.5 d1ctna2 
c.1.8.5 d2hvma_ 
c.1.8.6 d1qbaa3 
Connected 
Connected 
Connected 
Connected 
Connected 
Connected 
Connected 
Connected 
 
Triose phosphate 
isomerase (TIM)  
1TPF Connected 
 
c.1.1.1 d1tpfa_ Connected 
 
NADP-dependent 
oxidoreductase (NADO) 
1ADS 1LWI 
2ALR 
Not connected c.1.7.1 d1adsa_ 
c.1.7.1 d1lwia_  
c.1.7.1 d2alra_ 
Connected 
Connected 
Connected 
tRNA-guanine (tRNA-G) 1WKF Connected 
 
c.1.20.1 d1wkfa_ Connected 
 
Rubisco (RUB) 1RBL Connected c.1.14.1 d1rbla1 Connected 
Enolase superfamily  
(ENOL) 
1ONE 
1MDL 
Connected 
Connected 
c.1.11.1 d1onea1 
c.1.11.2 d1mdla1 
Connected 
Connected 
FMN-dependent 
oxidoreductase and 
phosphate (PP) binding 
enzymes (FMOP) 
1FCB 1GOX 
2TMD 1OYA 
1AK5 2TPS 
1UBS 1PII 1NSJ 
Connected 
Connected 
Connected 
Connected 
 
c.1.4.1 d1fcba1 
c.1.4.1 d1goxa_ 
c.1.5.1 d1ak5a1 
c.1.3.1 d2tpsa_ 
c.1.2.4 d1piia1 
c.1.2.4 d1ubsa_ 
Connected 
Connected 
Connected 
Connected 
 
Metal-dependent hydrolases 
(MHYD) 
1A4M 2KAU 
1PSC 1BF6 
Connected 
Connected 
c.1.9.1 d1a4ma_ 
c.1.9.2 d2kauc2 
c.1.9.3 d1psca_  
c.1.9.3 d1bf6a_ 
Connected 
Connected 
 
Divalent-metal-dependent 
enzymes (xylose isomerase-
like  
Proteins) (XYLL)  
1XIB 1A0D 
1QTW 
Connected 
Connected 
c.1.15.3 d1xiba_ 
c.1.15.3 d1a0da_ 
c.1.15.1 d1qtwa_ 
Connected 
Connected 
 
Aldolase class II (ALD2) 1B57 Connected c.1.10.2 d1b57a_ Connected 
Phosphatidylinositol (PI) 
phospholipase C (PIPLC) 
1GYM 
1QAS 
2PLC 
Not connected 
Not connected 
Not connected 
c.1.18.2 d1gyma_ 
c.1.18.1 d1qasa3 
c.1.18.2 
Connected 
Connected 
Connected 
Quinolinic acid 
phosphoribosyl(QAPR) 
transferase (QAPRT)  
1QPO Connected c.1.17.1 d1qpoa1 Connected 
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3.2 Flavodoxin-like fold evolutionary relationships 
 
Our analysis is the first study that explores whether the superfamilies that adopt the 
flavodoxin-like fold share a common evolutionary origin. In contrast to the observed 
superfamily connectivity pattern of the (βα)8-barrel fold, the graph in figure 7 shows 
few high probability bidirectional connections. The Precorrin-8X methylmutase 
CbiC/CobH superfamily (SCOP c.23.17) did not hit any other superfamily with more 
than 20% probability. In fact, only 8 of 15 superfamilies were connected by 80% 
bidirectional probability hits. The Class I glutamine amidotransferase-like 
superfamily is a hub that connects most of the superfamilies.  
 
 
Fig. 7: Pairwise profile-profile sequence comparison of flavodoxin-like fold 
superfamilies. The query superfamilies are listed at the edges using the specific 
superfamily identifiers as labels. The label prefix: c.23 (class α/β and flavodoxin-
like fold) was omitted for clarity. Each column indicates which other flavodoxin-
like fold superfamilies from the dataset are detected by HMM-HMM in a 
probability range of 100% to 20% (100-80 dark red highlighted). 
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In contrast to what has been shown regarding the evolutionary origin of the (βα)8-
barrel fold, little is known about the evolutionary scenario behind the flavodoxin-like 
fold superfamilies. We discovered a strongly supported sequence-based connection 
that indicates a homologous relationship between six flavodoxin-like fold 
superfamilies using profile-profile comparisons.  
 
The enzymes that belong to the Class I glutamine amidotransferase-like superfamily 
(SCOP c.23.16) remove the ammonia functional group from glutamate to transfer it 
into a specific substrate. This superfamily reveals itself as a hub connecting five other 
flavodoxin-like fold superfamilies, with more than 80% HHsearch bidirectional 
probability: CheY-like (SCOP c.23.1), Hypothetical protein MTH538 (SCOP c.23.3), 
succinyl-CoA synthetase domains (SCOP c.23.4), flavoproteins (SCOP c.23.5) and 
the B12-binding domain superfamily (SCOP c.23.6).   
 
Although the Class I glutamine amidotransferase-like superfamily was the most 
connected group of proteins, we will discuss in detail the sequence based connection 
between the response regulators (SCOP c.23.1) and the B12-binding domains (SCOP 
c.23.6) because these superfamilies were strongly related with (βα)8-barrel fold 
superfamilies, as will be discussed in the next section.  
 
CheY (one of the most studied member of the c.23.1 superfamily) is activated by 
auto-phosphorylation at a conserved aspartic acid after the recognition and binding to 
the P2 domain of CheA.  Later on, it interacts with its target FliM to trigger flagella 
movement. Finally, it becomes dephosphorylated by CheZ. In contrast, the B12-
binding domains (SCOP c.23.6) are found in proteins that perform distinct kinds of 
reactions at the cobalt carbon bond. These proteins bind B12 using a conserved 
histidine in a DXHXXG sequence. Thus, both flavodoxin-like superfamilies carry out 
very different activities although they belong to the same fold and appear to be 
related.  
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A profile-profile alignment with 113 aligned columns and 96.93 HHsearch probability 
between CheY (PDB 2PMC, from Salmonella enterica subsp. enterica serovar 
Typhimurium) and the B12-binding domain (PDB 7REQ, Methylmalonyl-CoA 
Mutase from Propionibacterium freudenreichii subsp. shermanii) revealed 10 
identical.  
 
As expected, given that both proteins have very different associated functions, no 
apparent conserved functional residues are revealed by the profile-profile alignment. 
Unexpectedly, the first beta strand is not matched in this sequence-based alignment; 
in contrast, in a pure structure-based alignment of the two proteins, the first beta 
strand is matched (97 C-alpha carbons were structural superimposed with an RMSD 
of 2.3).  This discrepancy between sequence and structure-based findings suggests 
that β1 is a late or divergent embellishment of the fold.  
 
The superposition shows a conserved proline (P706 in 7req and P110 in 2mpc) that 
seems to be important in order to build a turn from β5 to α5 in both proteins. The 
structure-based alignment also reveals that the β/α loops are longer in the B12-
binding domain than in the response regulator, probably due to functional reasons. 
7req interacts with cobalamin via key residues that are present in the above-
mentioned loops.  
 
A leucine-glycine-phenylalanine motif conserved in both proteins (located in the 
α1/β2 loop) seems to play a structural role, since no functional residues have been 
mapped there. The highly conserved histidine (that binds the cobalt of the B12 
molecule) from the B12-binding domain is in an equivalent position of a 
phenylalanine in the response regulator. Moreover, the phosphorylation site in CheY 
(ASP57) is replaced by a serine (that establishes a hydrogen bond with the nucleotide 
part of the B12 molecule) in the B12-binding domain.   
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The conserved glycine, which establishes hydrophobic interactions with the 
nucleotide part of the B12-binding domain, was aligned with a threonine in its 
equivalent position on the response regulatory protein. In contrast to the evolutionary 
scenario drawn in the barrel superfamilies, where many functional features that 
include a phosphate-binding site are linking different superfamilies, these two 
flavodoxin-like fold superfamilies show an evolutionary signal present only in the 
global profile-profile alignment. This outcome is expected, given that both 
superfamilies are performing rather different functional roles.  
 
One possible explanation for the observed sequence based similarities without any 
apparent functional connection, is that both superfamilies evolved to be specialized 
and fulfill two different functions. From this perspective, the comparison performed 
with these two superfamilies offers a simple method to discriminate between 
functional and structural important residues in protein scaffolds.  
 
3.3 Sequence-based evidences of homology between (βα)8-barrel and 
flavodoxin-like fold superfamilies.  
 
Having explored the intra-fold evolutionary relationships we then recorded the hits 
between the two folds. Figure 8 shows the results of searching the SCOP95 database 
with HMM profiles of all (βα)8-barrel (left) and flavodoxin-like fold  (right) 
structures. We plotted density of the HHsearch hits versus probability (see figure 8 
legend for details). Remarkably, when we launched a search starting with a (βα)8-
barrel query, at around 75 % probability the number of flavodoxin-like fold hits is 
comparable with the number of (βα)8-barrel fold hits (self-hits). The opposite case 
occurs around a 90 % probability cut-off. What is more, searches with flavodoxin-like 
fold queries at 75 % probability cut-off hit as much as two times more (βα)8-barrels 
than any other fold. A heat-map of the maximum probabilities reached between 
(βα)8-barrel and flavodoxin-like superfamilies is provided in figure 9. Lines are 
labeled with the SCOP identifiers and the legend indicates the color scale associated 
with a probability score.  
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We analyzed in detail the inter-fold hits to find superfamilies from the different folds 
that share a common evolutionary origin. We discovered that only two flavodoxin-
like fold superfamilies hit with more than 80% bidirectional probability a number of 
(βα)8-barrel superfamilies: the CheY-like (SCOP c.23.1) and the  B12-binding 
domains (SCOP c.23.6) (see figures 9 and 10 for details).  
 
The observation is remarkable because the flavodoxin-like fold is populated by 15 
homologous superfamilies, and only two of them showed connections with (βα)8-
barrel superfamilies. Therefore we can argue that the high probability hits between 
different folds is not only due to the high structural similarity of the flavodoxin-like 
fold with the (βα)8-barrel fold. For instance, the CheY-like (SCOP c.23.1) 
superfamily hit with 93%  (HHsearch probability) the ribulose-phoshate binding 
barrels (SCOP c.1.2). The probability with which the ribulose-phoshate binding barrel 
hit the CheY-like superfamily was 88% (see figures 9 and 10 for details). This data is 
very suggestive evidence for common ancestry of these two superfamilies. The CheY-
like superfamily hit with 94% HHsearch probability the ThiG-like superfamily. These 
enzymes are involved in the biosynthesis of thiamine and share the same phosphate 
binding site with other (βα)8-barrel superfamilies.  
 
The ThiG-like superfamily (SCOP c.1.31) hit the CheY-like (SCOP c.32.1) 
superfamily with >90% HHsearch probability. And the B12-binding domain (SCOP 
c.23.6) also hit with very high probabilities many (βα)8-barrel fold superfamilies; it 
was aligned with high (>80%) bidirectional probability to 12 (βα)8-barrel fold 
superfamilies. Some of the (βα)8-barrel fold superfamilies that are strongly related 
with the B12-binding domains are: the phosphate binding barrels, aldolases, the 
phosphoenolpyruvate/pyruvate domains, nicotinate/quinolinate PRTase C-terminal 
domain-like, and ThiG-like among others. 
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Fig. 8: The SCOP95 database represented by HMM profiles was searched with 
the HMM profiles of all (βα)8-barrel and flavodoxin-like fold structures. We 
plotted density of the HHsearch hits versus probability. Left: hits of (βα)8-barrel 
to other (βα)8-barrel (blue), to flavodoxin-like (green) and to all other folds 
(grey). Right: hits of flavodoxin-like to other flavodoxin-like (green), to (βα)8-
barrel (blue) and to all other folds (grey). 
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Fig. 9: Heat-map of the maximum probabilities reached between (βα)8-barrel 
(c.1) and flavodoxin-like (c.23) superfamilies. Lines are labelled with the SCOP 
identifiers and the legend indicates the colour scale associated with a probability 
score. 
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Fig. 10: Sequence-based exploration of all SCOP homologous groups that fold 
into the (βα)8-barrel (33 homologous superfamilies represented by blue circles) 
and flavodoxin-like folds (15 superfamilies represented by green diamonds). The 
black (intrafold hits) and red (interfold hits) edges are bidirectional HHsearch 
hits with probabilities higher than 80%. 
In figure 9 we can see many more hits between flavodoxin-like and  (βα)8-barrel fold 
superfamilies. Most of these hits were recorded with low probability, being clearly 
weaker than the connections established by the CheY and B12-binding superfamilies.  
Our analysis allowed us to identify which superfamilies from different folds are more 
closely related. The representation shown in figure 10 clearly demonstrates the strong 
sequence based relationship between the superfamilies form different folds. Together, 
our findings represent the first indication of common ancestry for these folds. Also 
show which homologous groups are located at the sequence space interface of the 
(βα)8-barrel and the flavodoxin-like fold. After finding that the two super-folds are 
related, we wanted to know how one fold could have converted into the other. 
Therefore we launched remote homologous searches to explore the vast sequence 
space that separates these two ancestral folds.  
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3.4 Searching for sequences with intermediate features between two super 
folds.  
 
Once we found sequence-based evidences for homology between the two super-folds, 
we wanted to know how one fold could have interconverted into the other. In order to 
explore this possibility, we searched the huge sequence space yielded by the recent 
mass sequencing genome projects.  
Folds can be populated by certain sequences that are compatible with them. Protein 
sequences for which there are no structural representatives can be compared with 
homologous sequences that have structures deposited in the protein data bank (PDB). 
Generally speaking, the structure or function of a novel sequence protein can be 
deduced based on homology to known proteins.  A protein sequence with unknown 
structure, which is 35% identical to another homolog that folds as a β-barrel, is very 
likely to be folded as a β-barrel as well. We theorized that by searching for 
ambiguous sequences, specifically those sequences that are equally related to 
members of a (βα)8-barrel and a flavodoxin-like structures, we would find interesting 
information on the evolution of these folds.  
It is very unlikely to find amino acid sequences that are more than 30% identical, over 
the entire polypeptide chain, to two folds simultaneously. Only some special cases are 
documented: two were engineering experiments (65, 66) to specifically explore this 
possibility and one more was identified by a stepping stone method (67).  Our 
approach is fundamentally different, since we want to systematically find natural 
sequences that can be seen as the fossil record of fold evolution.  
If we start a BLAST search with a protein sequence for which the structure is known 
to be a (βα)8-barrel we can be confident that most of the homologous hits, up to 
certain identity threshold, would also adopt a (βα)8-barrel fold. For instance, if a 
pairwise sequence alignment between protein X and Y, for which only Y has a known 
3D structure, shows that both proteins share 35% of identical residues we can then 
imply that protein X has the same fold as Y. The key point of our research is to find 
sequences that are related, but not too closely, with sequences that fold into (βα)8-
barrel and flavodoxin-like fold structures.  
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If we imagine the sequence space as an ocean, we have to sail the sequence space 
away from the (βα)8-barrel structural island towards the flavodoxin-like fold 
structural island. We wanted to solve the structure of the sequences that were located 
in the middle of our journey in order to gain structural insight on the fold change path 
between both folds.  
Once we analyzed the profile-profile pairwise comparisons we launched HHsenser 
searches using few sequences from the (βα)8-barrel and flavodoxin-like fold 
structures that are most closely related. For further work, it will be necessary to 
launch searches not only with one seed per superfamily but also many different 
starting sequences. We recognize that this is a necessary analysis, because the 
sequences from the structures in the same superfamily are highly diverse.  
 
For instance, the sequences from 1I9C, 7REQ, 1BMT and 2YXB (all protein 
structures classified into the c.23.6 superfamily, or B12-binding domains) only cluster 
together if the sequence identity among all the proteins in the cluster goes as low as 
25%.  In other words, 1I9C only shares 25% identical residues with 1BMT. For 
further work it is necessary to launch a BLAST search using the sequence from one 
B12-binding domain structure, organize the hits by sequence identity and launch 
HHsenser searches using all non-redundant hits (e.g. 1I9C and 1CCW are 98% 
identical, one has the ligand bound). By following this procedure the possibility of 
missing informative intermediate hits is reduced.  
 
I am going to explain in detail the selection procedure of some targets, illustrating the 
difficulty to outline a general systematic methodology for choosing targets. I first 
started by collecting several HHsenser outputs produced by using (βα)8-barrel and 
flavodoxin-like fold sequences as queries. By launching HHsenser, you can have 
access to different kinds of alignments, I mainly used two: a large permissive 
alignment (where many homologous hits could be found, and sometimes non 
homologous spurious hits are included) and a reduced version of the previous 
alignment (including the 100 most diverse hits).  
 51 
I used this last type of reduced alignment to build a clustering map in which two 
clusters of flavodoxin-like fold superfamilies (c.23.6 and c.23.1) are located close to 
the core of  (βα)8-barrel superfamilies. This data is not included due to the 
redundancy of the experiment.  
 
For searching the intermediate candidates I set very relaxed parameters of the 
HHsenser search engine to include as many homologous hits as possible (see methods 
for details). The sequences listed in table 10 were used as queries to launch HHsenser 
searches. 
 
 
Table 10: Selected queries to perform HHsenser searches of remote homologous 
sequences. It is listed the superfamily in which the query sequences are 
classified. 
(βα)8-barrel and Flavodoxin-like 
fold superfamilies 
Superfamily name (selected sequences) 
c.1.2 Ribulose-phoshate binding barrel (hisF, hisA, 
IGPS) 
c.1.3 Thiamin phosphate synthase (thiamine synthase) 
c.1.5 Inosine monophosphate dehydrogenase (IMPDH) 
c.1.33 EAL domain-like  
c.1.17 Nicotinate/Quinolinate PRTase C-terminal 
domain-like 
c.23.1 CheY-like 
c.23.6 B12-binding domain 
 
We searched the non-redundant and the environmental sequences databases using the 
queries indicated in table 10. HHsenser can detect thousands of homologous proteins. 
Interestingly, the searches using the sequence from CheY (Thermotoga maritima) 
produced around 22,000 hits.  
 
This is a special case of sequence-function relationship, since an infrequently high 
number of non-redundant sequences are compatible with a single fold that shows a 
narrow well defined specific function (flavodoxin-like fold, response regulator). So 
far, the sequence from CheY was the query that produced the most hits of all the 
queries tried.  
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We collected two HHsenser permissive alignments, one produced by a (βα)8-barrel 
fold query  (hisF; SCOP c.1.2, for instance) and another alignment produced by a 
flavodoxin-like fold query (CheY ;  SCOP c.23.1, for instance).  We merged them 
into a single input file to feed the clustering program CLANS.   
 
CLANS is a program implemented as a variant of the Fruchterman and Reingold 
graph layout algorithm (35) that provides representations of pairwise sequence 
similarities. Dots represent sequences in a three-dimensional map; high scoring 
segment pairs (from BLAST/PSI-BLAST) are shown as edges that connect the dots. 
Attractive forces are proportional to the negative logarithm of the high scoring 
segment pairs (HSPs) P-values. The lower the P-value the stronger the attractive 
force.  Between 3000 and 9,500 sequences composed the regular input files for 
CLANS.  
 
The upper limit of clustering in a desktop computer was 10,000 sequences; we 
clustered up to 9500. Using more than this number caused the graphical interface of 
CLANS to freeze. The program performs BLAST searches first; subsequently, using a 
graphical interface, the user starts the actual clustering.    
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Fig. 11: CLANS clustering map showing flavodoxin-like fold hits in blue, and 
(βα)8-barrel hits in green. The starting queries are highlighted as red circles. The 
sequence (sub-domain size fragment, 31-163 from 165 residues) of the glutamate 
mutase S-chain from Streptomyces halstedii is highlighted in orange/green right 
at the middle of the cluster map. The high scoring pair hits from the BLAST 
searches, at a better P-value of 1.0e-8, are shown as connecting edges. 
 
The clustering map in figure 11 shows flavodoxin-like fold hits colored in green, and 
(βα)8-barrel hits colored in blue. The flavodoxin-like fold query was the sequence 
from 2YXB, while the (βα)8-barrel query was 1THF. It shows HSPs represented as 
edges that connect the dots at a P-value better than 1.0e-08. As expected, 1172 
flavodoxin-like hits (green) cluster together; it is the same case for 3040 (βα)8-barrel 
hits (blue). The hits were found in the nr and metagenomic sequences databases.. 
More interestingly, the clusters from different colors seem spliced into sub-clusters.  
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The configuration of the clusters reflects the deepness of the remote homologous 
search performed with HHsenser. It shows how a search started with Hisf from 
thermotoga maritima (highlighted as the red dot confined in the blue cluster at the 
upper right), can reach the homologous family HisA (blue cluster, upper left). In the 
case of the flavodoxin-like clusters (green) the search started with the B12-binding 
domain (highlighted as the red dot confined in the green cluster at bottom left), of the 
methylmalonyl-CoA mutase alpha-subunit from Aeropyrum pernix, reached B12-
binding domains from the methionine synthase family (green cluster at the bottom 
center). 
 
The sequence that connects clusters from different colors, highlighted as a 
green/orange dot, is a fragment (131 residues from 165) of the glutamate mutase S-
chain from Streptomyces halstedii. As the first step performed to evaluate whether 
this protein could be considered as an intermediate hit, we searched the PDB database 
(using BLAST) with the short fragment. It showed sequence similarities to 
flavodoxin-like fold structures (2XYB, 2GKG) and (βα)8-barrel structures, see table 
11 for details.  
 
 
Table 11: Hits of a BLAST search launched using the sequence fragment (131 
residues from 165) of the glutamate mutase S-chain from Streptomyces halstedii. 
The identities over the aligned region are listed, and the E-values of the hits are 
also shown.   
Hits (number in hit-list)  Identities E-value 
1. 2YXB, 
Coenzyme B12-dependent 
mutase 
SCOP c.23.6  
25/99 (25%) Expect = 3e-04 
2. 2GKG, Response 
regulator homolog 
SCOP c.23.1 
24/78 (30%) Expect = 0.001 
8. 1VRD, IMPDH 
SCOP c.1.5  
20/66 (30%) Expect = 0.081 
 
By resubmitting the search with the complete sequence, we found a different 
distribution of values for the hits; moreover, a different (βα)8-barrel structure is found 
among the top hits (table 12).  
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Table 12: Hits of a BLAST search launched using the whole sequence (165 
residues) of the glutamate mutase S-chain from Streptomyces halstedii. The 
identities over the aligned region are listed, and the E-values of the hits are also 
shown.   
Hit (number)  Identities E-value 
1. 1CCW, 
Protein (glutamate mutase) 
SCOP c.23.6  
29/122 (23%) Expect = 1e-05 
2. 2GKG, Response 
regulator homolog 
SCOP c.23.1 
19/47 (40%) Expect = 2e-04 
11. 2HTM, Thiazole 
biosynthesis protein  
SCOP c.1.31 
30/101 (29%) Expect = 0.89 
 
The size of the intermediate query used to perform a back validation search is going 
to strongly influence the list of hits. The first hits shown in tables 11 and 12 suggest 
that this protein may adopt the flavodoxin-like fold; nonetheless, there are also high 
local similarities to (βα)8-barrel fold structures.   
 
Given the size and BLAST result, we could assume that this novel protein sequence 
will adopt the flavodoxin-like fold. However, it also shows some local sequence 
similarities to (βα)8-barrel structures. We then performed a secondary structure 
prediction (Quick 2D server MPI toolkit) on this intermediate sequence. The server 
predicted a mixed beta/alpha protein with the following topology: the first 20 residues 
are predicted as disordered and then we found four beta/alpha modules (βα)4.  
The glutamate mutase S-chain from Streptomyces halstedii is therefore chosen for 
experimental characterization because: a) it shows similarities with the two folds 
analyzed in this work; b) despite the similarity in size to the flavodoxin-like fold, the 
secondary structure prediction of the protein [(βα)4] suggests a possible dimeric 
arrangement that may fold in some way similar to a (βα)8-barrel. 
 
The previously discussed remote homologous search and clustering process, was not 
deep enough to allow an effective search of sequences with novel structural features. 
Therefore, we selected the sequences from the glutamate mutase from Clostridium 
cochlearium (SCOP c.23.6; PDB 1I9C) and the inosine monophosphate 
dehydrogenase from Streptococcus pyogenes SCOP c.1.5; PDB 1ZFJ) to perform a 
new search of the non-redundant and metagenomic sequences databases. 
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Fig. 12: CLANS clustering map showing 4094 flavodoxin-like hits colored in 
green and 5116 (βα)8-barrel hits colored in blue. The starting queries are 
highlighted as red circles. The high scoring pair hits from the BLAST searches, 
at a better P-value of 1.0e-10, are shown as connecting edges. The orange circle 
(emphasized by an arrow) is the sequence of the hypothetical protein TM0182 
from Thermotoga maritima, while the pink circle is the sequence of the 
hypothetical protein STH347 from Symbiobacterium thermophilum 
The clustering map in figure 12 shows 4094 flavodoxin-like hits colored in green and 
5116 (βα)8-barrel hits colored in blue. The sequences were compared by BLAST and 
5000 rounds of clustering were performed; the queries for the HHsenser search are 
highlighted as red circles. There are two more sequences highlighted as circles: the 
orange circle is the sequence of the hypothetical protein TM0182 from Thermotoga 
maritima, while the pink circle is the sequence of the hypothetical protein STH347 
from Symbiobacterium thermophilum. BLAST hits (better 1.0e-10 P-value) are shown 
as edges in the map.   
 
The first interesting feature to analyze in the CLANS map in figure 12 is the 
overlapping of two clusters from different colors around the (βα)8-barrel query. 
Remarkably, the search launched with a flavodoxin-like fold query reached the (βα)8-
barrel sequence space: sequences annotated as inosine-5'-monophosphate 
dehydrogenases (IMPDH) were hit; the IMPDH function is associated with the (βα)8-
barrel fold.  
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The configuration of this cluster reveals that one of the interfaces between both folds 
is indeed located between the B12-binding (flavodoxin-like fold c.23.6) and the 
IMPDH  [(βα)8-barrel c.1.5.1] superfamily. The sequence space search, started on the 
flavodoxin-like fold structural island, hit many sequence intermediates to reach the 
(βα)8-barrel fold structural island. We performed a BLAST search using one of them: 
the hypothetical protein STH347 from Symbiobacterium thermophilum. This 
sequence is a 91 residues fragment of a 254 full-length protein; moreover, 17 residues 
at random positions are missing in this short fragment. This is a problem of the 
HHsenser searches, where the hits of the alignments are missing residues.  
 
 
Fig. 13: BLAST result of searching the CDD using the sequence from the 
hypothetical protein STH347 from Symbiobacterium thermophilum (91 residue 
fragment). 
 
The BLAST search with the short raw fragment displays a remarkable mixed signal 
towards flavodoxin-like and (βα)8-barrel families of proteins (figure 13). 
MM_CoA_mut_B12_BD, B12-binding, acid CoA_mut_C and Sbm are flavodoxin-
like fold families. NanE, IGPS, thiE, aldolase and TIM_phosphate_binding are (βα)8-
barrel families.  
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Fig. 14: BLAST result of searching the conserved domain database using the full 
sequence from the hypothetical protein STH347 from Symbiobacterium 
thermophilum (254 full-length sequence). 
 
In a subsequent step, we used the complete sequence to perform a new BLAST search 
and the signal towards the flavodoxin-like fold families vanished (figure 14). The 
variation of the hits found in function of the query size indicates that the mixed signal 
towards both folds is local. Nonetheless, taking into account the length of the full 
sequence, it is likely that this protein adopts the (βα)8-barrel fold. Therefore, we did 
not choose this target for experimental characterization with high priority.  
 
Besides of the cluster of mixed colors, another three flavodoxin-like fold clusters can 
be recognized in the cluster map from figure 12. The cluster where the flavodoxin-
like fold query is confined corresponds to the B12-binding domain superfamily. 
Interestingly, members of the CheY-like superfamily compose the group of 
flavodoxin-like fold hits that appears on the left corner, away from the center of the 
map. The HHsenser search performed with the B12-binding domain query (1I9C, 
flavodoxin-like fold c.23.6) was deep enough to reach the sequence space of the 
homologous CheY-like superfamily.  
 
The hypothetical protein TM0182 from Thermotoga maritima, highlighted as an 
orange circle in figure 12, is present in the green cluster located close to the middle of 
the map. It is not possible to find statistically significant hits by searching the PDB 
database using this sequence as query.  
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Searching the non-redundant database of proteins, with the raw short fragment, we 
found members of the B12-binding domain-like associated with radical SAM domain 
family of proteins. Two domains compose these proteins: the N-terminal domain is 
similar to the B12-binding domain superfamily, however it lacks the signature motif 
Asp-X-His-X-X-Gly that binds to cobalt. The function of these proteins is not known.  
 
The B12-binding domain_like cluster of proteins is located in the middle of the map. 
As previously discussed in the introduction, the function and fold of these proteins 
was unknown, and they show similarities towards flavodoxin-like and (αβ)8-barrel 
structures. Therefore, we decided to experimentally characterize the N-terminal 
domain of the TM0182 protein, a member of the B12-binding domain-like family of 
proteins, for which no structure is known so far. 
 
The cluster map in Figure 15 shows 4749 flavodoxin hits highlighted in green and 
4288 (βα)8-barrel hits colored in blue. The flavodoxin-like fold query used for the 
HHsenser search is the sequence of 2XYB (B12-binding domain SCOP c.23.6.1) 
while the (βα)8-barrel query was 1VRD  (IMPDH SCOP c.1.5.1). We modified 
several parameters of the clustering process: a) we set an arbitrary cutoff P-value 
1.0e-06 to remove many singletons after the clustering; b) we doubled the repulsion 
values, and c) we re-positioned the sequences to cluster again for 5000 rounds. This is 
why the map looks cleaner than the one shown in figure 12.  
 
In the CLANS clustering map from figure 15 we recognize: a) B12-binding domain 
cluster (where the flavodoxin-like query is highlighted in red), b) the response 
regulators cluster (upper left), the B12-binding domain-like cluster of proteins 
(highlighted in green/orange), c) the sequence of the putative Fe-S oxidoreductase 
from Pelobacter Carbinolicus (fragment 21-143 from 425 residues) colored in pink 
and d) the cluster of the IMPDH family of proteins where the (β/α)8-barrel query 
(highlighted in red) is confined.  
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Fig. 15: CLANS clustering map showing 4749 flavodoxin hits highlighted in 
green and 4288 (βα)8-barrel hits colored in blue. The connections are showed at 
better P-value better than 1.0e-10. The queries are highlighted in red (2XYB and 
1VRD). The B12-like associated with SAM radical family of proteins is 
highlighted in orange. The putative Fe-S oxidoreductase from Pelobacter 
carbinolicus (fragment 21-143:425) is colored in pink. 
From the map it becomes clear that the sequence of the putative Fe-S oxidoreductase 
is an interesting target. We performed a BLAST search with the raw fragment found 
by HHsenser to detect a mixed signal to the B12-binding superfamily (flavodoxin-like 
fold associated) and to the IMPDH superfamily [(βα)8-barrel fold associated]. The 
putative Fe-S oxidoreductase is a multi-domain protein; the C-terminal domain is 
similar to SAM radical proteins while the N-terminal domain (found by the HHsenser 
search) shows a mixed signal towards the B12-binding superfamily and IMPDH 
family of proteins. The size of the full length N-terminal domain of this protein is 
compatible with a flavodoxin-like fold structure (150 residues); nevertheless, a (βα)8-
barrel structure is found as first hit in a search of the PDB.  
 
Remarkably, the mixed signal towards both folds was not affected by doing the 
BLAST search with the complete N-terminal sequence of the putative Fe-S 
oxidoreductase (renamed PC04) instead of using the raw small sequence found by 
HHsenser. 
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We decided to experimentally characterize this protein taking into account the 
following observations: a) the protein size is compatible with a flavodoxin-like fold 
but it hits first a (βα)8-barrel structure in a BLAST search and b) the mixed signal 
towards both folds is strong while doing a BLAST search with the full length domain.  
 
As a final example of the selection procedure for the intermediate targets, we 
identified the hypothetical nicotinate phosphoribosyltransferase from Aquifex 
aeolicus. It was located between two clusters from different folds (see figure 16 for 
details). There were multiple connections directly between the two clusters from 
different folds; and the position of the protein was indicative of its intermediate 
nature. We first started doing a BLAST search with the raw short fragment identified 
in the CLANS clustering map.  We pulled the complete sequence from the NCBI 
website (gi 499183116) to perform a search of the conserved domain database with 
the complete sequence (residues 1-426) and found similarities towards the Nicotinate 
phosphoribosyltransferase (NAPRTase) family of proteins. These enzymes catalyze 
the formation of NAMN and PPi from 5-phosphoribosy -1-pyrophosphate (PRPP) and 
nicotinic acid; they are present in Bacteria and Eukarya.  
 
We searched the SCOP database to fully identify the domains present in this 
sequence. The N-terminal region (residues 1-131) hits with high probability the 
alpha/beta-hammerhead fold and the C- terminal region hits the (βα)8-barrel fold 
(residues 132-426). The most identical (βα)8-barrel fold structure is the putative 
nicotinate phosphoribosyltransferase from Enterococcus faecalis (SCOP c.1.17.1, 
PDB 2F7F).  Seven parallel beta-strands compose the structure 2F7F forming an 
incomplete (β/α)8 barrel. The profile-profile sequence alignment between hypothetical 
NAPRTase from A. aeolicus and 2F7F extends over 291 residues, being 42% of these 
residues identical between both proteins. In consequence, the C-terminal domain of 
the hypothetical NAPRTase would likely fold into a (βα)8-barrel. Nonetheless, an 
HHpred search also shows a highly scored alignment between the NAPRTase and a 
flavodoxin-like fold structure: the methylmalonyl-CoA mutase alpha subunit, C-
terminal domain from Propionibacterium freudenreichii, aligns over 89 residues with 
the NAPRTase having 29% of identical residues. 
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Fig. 16: CLANS clustering map showing 2425 (βα)8-barrel fold hits in blue and 
1718 flavodoxin-like fold hits in green. The queries highlighted in red, were: The 
putative N-acetylmannosamine-6-phosphate 2-epimerase NanE from 
Staphylococcus aureus (PDB 1y0e; SCOP c.1.2.5) and the glutamate mutase, 
small subunit from Clostridium cochlearium (PDB 1CCW; SCOP c.23.6.1). The 
hypothetical nicotinate phosphoribosyltransferase from Aquifex aeolicus is 
highlighted in orange/green. Connections are shown a P-value of 1.0e-06. 
 
A theoretical evolutionary path of fold change can be envisioned by using the 
sequence from the hypothetical nicotinate phosphoribosyltransferase (Aquifex 
aeolicus) as an anchor between the sequences of 7REQ and 2F7F. Since the pairwise 
alignment between the Aquifex sequence and 2F7F (over the entire incomplete (βα)7-
barrel fold domain) is 42% identical, then is likely that the aligned region of 
intermediate target sequence adopts the same fold if cloned without the N-terminal 
domain.  However this sequence is also 30% identical (locally) with the sequence of 
the methylmalonyl-CoA mutase alpha subunit, C-terminal domain from 
Propionibacterium freudenreichii.  These 85 residues are roughly folded into an (βα)3 
element corresponding to the α5β5α6β6α7β7  region of 2F7F and the α2β3α3β4αaβ5 
region of 7req. Hence this region being 42% identical to the (βα)8-barrel and 30% 
identical to the flavodoxin-like fold can be considered as an ancestral fragment (figure 
17).  This subdomain-sized fragment appears to be compatible with both folds.  
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It has been postulated that the (βα)8-barrel fold evolved by two fold duplication and 
fusion of (βα)2 elements.  One could envision that the sequence signal is lost (or 
changed to adapt to the barrel context) in one αβ element from the (βα)3 ancestral 
fragment. By the addition of one ab element to this ancestral (βα)3 and later 
duplication and fusion, a full (βα)8-barrel could be generated. On the other hand, 
assuming that the intermediate state between the (βα)8-barrel and the flavodoxin-like 
fold is a (βα)4 element, to form a flavodoxin-like fold starting from the ancestral (βα)3 
element, requires major secondary structure rearrangements.  
 
An extra sequence folded as β1 has to invade the 5-stranded β-sheet between β2 and β3. 
Secondly, the next region of this extra sequence folded as α1 has to flip to the other 
side of the 5-stranded β-sheet. Finally an extra C-terminal sequence has to form α5 
also on the same side of the 5-stranded β-sheet as α1.  
 
The previous evolutionary scenario is not very likely to occur. It is more likely that a 
sequence before α5 in the barrel and α1 in the flavodoxin-like fold shows high 
plasticity and could be folded as either β-strand or α-helix in function of the structural 
context. A similar scenario would be required after β7 in the barrel and β5 in the 
flavodoxin-like fold to fully recreate a flavodoxin-like fold from a sub-domain size 
(βα)7-barrel sequence, see figures 17 and 18 for details.     
 
This is exactly the case of the NAPRTase from Aquifex aeolicus, because its 
secondary structure prediction seems to be ambiguous in the required regions (aligned 
with the full NAPRTase 2F7F). Since the 2F7F (βα)8-barrel seems to be already an 
intermediary step on the path towards a flavodoxin-like fold, one could imagine a 
scenario where cloning the region corresponding to the size of the flavodoxin-like 
fold, followed by either directed evolution or computational design in the ambiguous 
regions, this protein could be folded as a flavodoxin-like fold (see figure 18 for 
details).  
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Fig. 17: Secondary structure prediction of the NAPRTase from Aquifex aeolicus. 
The prediction of 4 servers (PSIPRED, JNET, Quali, and Rost) gathered by the 
meta-server Quick2D (68), is depicted as alpha helices (H) and beta strands (E). 
The confidence values for the predictions are shown in numbers (range 0-9). The 
sequence of the NAPRTase was aligned to the canonical barrel domain from 
2F7F  (the secondary structure elements are shown in blue) and the B12-binding 
domain from 1REQ (the secondary structure elements are shown in green). We 
aligned the two folds using the NAPRTase sequence as anchor. Transparent 
orange squares denote plastic regions of the NAPRTase sequence, where the 
prediction of the secondary structure type is ambiguous. The NAPRTase is 42% 
identical with 2F7F over the whole alignment; while it is 29% identical with 
1REQ over 85 residues (indicated with a shaded green bar). 
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Fig. 18: Hypothetical evolutionary path of fold change between the (β/α)7-barrel 
2F7F towards the flavodoxin-like fold B12-binding domain (1REQ). In blue and 
green are highlighted the (αβ)3 elements shared by the two folds. In the lower 
model two plastic regions, which may facilitate the fold change path, are 
highlighted in pink. 
The visual inspection of many CLANS maps provided us with a long list of 
interesting proteins; see section 8.4 from the appendix. Different aspects prompted us 
to select these targets; however, two PFAM families were the two most promising 
groups of proteins: a) the uncharacterized protein family UPF0004 appears in 
conjunction with a C-terminal domain of MiaB proteins, and b) the Radical SAM N-
terminal family, which was already discussed previously. In section 8.4 from 
appendix we show many targets. It is indicated how similar the intermediate 
sequences are towards flavodoxin-like and (β/α)8-barrel fold structures. In addition, 
we show the gene identifier and the source organism. It is very difficult to evaluate 
whether any of the listed sequences will provide significant information about the 
evolution of the two superfolds under study. However, we can re-evaluate every hit 
before an experimental characterization. 
 66 
Certain sequences were selected in function of many different factors: a) the 
similarity was high towards one fold but the length was more similar towards the 
other one, b) the protein was not annotated because there was no clear similarity 
towards any known function but it was similar to both folds, c) the length of the 
protein is compatible with a half barrel (100 residues) and shows high similarity 
towards both folds, d) we found many sequences from the same protein family, e) the 
topology suggested a duplicated flavodoxin-like fold in the barrel size, f) the protein 
is annotated with a function associated with a flavodoxin-like fold but it has the size 
of a (β/α)8-barrel. From the overall analysis of the candidates outlined here, we 
selected some proteins that were cloned in different versions. In the next chapter we 
discuss the experimental characterization of the candidates.  
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3.5 Experimental characterization of the intermediate candidates  
 
The main goal of the experimental work was to obtain structural information in 
atomic detail from the intermediate candidates. Therefore, we selected several 
proteins to be experimentally characterized. For most of the hits, it was only possible 
to perform partial characterization steps. A summary of the data generated from 20 
different proteins is provided in table 13. We determined the crystal structure of 
NTM0182, one of the intermediate proteins. The characterization procedure is fully 
outlined only for this variant.  
 
 
Table 13: Summary of the data generated from the intermediate candidates 
experimentally tested. The amount of protein, in the soluble or insoluble fraction, 
is indicated by the number of (✓) symbols. Success or failure of the refolding 
protocol and crystallization attempts is indicated with (✓) or (X) respectively.  
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TM02 ✓       ✓ 3.2 Å 
CM01 ✓ ✓✓ ✓ ✓  ✓ ✓   
CM02 ✓ ✓✓ ✓ ✓      
SS01  ✓ X       
SS02  ✓        
SS03  ✓ X       
PC01 ✓ ✓✓ X       
PC02 ✓ ✓✓ X       
PC03 ✓ ✓✓ X       
PC04 ✓✓ ✓✓ X  ✓ ✓ ✓ ✓ 9.0 Å 
PC05 ✓ ✓✓ X       
PC06 ✓ ✓✓ X       
HI01  ✓ X       
CB01 ✓ ✓✓ ✓       
CB02 ✓ ✓✓        
CT01  ✓ X       
OB01  ✓ X       
OB02  ✓ X       
SM01 ✓   ✓   ✓ ✓ X 
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3.6 NTM1082 characterization  
 
We cloned, expressed and purified the 128 N-terminal residues of the hypothetical 
protein TM0182 from Thermotoga maritima (NTM0182). In order to define the 
domain boundaries, we analyze both, a multiple sequence alignment and a consensus 
result obtained from various web servers (PRODOM, DOMPRED and PSIPRED). 
First, we obtained the gene from the hypothetical protein TM0182 by PCR from 
genomic DNA. We cloned the first 128 residues including a 6X-His-Tag.   
 
The molecular weight of the protein is 14952.1 Daltons, and it has an isoelectric point 
of 6.29. We purified the protein by nickel affinity and size exclusion chromatography.  
The oligomeric state was characterized using analytical gel filtration and light 
scattering. In the purified protein solution, two concentration independent 
oligomerization states were identified corresponding to a monomer and a dimer (see 
figure 19 for details). The stability of both states can be explained by analyzing the 
atomic model determined. We will discuss this finding later on this dissertation.  
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Fig. 19: Light scattering and gel filtration curves of monomeric (blue) and 
dimeric (red) NTM0182. The experimentally determined molecular weight is 
indicated.  
Analytical gel filtration was performed using a column Superdex 75 10/300 GL 
column (Amersham Pharmacia) and was coupled to a light scattering device for 
subsequent analysis. Multiangle static laser light-scattering experiments (MALLS) 
were done online with analytical size-exclusion chromatography using miniDAWN 
TREOS and Optilab rEX instruments (Wyatt Technologies) and the associated 
software (AstraV) for molecular weight determination. The protein (0.3 mg/ml) was 
eluted at a flow rate of 0.8 ml/min in 50 mM Tris, 300 mM KCl (pH 7.5) and the 
apparent size of the two peaks was analyzed by dynamic light scattering. The molar 
mass (g/mol) was determined: monomer 1.292e+4 (error of 0.8%), dimer 2.382e+4 
(error of 1%).  
 
The results from far-UV circular dichroism suggested that, in agreement with 
previous bioinformatic predictions, NTM0182 displayed a mixed content of 
beta/alpha secondary structural elements. Both oligomeric states show a very similar 
curve (Figure 20). 
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Fig. 20: CD spectra of monomeric (blue) and dimeric (red) NTM0182 CD 
spectra were recorded with a JASCO model J-810 spectropolarimeter. The 
measurements were performed using protein concentration of 0.1 mg/ml in 20 
mM Tris and 100 mM KCl (pH 7.5) at room temperature. 
 
The tertiary structure was evaluated by fluorescence spectroscopy (figure 21). The 
dimeric protein shows a maximum at 320.5 nm while the monomer curve displays a 
maximum at 340 nm. Also, the intensity of both curves is different, being lower for 
the monomer, although the concentration of both samples is the same. Overall, the 
data suggests a better shielding of aromatic residues in the dimeric arrangement. 
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Fig. 21: Fluorescence spectroscopy curves of monomeric (blue) and dimeric 
(red) NTM0182. The measurements were carried out with a JASCO FP-6500 
spectrofluorometer; the experiment was performed using protein concentration 
of 0.1 mg/ml in 20 mM Tris and 100 mM KCl (pH 7.5) at room temperature. 
The monomer spectrum has a maximum at 341 nm, while the dimer spectrum 
has a maximum at 320 nm. 
 
The biophysical characterization of NTM0182 shows a well-folded protein domain, 
with a mixed alpha/beta content, that adopts two concentration-independent 
oligomerization states. Nonetheless, the data provided here does not aid to understand 
the evolution of the two folds under study. Therefore, we set crystallization trials to 
produce an atomic model of NTM0182.  
 
The x-ray crystal structure of NTM0182 was determined by experimental phasing. 
We selected this methodology instead of molecular replacement because the average 
sequence identity shared between NTM0182 and any known protein structure was 
lower than 18%; moreover, we wanted to avoid bias towards any fold while solving 
the phase problem.  
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A crystallization screening produced hits in different conditions; the crystals were 
needle-like shaped in different sizes. We determined that NTM0182 crystallizes in an 
orthorhombic lattice of the space group C2221, the solvent content of the crystals was 
58%, and there were six monomers per asymmetric unit.  The crystals diffracted up to 
3.2 Å resolution.  A double SAD (single wavelength-anomalous diffraction) 
experiment was performed where two anomalous datasets, coming from different 
crystals soaked in platinum, were collected. We merged these datasets to achieve 
enough phasing power to determine an initial experimental map. Several cycles of 
density modification, model building, and refinement were carried out to obtain a 
final refined model of NTM0182 (R-work of 0.24, R-free of 0.28). See table 14 for 
full X-ray, phasing and refinement statistics for NTM0182 
 
 
 
Fig. 22: The X-ray crystal structure of NTM0182 was determined by 
experimental phasing. The monomers in the asymmetric unit swapped the first 
N-terminal β-strand forming a close dimeric arrangement. The chains D  
(orange) and F (gray) are shown in cartoon representation. 
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Table 14: X-ray, phasing and refinement statistics for NTM0182 
Data collection  
Wavelength (Å) 1.069800 
Space group C222(1) 
Cell dimensions (Å, °) a=102.05,b=145.30, c=141.71 a=90.0, b=90.0, γ=90.0 
Resolution (Å) 39.6-3.19 (3.27-3.19) 
Unique reflections 33,708 (2,241) 
Redundancy 6.3(5.7) 
Completeness % 99.1%(88.6%) 
Rmerge % 14.7 (83.1) 
I/sigma (I) 15.01(2.02) 
Wilson B factor 67.8 
Phasing statistics  
No of Platinum sites 2 
Phasing power Anomalous 0.982 (0.205) 
Rcullis 0.966 
Refinement statistics  
Space group C222(1) 
Resolution (Å) 39.6-3.19 (3.3-3.19) 
Figure of merit  0.77 (0.70)  
Phase error 29.82 (36.55) 
Rcryst, % 0.2465 (0.33) 
Rfree, % 0.2881 (0.37) 
Mean B-value (Å2) 78.5 
Nonhydrogen atoms 5246 
Number of water molecules 29 
Number of platinum molecules 2 
rmsd of bond length (Å2) 0.004 
rmsd of angle (°) 1.005 
Model quality   
Clashscore, all atoms 8.09    (95th percentile) 
MolProbity score (69) 2.02    (100th percentile) 
Poor rotamers 1.0% 
Ramachandran outliers 0.31% 
Ramachandran favored 90.22%  
Cβ deviations 3 
Residues with bad bonds 0.00% 
Residues with bad angles 0.06% 
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Three layers of secondary structural elements compose the NTM0182 structure: a six-
stranded β-sheet (order 213456) sandwiched by two α helices on one side, and three 
α helices on the other side (figure 22). The arrangement of the monomers in the 
asymmetric unit was strikingly unusual; the first ten residues (β1 + 3 residues) from 
each monomer were swapped. This beta-strand swap produced a closed dimeric 
arrangement. A detailed observation of the components of the asymmetric unit 
showed that the chains did not superpose well. Instead, the angle formed by the 
residues after the swapped region from each monomer deviated by several degrees. 
The closed dimeric arrangement in the crystal structure correlates very well with the 
concentration independent oligomerization state of the protein in solution.  
 
Three chains displayed C-β deviations (TRP12 from chain B, ASN10 and TRP12 
from chain D) that could not be fixed, despite many cycles of rebuilding and 
refinement. These positions are localized where the swapped β-strands point away 
from the monomers. The swapping of the β-strands may be the cause of this unusual 
atomic arrangement.  
 
To further perform structural comparisons it was necessary to define an operational 
monomer: we took β-strand 1 from chain F and the rest of the secondary structural 
elements from chain D. The topology of NTM0182 did not precisely match any fold 
in the most widely used classification systems (SCOP and CATH); therefore, it could 
be defined as a novel fold.  
 
3.7 Sequence and structural based comparison of NTM0182 with the 
flavodoxin-like and the (αβ)8-barrel folds.  
 
We aligned (guided by profile-profile pairwise sequence alignments) the NTM0182 
structure with the Inosine monophosphate dehydrogenase from Streptococcus 
pyogenes [PDB 1ZJF, (αβ)8-barrel fold) and the glutamate mutase (B12-binding 
domain) from Clostridium cochlearium (PDB 1I9C, Flavodoxin-like fold). The 
protein sequence from NTM0182 was initially detected using the sequence of 1I9C as 
query for a HHsenser search.  
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We followed sequence based information, in order to  guide the structural 
superpositions, because many members of the SCOP α/β class show structural 
similarities that may be the result of convergence and not necessarily due to common 
ancestry (data not shown). A detailed inspection of these superpositions revealed a 
conserved (in sequence and structure)  αβαβ element among the three different folds 
(figure 23).  
 
 
Fig. 23: A structure-based sequence alignment of the of NTM0182 (orange) with 
the flavodoxin-like protein glutamate mutase from C.cochlearium (PDB 1I9C, in 
green) and the (βα)8-barrel inosine monophosphate (IMP) dehydrogenase from 
S.pyogenes (PDB 1ZFJ, in blue). The alignment reveals an area of highest 
similarity around α3β4α4β5 indicated by the red bar. The amino acid sequences 
are shown with the secondary structural elements indicated above. Increasing 
sequence conservation within each family is indicated through more intense blue 
shading of the 1-letter code. Capital letters denote structurally aligned residues. 
Identical residues between the three proteins are highlighted by reddish 
background. 
 
Interestingly, the structure-based sequence alignment shows that the highest similarity 
of NTM0182 to either the flavodoxin-like or the (βα)8-barrel fold is confined in a 42 
residues long fragment that encodes the α3β4α4β5 element (figure 23).  
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While the NTM0182 domain aligns upon superposition with only 13 and 19% over 67 
superimposed residues to glutamate mutase and IMP dehydrogenase, respectively, the 
α3β4α4β5 element from NTM0182 shows a higher sequence identity of 23% and 28% 
over 40 aligned residues with the corresponding fragments of glutamate mutase and 
IMP dehydrogenase. On the contrary, the proteins glutamate mutase and IMP 
dehydrogenase share only 15% sequence identity in both, the local and the global 
alignment. The structural alignment may further suggest that the homology among the 
three different folds is restricted to a smaller fragment, e.g. the conserved (αβ)2 
element.  
 
Fig. 24: Structure-based sequence alignment of the N-terminal domain of 
TM0182 with the flavodoxin-like B12-binding from Desulfitobacterium 
hafniense (PDB-id: 4JGI) and the (βα)8-barrel class I KDPG aldolase from 
Thermotoga maritima (PDB-id: 1WA3). The (αβ)2 fragment with the higher 
identity/similarity is colored in black in the alignment as well as in the structural 
models (depicted as cartoon), while the rest is in gray. Capital letters denote 
structurally aligned residues. The scores for the superpositions are shown in table 
14. 
  
1WA3! !11-46    KIVAVLR---ANsveeak------------------------ekalaVF----EGGv---HLIEITFTvP-!
    ! !           ||                                                         ||  |*    !
TM0182 !1-56     MYILFRE---MK-NNWY--SLAALLSTiysrhldVEARPV----KFEEI----KKFPpeKTIVAYSFMSF-!
    !  !           *|                   |  |        *|  |        *    *       **  * |   !
4JGI! !90-152   AKIVLATvegDLhDIGKniFRTMAEASg------FEVFDLgidvPVKIIvdkvKEVN--PEIVGLSGVLTl!
            ! ! ! ! !     !
1WA3! !47-110   DADTVIKELSFLKEK-GA---IIGAGT--VTsveqCr-kAVE-SGAEFIVSpHldeeisqfckekgVFYMPG!
    ! !         *|***  *|  ***| *     | **   **         |   * | | |   |* *  *          *!
TM0182 !57-120   DLDTVREEVKTLKER-GY---TLIAGGphVTa---DpegCLR-MGFDHVFTgDGeENILKFLMGErKKIFDG!
    ! !          **||** *  **         |*|**  *             |* *   *       |*           !
4JGI! !153-211  ALDSMRETVDALKAEgLRndlKVIIGGvpVNe---N---VCQrVGADDFST-NA-ADGVKICQRW-vg----!
1WA3! TM0182! 4JGI!
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The high sequence identity of the element (βα)2 among all the folds, could be seen as 
suggestive evidence of common ancestry. However, the identities would lie below 
certain strict empirical thresholds  to support homology between proteins based on 
fragment length and sequence identity (70). We therefore searched for proteins with 
even higher sequence identities and identified a recently released flavodoxin-like 
structure (PDB-id: 4JGI, SCOP: c.23.6) as well as a (βα)8-barrel structure (PDB-id: 
1WA3, SCOP: c.1.10) that both share 37% sequence identity within the (βα)2 
fragment of TM0182 (alignment in figure 24). 
The data generated by the HMM-HMM comparisons combined with the previously 
discussed structural superpositions, significantly diminish the possibility of 
independent origin of the (βα)8-barrel and the flavodoxin-like fold.  
 
Table 15: Scores for alignment in figure 24. 
Structurally aligned  SeqID 
Global 
RMSD 
Global 
SeqID 
Local 
RMSD 
Local 
1WA3 vs. TM0182 24 % 2.5 Å 37 % 2.3 Å 
4JGI vs. TM0182 20 % 2.3 Å 37 % 2.0 Å 
1WA3 vs. 4JGI 9 % 2.7 Å 18 % 2.8 Å 
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3.8 The (αβ)2 element can be structurally superposed onto different (β/α)8-
barrel and flavodoxin-like fold superfamilies.  
 
Previously, different research groups (27, 71) proposed an evolutionary scenario in 
which HisA and HisF, histidine biosynthesis enzymes, evolved through duplication 
and fusion of a gene encoding a half-barrel ancestor.  The Nagano group (31), in a 
very extensive work on the (β/α)8-fold, found a common G-X-D motif in the even 
loops of the barrels (α1-β2; α3-β4; α5-β6; α7-β8). This structural feature suggested a 
4-fold duplication of an ancestral (αβ)2 motif. In our global analysis, using state of the 
art tools for homology detection, we confirm the same relationships among (β/α)8-
barrel fold  superfamilies  (30, 31) that were previously established; moreover, we add 
new sequence-based links to additional superfamilies.  
 
The 4-fold or 2-fold duplication has been then repeatedly hypothesized as the source 
of the approximate 8-fold structural symmetry in the (β/α)8-barrel fold. Söding and 
co-workers, with the development of the HHrep software (72), provided sequence-
based evidences that support the evolution of the (α/β)8 barrel fold by duplication and 
fusion of smaller (αβ) motifs. They found both, a strong (P-value 9.7x10-13) two-fold 
symmetry, and a weaker 4-fold symmetry (P-value 5.1x10-04) in HisF (PDB 1THF). 
Other (β/α)8-barrel fold superfamilies also displayed 4-fold symmetry: the KDPG 
aldolase (PDB 1fg0; SCOP c.1.10.1) displayed a weak four-fold symmetry (P-value 
5.4x10-7),  and the phosphoenolpyruvate mutase (PDB 1s2w , SCOP c.1.12.7). 
Lastly, a  three-fold symmetry was detected in the inosine monophosphate 
dehydrogenase (PDB 1ZFJ, SCOP c.1.5.1). Together, these results suggests that the 
(β/α)8 barrel fold may have arisen by a 4-fold duplication of a (β/α)2 module.  
 
Our rationale indicates that a homologous (β/α)2 element, which links the flavodoxin-
like with the (β/α)8-barrel fold, should also connect the (β/α)8 barrel fold 
superfamilies that were either established as having common ancestry, or proven to 
display symmetric properties. In table 16 we summarize the results of multiple 
structural superpositions, using the α3β4α4β5 element, of NTM0182 with eleven 
(β/α)8-barrel fold superfamilies and one flavodoxin-like fold superfamily. Our results 
are completely consistent with previous findings.  
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Table 16: Superposition of the NTM0182 αβαβ element on different (βα)8-barrel  
fold structures. 
SCOP Superfamilies SCOP (PDB) 
 
RMSD % Seq. ID  Aligned 
length 
(αβαβ) 
Triosephosphate 
isomerase (TIM) 
c.1.1.1(1W0M) 2.0 22.0 41 
Ribulose-phoshate 
binding barrel 
c.1.2.1 (1THF) 
c.1.2.5 (3IGS) 
c.1.2.1 (1KA9) 
2.1 
1.8 
2.0 
27.3 
29.7 
29.3 
40 
37 
41 
Thiamin phosphate 
synthase 
c.1.3.1 (1XI3) 2.2 30.0 30 
FMN-linked 
oxidoreductases 
c.1.4.1(1GOX) 2.2 25.0 44 
Inosine 
monophosphate 
dehydrogenase 
(IMPDH) 
c.1.5.1 (1ZFJ) 2.0 27.5 40 
Aldolase c.1.10.1 (1WA3) 2.7 31.7 41 
Phosphoenolpyruvate 
domain 
c.1.12.1 (1E0U) 2.8 27 37 
Nicotinate/Quinolinate 
PRTase C-terminal 
domain-like 
c.1.17.1 (1QPO) 1.6 18.0 39 
PLC-like 
phosphodiesterases 
c.1.18.1 (2PZ0) 1.4 31.4 35 
(2r)-phospho-3-
sulfolactate synthase 
ComA 
c.1.27.1(1QWG) 2.3 28.6 42 
GlpP-like c.1.29.1.1 
(1VKF) 
1.6 23.5 34 
Cobalamin (vitamin 
B12)-binding domain 
c.23.6.1(2XIJ) 2.0 28.9 38 
 
The fragment α3β4α4β5 has an equivalent structural match with high sequence 
identity and low RMSD in 11 different (βα)8-barrel fold superfamilies. These 
superfamilies were already proven to be homolgous (e.g Ribulose-phoshate binding 
barrel and Thiamin phosphate synthase) or have displayed a three-fold repeat pattern 
(Inosine monophosphate dehydrogenase).  
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3.9 The (αβ)2 element can be shifted and superposed three times onto the 
Inosine monophosphate dehydrogenase structure.  
 
The Inosine monophosphate dehydrogenase previously showed a three-fold repeat 
pattern (PDB 1ZFJ; SCOP c.1.5.1). We tested whether the detected conserved 
fragment would match the three-fold repeat in 1ZFJ. For this, we superposed and 
shifted this element three consecutive times onto the barrel. The results of the 
superpositions are summarized in table 16.  
 
Table 17: Three consecutive structural superpositions of the NTM0182 
αβαβ element on the 1ZFJ structure 
Superposition range 
on 1ZFJ 
RMSD (Å) % Seq. id 
(similarity)  
Aligned length 
(αβαβ  element) 
GLN83 — ASP 253 
Conserved motif 246-
248 
GXD identical 
2.1 23.32 (43)  37 
SER259 — GLY303 
Conserved motif 296-
298 
GXD identical 
1.8 23.31 (42) 38 
VAL323 — GLY 366 
Conserved motif 296-
298 
GXN not conserved 
2.0 27.50 (32) 40 
 
Remarkably, the (βα)2 element can be superposed with significant high scores (when 
considering comparisons of proteins from different folds) over three consecutive 
regions (corresponding to a quarter barrel) onto 1ZFJ. These superpositions also 
match two times (only the glycine is conserved the third time) the conserved GXD 
motif that was interpreted as evidence for the (βα)2 modular unit from which the (βα)8 
barrel fold might have originated. 
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Fig. 25: The conserved α3β4α4β5 element can be superposed three consecutive 
times on 1ZFJ (Inosine monophosphate dehydrogenase). 
 
Fig. 26: The conserved α3β4α4β5 element can be superposed two times on 
1KA9 (HisF). The scores are summarized in table 18. 
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Table 18: Structural scores and sequence identity for superpositions in 
figure 26   
Superposition range 
on 1ka 
RMSD (A) % Seq. id 
(similarity)  
Aligned length 
(αβαβ  element) 
ALA54 —  ASN 103 
Conserved motif 96-98 
GAD identical 
2.0 29.3 (40)  41 
ASP183 — SER225 
Conserved motif 218-
220 
GAE not identical but 
similar 
1.7 21.6 (35) 37 
 
HisF (e.g PDB 1ka9) has been the most mentioned example of a 2-fold symmetric 
(βα)8-barrel fold. Therefore, we expected to be able to superpose with good scores the 
conserved quarter barrel at least twice. Indeed, the (βα)2 element was superposed two 
times on the structure of HisF (1KA9), the imidazole glycerol phosphate synthase 
subunit, with low RMSD and high sequence identity. Moreover, we found good 
agreement on the superposition of the conserved GXD (in this case the motif was 
GAD) motif present in most (βα)8-barrel fold structures: the motif was completely 
aligned on the first half, and the second motif showed a glutamic acid instead of the 
canonical aspartic acid (figure 26 and table 18). Thus, our data supports the model of 
evolution previously proposed for the (βα)8-barrel fold, where a 4-fold duplication 
and fusion of a quarter barrel yielded the contemporary (βα)8-barrel fold. 
 
  
3.10 Functional constraints may be the basis of the high conservation of 
the (αβ)2  element.  
 
The GG motif for instance (involved in the binding of the nucleotide-region of the 
B12 molecule) is located in equivalent positions in a structural alignment between 
1BMT and NTM0182 (11 identical residues; 86 C-alpha carbons and 2.2 Å RMSD). 
The structure of NTM0182 showed a dimer configuration where the first beta-strand 
(residues 1-8) from each chain is swapped between two interacting monomers. W11 is 
the first residue that packs back against the source monomer that swapped the first N-
terminal beta strand (see figure 27).  
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In the surrounding regions of W11 in all monomers present in the asymmetric unit, 
the geometrical scores for NTM0182 are not optimal (rotamer occurrence, length and 
angles of the bonds). The structural superposition in figure 27 places the indole ring 
of W11 almost completely aligned in the same plane with the indole ring of the 
nucleotide from the B12 in 1BMT.  
 
The NTM1082 β-strand swapping may be a crystallographic artifact caused by the 
missing C-terminal domain in the following way: the lateral chain of W11 may be 
mimicking the binding of a nucleotide-containing substrate on NTM0182 and this fact 
triggers the unusual packing in this area.  
 
 
Fig. 27: Structural alignment of 1BMT (green) and NTM1082 (orange). 11 
identical residues between both structures identified in the alignment are 
highlighted in stick representation. B12 (1BMT ligand) is shown in black sticks. 
The lateral chain of W12 from NTM0182 (stick orange representation) aligns 
with the indole ring of B12. 
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Fig. 28: Structural alignment of 1ZFJ (blue) and NTM1082 (orange). 11 
identical residues between both structures are highlighted in stick 
representation. IMP (Inosinic acid, the ligand of 1ZFJ) is depicted in black 
stick model. Two glycines (phosphate-binding site in many (β/α)8-barrel 
structures) are aligned in both structures and lie in range (> 3.5A) of 
establishing interactions with the phosphate group of the ligand. 
 
In contrast to the previously explored superposition between the flavodoxin-like fold 
and NTM0182, the identities (11 residues) found between 1ZFJ and NTM1082 are 
confined to the αβαβ element (40 C-alpha carbons and 1.7 A RMSD). The αβαβ 
module of 1ZFJ and NTM1082 are more identical between each other than with 
1BMT, which in turn displays a more similar overall fold to NTM0182.  This fact 
emphasizes the intermediate nature of NTM0182. Two glycines that make contacts 
with the ligand (inosinic acid) in 1ZFJ are conserved in the structural superposition 
(figure 28). Both are very close to the nucleotide part of the inosinic acid, particularly 
near to the phosphate ion. 
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In summary, we may conclude that the conservation of the αβαβ element among the 
three protein folds is preserved due to functional reasons. The maximal sequence 
identity, and structural similarity, is confined to the region where the nucleotide binds 
in both, the flavodoxin-like fold (B12) and the (αβ)8-barrel fold (inosinic acid). In 
consequence, we could hypothesize that the three folds are binding ligands with 
phosphate moieties.  The conserved αβαβ element will be involved in the interaction 
with the common phosphate moieties, and the rest of the fold evolved to 
accommodate divergent areas of the ligands.  
 
Having found evidences of common ancestry between the (αβ)8-barrel and the 
flavodoxin-like fold, we proceeded to explore the rest of the α/β class in SCOP. Our 
approach combined profile-profile comparisons with structural superimpositions. 
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3.11 Sequence-based exploration of the α /β  class in SCOP.  
 
The profile-profile comparisons of the (αβ)8-barrel and flavodoxin-like fold revealed 
striking local structural similarities. We then envisioned that by comparing Profile 
Hidden Markov Models  (HMM) representing all the α/β class in SCOP we could 
generate a database of interchangeable sub-domain fragments from different folds. 
Potentially, this database could be use as a framework to engineer novel 
functionalities that are present in different folds and could be combined in a single 
scaffold. As starting point, we aim to produce a well-folded protein starting by using 
fragment from divergent folds.  
 
We took all the profiles that represent the structures classified in SCOP70 as α/β folds 
(147 folds) and we compared all against all. By this we generated a database of 
HHsearch outputs that contained the result of the comparisons. The database 
contained a huge amount of data; therefore we decided to only explore the most 
ancient connections.  
 
To determine which were the most ancient folds we refer to an extensive work from 
Caetano-Anollés and coworkers (16). This work is based on a genomic demography 
involving hundreds of genomes. They measured the frequencies of occurring of 
protein folds in individual genomes as a phylogenetic character that describe how 
popular folds are in nature. They derived a phylogenetic tree in which the 3-helical 
bundle is the most ancestral fold followed by the (αβ)8-barrel  and the Rossmann fold. 
We therefore started looking for high-scoring pairwise connections established among 
the folds listed in table 19.  
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Table 19: The most ancestral folds in nature, the table was adapted from (16)  
SCOP label Fold 
c.37 P-loop containing nucleoside triphosphate hydrolases  
3 layers with α/β/α arrangement, parallel or mixed β-sheets of 
variable sizes 
a.4 DNA/RNA-binding 3-helical bundle  
Core: 3-helices; closed or partly opened bundle, right-handed twist; 
up-and-down 
c.1 (β/α)8-barrel Closed barrel with parallel β-sheet and strand order 
12345678 
c.2 NAD(P)-binding Rossmann-fold domains 
Core: 3 layers in α/β/α arrangement; parallel β-sheet of 6 strands, 
order 321456 
d.58 Ferredoxin-like 
Core: 3 helices; closed or partly opened bundle, right-handed twist; 
up-and-down 
c.23 Flavodoxin-like 
3 layers with α/ β /α arrangement; parallel β-sheet of 5 strands, order 
21345 
c.55 Ribonuclease H-like motif 
3 layers with α/β/α arrangement; mixed β-sheet of 5 strands, order 
32145 with strand 2 antiparallel to the rest 
b.40 OB-fold 
Closed or partly opened barrel, with greek-key motif 
c.66 
 
S-adenosyl-L-methionine-dependent methyltransferases 
Core: 3 layers with α/β/α arrangement; mixed β-sheet of 7 strands, 
order 3214576 with strand 7 antiparallel to the rest 
 
The Virulence factor MviM from Escherichia coli (SCOP d1tlta1 c.2.1.3, Rossman 
fold) was aligned with the KDO8P synthase from Haemophilus influenza (SCOP 
d1o60a_ c.1.10.4 (αβ)8-barrel fold). 74 columns were aligned with a probability of 
76.29 and E-value of 0.43. Having found the homologous region with HHsearch we 
then structurally superimposed 62 C-alpha carbons with an RMSD of 2.31 and 4.680 
Z-score (figure 29). The Z-score indicates how statistically significant is the 
superposition 
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Fig. 29: A sequence-based profile-profile alignment between different folds 
indicates structurally conserved fragments. A) The KDO8P synthase and B) 
Virulence factor MviM. The aligned region is highlighted in color. 
  
The NAD(P)-binding Rossmann-fold (SCOP c.2) also hit with high HHsearch 
probability another ancestral fold, the S-adenosyl-L-methionine-dependent 
methyltransferases (SCOP c.66). The bacterial secondary alcohol dehydrogenase from 
Clostridium beijerinckii (SCOP c.2.1.1) was aligned to the hypothetical protein 
Ta0852 from Thermoplasma acidophilum (SCOP c.66.1.13) with the following 
scores: probability of 97.05 and E-value of 1.5e-06 for a 110 columns profile-profile 
alignment (see figure 30 for details).  As we did with the first example, we proceeded 
to structurally superimpose the homologous regions in both folds detected by 
sequence. We generated an alignment of 118 C-alphas with a RMSD of 3.0 Å. The Z- 
score was 6.67.  
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Fig. 30: Two three-layered folds share a conserved fragment. The NAD(P)-
binding Rossmann-fold (A) shares a sub-domain size fragment with the S-
adenosyl-L-methionine-dependent methyltransferase fold (B). 
 
Among the results we detected an especially remarkable case of hit between two 
different SCOP fold classes. The DNA-binding protein Sso10a from Sulfolobus 
solfataricus (SCOP a.4) that belongs to the all-alpha fold DNA/RNA-binding 3-
helical bundle found with very high probability the (αβ)8-barrel HemN from 
Escherichia coli. The alignment consisted of 54 columns, with HHsearch probability 
of 90.36 and reported E-value of 0.02. At the first glance, this hit would look like a 
false positive because the aligned pairs are classified in different classes. Pairs form 
different classes would be by definition not easy to align because of the topology of 
their secondary structural elements. However, the structural alignment returned very 
good scores: 36 c-alpha carbons (RMSD of 2.2 A) and Z-score of 6.0.  
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Fig. 31: A super-secondary structure is shared between members of 
different SCOP classes. The (αβ)8-barrel 1olt (A) shares an α/β/β element 
with the alpha helical bundle 1r7j (B).  
 
The structural comparison depicted in figure 31 can be interpreted in several ways. It 
can be seen as a false positive found by the HHsearch algorithm. On the other hand, it 
can reflect the subjective nature of the SCOP classification. The aligned fragment 
between the barrel and the helical bundle is not part of the canonical barrel fold. The 
probability is among the highest ranked probability hits, it could therefore imply that 
this fragment is indeed an ancestral reminiscent fossil in both folds.  
 
Fig. 32: The SIS fold (A) shares the typical three-layer architecture of the 
flavodoxin-like fold (B).  
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In figure 32 we found a shared fragment between the ribosomal protein S2 from 
Archaeoglobus fulgidus (SCOP c.23.15.1, flavodoxin-like fold) and the 
phosphoheptose isomerase GmhA1 from Vibrio cholerae (SCOP c.80.1.3, SIS 
domain fold). The profile-profile alignment between the sequences of 1X94 (protein 
S2) and 1VI6 (phosphoheptose isomerase) returned the following values: 85.48 
HHsearch probability, 133 columns aligned and E-value 0.11. The structural 
alignment returned the following values: 121 C-alpha carbons aligned, RMDS 2.3 and 
Z-score of 6.7. This superposition highlighted a very long sub-domain size fragment 
conserved between both folds.   
 
It was clear that a systematic exploration of the most ancestral folds (table 18) might 
provide useful information on early fold evolution. Especially if we can develop 
evolutionary models that can explain how the most basal folds gave rise to modern 
ones. Along these lines, the profile-profile comparisons were primarily envisioned as 
a methodology to find sub-domain size fragments between different folds that could 
be combined to design well-folded proteins with native-like properties. 
 
The pairwise relationships between different folds had to be automatically explored. 
Therefore, we started to work in collaboration with Saacnicteh Toledo and Matthias 
Schwer.  They developed an algorithm capable of filtering the results of the profile-
profile comparisons in function of multiple features: number of aligned columns, 
probability score, number of gaps, P-value, E-value. Moreover, an extension of their 
code performs multiple and dynamic structural superpositions to visualize shared 
fragments. This algorithm allowed us to discover three folds linked with high 
probability: (αβ)8-barrel (SCOP c.1), flavodoxin-like (SCOP c.23) and the 
Periplasmic binding protein-like I fold (SCOP c.93). In the next chapter, we discuss 
the construction of a chimeric protein using fragments from Periplasmic binding 
protein-like I and flavodoxin-like fold structures.  
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3.12 Mimicking fold evolution by combination of homologous fold 
fragments. 
 
In the last chapter we described a triple high probability connection between three 
folds: (αβ)8-barrel (SCOP c.1), flavodoxin-like (SCOP c.23) and the PBP-like I 
(SCOP c.93). The algorithm for data mining generated by our co-workers allowed this 
finding.  
 
We looked for suitable parental template proteins to be combined into a well folded-
chimera. In order to decide which proteins select as starting scaffolds we took into 
consideration many points: high probability profile-profile pairwise alignment, 
thermo-stability, single domain existence in databases, how easy can we handle the 
protein in the lab, etc.  
 
The first parental scaffold was CheY from Thermotoga maritima (SCOP c.23.1.1, 
flavodoxin-like fold) because we had experience handling this protein in the lab; it is 
thermo-stable and can be solubly expressed as a single domain. The second scaffold 
was the leucine-binding protein (LBP) from Escherichia coli (SCOP c.93.1.1, 
Periplasmic binding protein-like I fold) because it was also easy to handle, there were 
crystal structures in different conformations available in the PDB and because our 
general interest in this scaffold for protein design.   
 
3.13 Sequence-based alignments are used to structurally align the 
flavodoxin-like and PBP-like I folds.   
 
In order to build the chimera LBP-CheY we used the sequences of both proteins to 
perform a pairwise profile-profile search of the SCOP database. We searched the 
SCOP95 (SCOP filtered at 95% sequence identity) with default parameters (turning 
off the secondary structure scoring), to double check the homologous relationship 
between the flavodoxin-like fold and the periplasmic binding protein.  We started the 
bidirectional search hoping to converge to the same fragment in both directions. The 
likelihood of having a true positive hit is higher if both searches converge to the same 
hit with equivalent probabilities.  
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A pairwise profile-profile alignment between the sequences of 1USG and 1U0Y 
converged to the same aligned region in the longer protein, 1USG (see figure 33 for 
details).  
 
Fig. 33: The sequence (a) and structure (b) based alignments of 1TMY 
and 1USG. The scores for the sequence alignment are as follows: a) 
probability of 81.19, b) identities=15% and c) the number of aligned 
residues was 106. The structural scores are as follows: an R.M.S.D of 
2.667 Å for 95 c-α atoms with a Z-score of 5.35. 
 
Two intertwined lobes compose the periplasmic binding protein (figure 34). The N 
terminal lobe crosses the hinge region to the C terminal lobe at the end of β5. The β-
sheet from the C-terminal lobe starts in β6 and goes back to the N-terminal lobe in 
β10, to finally cross one more time after β10 to complete the extended β-sheet from 
lobe C with a β-meander (composed by the last two β-strands). The profile-profile 
pairwise alignment covers the CheY fold sequence from residue 2 until residue 109 
from β1 to the beggining of α5. In LBP, the alignment goes from residue 138 starting 
in β6 finishing in residue 253 in β10 (see figure 34).  
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Fig. 34: Structural superposition between 1USG (violet region) and 1TMY 
(green region). The alignment showed a conserved sub-domain size fragment 
between both folds. We generated a chimeric domain by replacing the violet 
region with the green fragment. 
 
We used the profile-profile alignment from figure 33 to guide a structural 
superposition of the two proteins shown in figure 34. The web server SSM allows 
users to perform range-restricted structural alignments; we therefore structurally 
aligned the regions of the folds that were aligned by HHsearch.  
 
The structural superposition produced the following scores: rmsd of 2.667 Å over 95 
Cα atoms and Z-score of 5.354. Interestingly, the Z-score reported for this alignment 
lies within the so-called twilight zone of structural homology: Z-score values below 2 
are considered insignificant, between 2-8 a gray zone of homology is determined and 
above 8 the pairs aligned are considered homologous proteins. The structural 
alignment with Z-score of 5.3 lies directly in between 2 and 8 therefore it is not 
possible to determine, with this single score, whether these two folds are homologous. 
Nonetheless, taking into account the bidirectional pairwise profile-profile alignment 
between LBP and CheY we can conclude that both folds are at least locally 
homologous. 
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Guided by the previous alignments (structural and sequence-based) we defined the 
region that would be interchanged between both folds. We assumed that the 
flavodoxin-like fold is homologous to the aligned region on the second C-terminal 
lobe of the leucine-binding protein. The alignments cover as much as three αβ 
elements plus an extra β-strand. We intended to interchange these elements to create 
chimeric proteins that would resemble how evolution would have created structural 
diversity starting from a set of reduced fragments.  
  
 
3.14 Homology modeling and computational chimera design   
  
We produced several versions of the LBP-CheY chimera. Versions 01 and 02 were 
initially tested for native like folding properties. Versions 03, 04 and 05 were attempts 
to generate protein crystals that would allow the determination of an X-ray crystal 
structure.  See appendix (section 8.2) and figure 35 for details about the different 
versions of LPB-CheY. 
 
 
Fig. 35: LBP-CheY-01 secondary structure representation. In the design 
procedure we did not include a lysine (highlighted in red). We engineered an N-
terminal methionine and a C-terminal 6X-His tag. We introduced the missing 
lysine in LBP-CheY-02 (see section 8.2 from appendix for sequence details on 
the different versions of the LBP-CheY chimera)   
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For the chimera building process we generated several homology models of all the 
chimeras. It is difficult to predict how the pieces from different folds are going to 
interact with each other; however, by using a comparative modeling protocol we 
could estimate the probable tridimensional arrangement. The homology modeling 
process involves four steps: fold assignment, target-template alignment, model 
building and evaluation of the model. We used as templates the coordinates from the 
leucine-binding protein from Escherichia coli  (1USG) and the response regulator 
CheY (1TMY) from Thermotoga maritima.  
 
We generated an alignment using the sequences from both folds in PIR format, see 
appendix for details (section 8.1). The alignment between the sequences of both 
structures is crucial because it will determine the transition of one sub-domain size 
fragment to the next one. We aligned the HMM of both structures in the HHpred web-
server, this kind of alignment is more precise than aligning single sequences.  
 
We checked the homology model using an internal evaluation protocol of Modeller. 
The evaluation protocol is called ANOLEA, where non-local interactions are used to 
assess the quality of the model. Of course, the most obvious assessment of the model 
is the one made by performing a careful visual inspection. A well-folded protein will 
feature a packed core with hydrophobic residues shielded from solvent.  
 
Modeller performs a raw minimization protocol. To evaluate the models more 
precisely we employed energy minimization with the program Rosetta. The idealize 
protocol was used, because it restructures a protein molecule by adjusting the bond 
lengths, and bond and torsion angles to idealized values. This protocol can yield 
structures with bad clashes; therefore, we subsequently used the rosetta-relax 
protocol. This approach is used to lower the energy of a model through minor changes 
to the backbone and side-chain torsion angles. The Rosetta relax algorithm can 
generate 100 structures (a higher number of structures can be specified) that will have 
different rosetta-energy units.  Rosetta does not calculate physical energies (i.e. 
kcal/mol); the calculated energy cannot be translated into physical energies but are 
useful to compare different structures from the same run.   
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We performed the Rosetta-protocol for all chimeric versions. The protocol we 
developed was useful to spot a missing lysine in LBP-CheY-01 (see figure 35 for 
details). The energy of the residues around the insertion site (two residues after β4) 
was unusually high. We observed that the peptide bond-length was quite far from the 
knowledge-based distribution of peptide-bond lengths in proteins. The missing lysine 
was added to version LBP-CheY-02. In general, the energy per residue of the 
different chimeras did not show any difference that could lead us to choose different 
insertion sites.  No chimera consistently displayed a better energy per residue than the 
rest. In other words, besides spotting errors in the design, we did not find any 
consistent significant difference in energy between all the versions (versions 1 to 5, 
shown in appendix section 8.2).  
  
 98 
3.15 Experimental characterization of the chimera LBP-CheY   
 
We constructed and tested LBP-CheY-01 and LBP-CheY-02 in the laboratory. No 
major differences between both chimeras were seen during the biophysical 
characterization. Therefore we show only the data for LBP-CheY-01.  
 
The chimera LBP-CheY-01 displayed native-like properties and could be purified as a 
monomer. Nonetheless, we were not able to produce crystals. Therefore we generated 
several variants of the initial construct. The data generated from the partial 
characterization of all chimeras are outlined in table 20.  
 
 
Table 20: Experimental characterization of LBP-CheY chimeras. The amount of 
protein, in the soluble or insoluble the fraction, is indicated by the number of (✓) 
symbols. Success or failure of the crystallization attempts is indicated with (✓) 
or (X) respectively. 
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LBP-CheY-01 ✓ ✓✓ ✓ ✓ ✓ ✓ ✓ ✓    X 
LBP-CheY-02 ✓ ✓✓ ✓ ✓ ✓ ✓ ✓ ✓    X 
LBP-CheY-03 ✓ ✓✓ ✓ ✓ ✓   ✓ 7 Å 
LBP-CheY-04 ✓ ✓✓ ✓ ✓ ✓   ✓ 7 Å 
LBP-CheY-05 ✓ ✓✓ ✓ ✓ ✓   ✓ X 
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Fig. 36: Nickel affinity purification of LBP-CheY-01. An increasing percentage 
of imidazole was used for elution. The purification and refolding of LBP-CheY-
01 was evaluated by SDS-PAGE. Lanes: 1) molecular weight marker, 2) 
insoluble fraction, 3) soluble fraction, 4) flow-through, 5) wash 5%, 6) elution 
40%, 7) elution 80%, 8) refolded protein and 9) molecular weight marker. A red 
dashed square indicates the LBP-CheY-01 band at around 35 kDa. 
 
We cloned the chimeras and LBP fused to a 6X His Tag. All the proteins were 
expressed in Escherichia coli using a standard protocol (see methods for details). 
LBP-CheY-01 was mainly expressed in the insoluble fraction (figure 36); however, 
some small amount (between 15 to 20 % of the total protein) was still soluble. LBP 
wild type was mainly expressed in the soluble fraction. Nickel affinity 
chromatography was the first purification step. A second purification step involved 
size exclusion chromatography.  
 
We performed analytical gel filtration runs with purified samples to estimate the 
oligomerization state of the chimera. The gel filtration run showed that it is possible 
to purify the chimera LBP-CheY-01 as a single monomeric protein and the size is 
similar to the size of the LBP (figure 37). LBP-CheY-01 eluted later than LBP; this 
could indicate that LBP wild type is more compact than the chimera. 
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Fig. 37: Analytical gel filtration curves of LBP (red) and LBP-CheY-01 
(blue). The calculated apparent molecular sizes of LBP wild type and 
LBP-CheY-01 were 39.7 and 42.3 kDa respectively.  
 
 
Fig. 38: Circular dichroism of LBP (red curve) and LBP-CheY-01 (blue 
curve). The secondary structure content of both proteins is similar. 
Nonetheless, the alpha-helical content is more pronounced in LBP wild 
type.  
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We measured far-UV circular dichroism to evaluate the secondary structure content of 
the chimera in comparison to the wild type LBP. The CD-spectra showed that both 
proteins have a very similar content of secondary structures. The signal for the alpha 
helical content is a bit stronger in the wild type protein than in the chimera. 
Nonetheless, the differences are small (figure 38).  
 
 
Fig. 39: Fluorescence spectroscopy curve of LBP-CheY-01. In red we observe 
the natively folded chimera with an emission maximum at 342 nm. After 
addition of 6 M GdmCl the signal is reduced and shifted. 
In order to assess the tertiary structure of the chimera, we performed fluorescence 
spectroscopy measurements (Figure 39). The protein showed a maximum at around 
340 nm indicating that the aromatic residues were shielded from the solvent. To 
evaluate how the protein unfolds we added 6 Molar Guanidine hydrochloride and we 
measured the spectrum again. The spectrum showed a maximum at 360 nm and lost 
about a third of its intensity. This is a clear indication that the protein was previously 
folded and after the addition of the guanidine hydrochloride, the aromatic residues 
were exposed to the solvent, causing a shift and a reduction in the relative 
fluorescence.  
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3.16 LBP-CheY crystallization efforts  
 
To evaluate how the two fragments from the different folds fit with each other we 
decided to produce an atomic model of the well-folded chimera. We expressed LBP-
CheY-01 and LBP-CheY-02 in large scale to set crystallization screenings because we 
needed big amounts of protein. Both chimeras were mainly expressed in inclusion 
bodies; only a few fraction of the total protein was soluble expressed. Therefore, we 
refolded LBP-CheY-01 and LBP-CheY-02 from the insoluble fraction. Generally, the 
protocol yielded 20 mg of pure protein starting from 4 liters of culture media. The 
success of the refolding protocol was evaluated by SDS-PAGE (lane 8 in figure 36).  
  
The chimeras were refolded into different oligomerization states. For crystallization 
purposes it was necessary to produce a monodisperse sample; therefore, we 
implemented a two-step purification protocol after the refolding to obtain a sample for 
crystallization. First, we used ion exchange to enrich the monomeric state over other 
states in our samples. Finally, we used size exclusion to isolate only the monomeric 
version of the chimeras. We concentrated samples of LBP-CheY-01 and LBP-CheY-
02 up to 10.0 mg/mL (400 µL each sample) to set a crystallization screening (6 plates 
x 96 conditions).   Unfortunately no crystals were produced from these crystallization 
attempts. 
 
 
Fig. 40: Crystals of LBP-CheY-03. The protein concentration was 23 mg/mL, 
and the conditions were: 0.2 M Ca Acetate, 0.1 M Na cacodylate pH 6.5 and 
18% PEG 8000 (w/v). These protein crystals diffracted up to 9.0 Å resolution. 
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We judged that the flexibility of the 6X His Tag represented a problem for 
crystallization. Moreover, our purification protocol did not require the presence of 
such a tag.  Therefore, we removed it to produce chimera LBP-CheY-03. We 
followed our established purification protocol from inclusion bodies to obtain a 
monodisperse sample that was concentrated up to 23 mg/ml. We set a crystallization 
screening using two drops, one with 20-fold molar excess of leucine and another drop 
only with protein. There was a crystal hit for the drop without leucine [mother liquor 
components: 0.2 M Ca Acetate, 0.1 M Na cacodylate pH 6.5 and 18% PEG 8000 
(w/v)]. The crystals were needle-like shaped and grew on the top of each other (figure 
40). We shot these crystals at the PXII beamline at the Swiss light source to confirm 
that they were protein crystals. The crystals diffracted with maximum resolution of 
9.0 Å.  
 
Visually, these crystals looked needle-like shaped with sharp ends and had a 
considerable size. We set optimization trials around the original conditions to 
subsequently fish and screen around 40 crystals. The variations only included the 
concentration of the contents of the drop and no additives. Unfortunately the best 
diffracting crystal only reach 7 Å. Interestingly, and as expected, the improvement in 
the diffraction followed an increase in the concentration of the precipitant, from 18 to 
22% PEG 8000 (w/v).  
 
Subsequently, we tried several documented optimization techniques to improve the 
diffraction of the crystals:  a) dehydration of the crystal directly at the beamline, b) 
dehydration of the crystal in the mother solution drop by direct contact with air, c) 
subsequent removal of solvent by transferring crystals from mother solutions with 
increasing precipitant. Yet, we did not manage to improve the crystals to reach a 
resolution that allowed structure determination. We then proceeded to re-design the 
LBP-CheY chimera in two subsequent experiments to create LBP-CheY-04 and LBP-
CheY-05.  
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LBP-CheY-04 is a design suggested by an unpublished algorithm (Nils Woetzel, 
personal communication) named BCL::FusionProtein. This algorithm takes into 
account several scores (e.g. clashes introduced, peptide bond distance between the 
fusion fragments) to suggest an insertion site in the acceptor scaffold. The algorithm 
localizes the insertion sites by cutting and pasting the donor fragment in the secondary 
structural elements.  
 
The difference between LBP-CheY 3 and 4 are the insertion points in the acceptor 
scaffold: chimera LBP-CheY-03 has the flavodoxin-like fold structure (starting at β1) 
inserted right at the end of the loop α5β6. In contrast, LBP-CheY-04 features the 
insertion of CheY after the first residue of β6 so we have a final fusion of β6 from 
LBP to β1 from CheY. The c-terminal insertion point is the fusion between β5 from 
CheY and β10 from LBP, right in the middle of the β-strand. This kind of 
configuration may yield a more rigid construct. 
 
We cloned, expressed and purified LBP-CheY-04 following the same protocol used 
for the other chimeras. During the purification process the chimera behaved in a 
similar manner than previous constructs. We did not perform a full biophysical 
characterization. A crystallization screening was set with the purified sample. From 
this attempt, we again produced good-looking crystals that diffracted no better than 
7.0 Å resolution. Then we decided to redesign the construct to produce LBP-CheY-05 
in an attempt to improve the resolution of the crystals.  
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3.17 LBP-CheY loop re-design 
 
For the design of chimeras 1 to 4 we used as template the open conformation of the 
leucine-binding Protein (1USG). For chimera 05 we switched our template to 1USK, 
that is the closed conformation of LBP. The region we estimated that might prevent 
compact packing in the chimera is highlighted in figure 41; the superposition shows 
that the loop β4α5 in CheY is clearly bigger than the topologically equivalent loop in 
LBP (booth loops crossed by red bars). Moreover, the loop from CheY is not only 
abolishing interactions for binding leucine but also it may be clashing with the upper 
lobe of LBP.  The composition of the loops is very different in the two proteins: 
CSAMGQ in CheY and GPEGVGN  (comprising a 310 helix) loop in LBP.  
 
 
Fig. 41: Zoom in into the superposition of 1TMY (green) and 1USK(violet). 
Two red bars delimit the loops that are different in length. In LBP, the loop 
includes 310-helix.  A red star indicates a probable clash in the chimeric protein 
that is preventing a close conformation. Leucine is highlighted in black sticks. 
Observing closely the binding pocket of 1USK we discovered that 9 residues establish 
direct contact with leucine. See table 21 for details.  
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Table 21: Residues in 1USK that do not have an equivalent in the chimera LBP-CheY. Also 
we highlight whether the residues would be clashing in the new chimeric context. 
Residue in LBP (1USK) Presence/absence (by replacing with loop 
from CheY) 
S79 Present 
G100 Present 
T102 Present 
Y202 Missing 
E226 Missing 
W18 (upper lobe) Present in LBP but maybe clashing with 
CheY loop 
Y150 Missing 
G227 Missing 
Y276 (upper lobe) Present in LBP but maybe clashing with 
CheY loop 
 
In LBP-CheY-03 two interactions with the ligand are missing, the ones established by 
E226 and G227. We think these residues are important to maintain the geometry of 
the binding pocket. What is more, two other interactions established by W18 and 
Y276 with the hydrophobic lateral chain of leucine, are also probably abolished.  It 
appears that the CheY loop is clashing with the hydrophobic residues W18 and Y276 
(see figure 41 for details).  
 
In order to build a design capable to adopt a closed conformation, that in principle 
could produce better crystals, we built chimera 05. In this chimera, the introduced 
CheY fragment is shorter than in previous chimeras; it includes up to the end of β4 of 
CheY. We therefore hoped to recover many interactions abolished in previous 
chimeras. We cloned, expressed and purified LBP-CheY-05 as we did with previous 
versions. We also set a crystallization screening with this version. Unfortunately, no 
crystals were produced.  
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4. Discussion  
 
4.1 Profile-profile comparisons of two superfolds 
 
As Charles Darwin recognized similarities between different species, protein 
scientists observe sequence, structure and functional shared patterns among proteins 
(10) (73). Through these observations, general sets of rules governing protein folding 
and function start to emerge. For instance, statistical studies of protein sequences 
revealed independent networks of coevolving functional residues that are more 
sensitive to mutation than others (74). Furthermore, comparative structural studies 
have shown how isolated protein domains with primitive functions can evolve to yield 
multi-domain proteins with sophisticated activities (75). Through the recognition of 
energetically unfavorable features in natural proteins, which arose by natural selection 
and random genetic drift, the design of ideal protein scaffolds (76) was successfully 
accomplished. These findings are the natural result of our better understanding of 
protein evolution. 
 
Our understanding of protein evolution is in constant expansion. Not only the 
development of novel tools for homology detection contribute to this advancement. 
Also protein-engineering experiments test our knowledge of the rules governing 
protein folding and function. With this work, we identified homology between 
proteins that adopt different folds. Structure-based evidences (36) and protein 
engineering experiments (37, 40) previously suggested this possibility. We then 
decided to use the best available sequence-based homology detection tools, working 
with the SCOP classification system, to explore the structures grouped into these 
folds.  
 
The exploration of the SCOP superfamilies from different folds by pairwise alignment 
of HMMs provided initial evidences for homology. This recently developed tool for 
homology detection is already used by many of the best structure prediction servers 
and has ranked best in last years CASP exercises (77). While the algorithm has 
proven to be one of the best of its class, at the time of its first benchmarking there 
were many hits between different folds, which could not be easily explained (33).  
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The high sensitivity of the HHsearch tool inspired sequence-based explorations of the 
structure space. For instance, by exploring the SCOP20 database (sequences are 
similar to a maximum of 20% sequence identity) Alva et al. presented a starting point 
in which a single image gives an overview of how some representative members of 
protein families and superfamilies cluster based on sequence. They showed that many 
of the superfamilies of one fold cluster together and that there appears to be more 
connectivity in fold space than previously expected.  
 
We then recognized the potential of HHsearch combined with structure-based 
observations to assess probable homologous relationships between distinct fold 
classes. As starting point of our research, we re-evaluated the sequence-based 
connections that support homology among the (βα)8-barrel fold superfamilies. We 
indeed reproduced previous results and extended it by connecting up to 30 from 33 
superfamilies. The most connected (βα)8-barrel fold proteins are the aldolases; not 
only were strongly connected to many phosphate binding barrels, but also with the 
two flavodoxin-like fold superfamilies that share local structural similarity  to (βα)8-
barrel fold proteins.  The 3 (αβ)8-barrel superfamilies that do not hit each other with 
more than 80% probability may not be well represented in the structural databases. 
Perhaps, as more structures, or sequences, become available, it will be possible to link 
all (βα)8-barrel fold superfamilies. On the flavodoxin-like fold side, the connectivity 
was less pronounced. Lacking enough structures in the databases, as previously 
discussed with the barrels, may be the reason of such observation. On the other hand, 
three-layered architectures, with variable topological connections, are rather common 
among many proteins in the databases. In consequence, a convergent origin of this 
fold seems plausible. 
 
The most interesting part comes when we evaluated the inter-fold connections. 
Strikingly, we found many connections between two flavodoxin-like superfamilies, 
the B12-binding domains and response regulators, with a number of  (βα)8-barrel fold 
superfamilies. We had to be cautious at this point, because every computational 
algorithm would in principle deliver a number of false positives.  
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Having this in mind, we set astringent measures to reduce the number of false positive 
instances: a) the probability connections had to be reciprocal, b) a stringent cut-off of 
80% Bayesian probability, c) secondary structure content was not considered, and d) 
many proteins from the same superfamily had to hit many members of the other 
superfamily-fold. 
 
Figure 8 shows the density of hits in function of probability by starting the HHsearch 
job with either a flavodoxin-like or a (βα)8-barrel fold query.  Here it is possible to 
appreciate that a high density of hits from the same fold class (self-hits) are indeed 
found at higher probabilities than 80%. What is more, starting the search with (βα)8-
barrel fold queries, we found the same number of flavodoxin-like hits than (βα)8-
barrel fold hits at around 80% probability.  
 
This overlap in the number of hits from both fold classes emphasizes the strong 
sequence-based connectivity. The flavodoxin-like fold queries found other 
flavodoxin-like fold hits in a very narrow probability space. Nevertheless, at very 
high probability many members of the (βα)8-barrel fold are found, at least two times 
more members than any other fold. One may argue that the secondary structure 
content, or the similar architecture of the αβ elements could be the source of these 
high-scored relationships. We can rule out this possibility since only two from 15 
members of the flavodoxin-like fold were hitting with such high probability scores a 
number of (βα)8-barrel fold superfamilies.  
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4.2 Searching the databases for intermediate sequences.  
 
The profile-profile searches allowed us to locate the sequence space interface between 
both folds where it was most probable to discover sequences with intermediate 
features.  We launched remote homologous searches using queries from both folds 
that were closely related. The searches were a relatively straightforward approach; the 
most difficult part of our research was the clustering and evaluation process of the 
intermediate sequences. Several factors made the evaluation a daunting task:  
 
1. The sequences coming from the raw HHsenser outputs are shorter than the 
complete hit, because the high scoring pair of the BLAST comparison is 
restricted to a local region of the query-hit alignment. In principle we could 
have extracted the full-length sequences found by HHsenser and cluster full 
domain proteins; the complication comes when the domain boundary has to be 
allocated. This is a very well known problem in protein evolution studies 
because domain boundary definitions are neither trivial nor easy. It usually 
requires the building of a single multiple sequence alignment per hit, and we 
clustered thousands of sequences. We could have clustered the sequences by 
families to well align them separately in order to define the domain 
boundaries. 
2. These sequences are not only short; they have missing residues as well. 
HHsenser only keeps the high scoring pair that matches hit and query, it does 
not keep the rest after seed extension. 
3. One sequence can be located in the middle of two clusters (while connecting 
them), but it could be a false positive. This sequence may be a very short 
fragment that has similarities to both folds but only locally. As soon as one 
pulls the complete sequence this hit would not appear in the middle anymore, 
it would be closer to the members of the cluster that are more similar to it (one 
or the other fold).   
4. A sequence is not in the middle but is connected to clusters from different 
folds. There is a short fragment-sequence, inside the cluster from fold x, that 
had strong similarities with one protein in the cluster from fold y.  
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In this sense, the repulsion and attraction values (selected by default in 
CLANS) are placing this protein inside of its “own” cluster, even if it had a 
high scoring pair (represented by edges connecting two clusters) in the cluster 
from the other fold. Because there are so many sequences in its family-cluster 
the attraction will be too strong and therefore this sequence would not appear 
in the middle. 
5. Connectivity among the clusters. The connectivity changes dramatically if the 
P-value of the connections is slightly changed. At a given P-value, a protein 
may seem a link between two clusters; however, when the complete protein 
replaces this hit the link may not hold. These borderline connections, can be 
either established or removed by varying the P-value one order of magnitude.  
6. Singletons (or unrelated proteins) pulled in the HHsenser search because very 
relaxed parameters were used. This would introduce visual noise into the 
cluster map. 
 
Having all these complications in mind, I looked for other features in the CLANS 
maps: the position, the connections, the length of the hit, and the P-value of the 
connection. 
 
We used the sequence of the glutamate mutase (SCOP c.23.6) from Clostridium 
cochlearium to perform the deepest homologous searches in this work. Remarkably, 
this search travelled the sequence space of the flavodoxin-like fold to find sequences 
associated with the (βα)8-barrel fold. There were several short (β/α)8-barrels that have 
high sequence identity towards both folds. The cluster map of the hits found is shown 
in figure 42. Highlighted in yellow, we found the sequences that belong to the “B12-
binding domain_like associated with radical SAM domain”. We also see some 
sequences that would hypothetically fold as (β/α)8-barrels; these are very similar to 
the sequence of one structure, also present in the map (colored in blue), the nicotinate 
phosphoribosyltransferase from Thermoplasma acidophilum (PBD 1YTD; SCOP 
c.1.17) 
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Fig. 42: Clustering map of the HHsenser output from 1I9C (SCOP c.23.6).  The 
coloring is as follows: a) flavodoxin-like fold hits highlighted in green, b) 
response regulators (CheY like superfamily C.23.1) in green/brown, c) 
B12_binding_like in green/orange, d) fragments of (β/α)8-barrels (in green/blue); 
among these sequences we can find the sequence from the structure 1YTD 
(c.1.17.1) and proteins that belong to the (β/α)8-barrel IMPDH superfamily 
(c.1.5.1), e) starting query 1I9C highlighted as red cross and f) NTM0182, 
highlighted as a violet cross. 
Remarkably, it seems that the deep remote homologous search, clustered in figure 42, 
travelled between the two different structural islands by finding fragments of (β/α)8-
barrels that are locally similar to both folds. Analyzing these sequences we did not 
find any kind of intermediate form (in size terms) between the clusters from the 
different folds (green and blue/green). It seems that there is a very discrete change, in 
function of the sequence, from one fold to the other.  Our rationale was that a single 
sequence connecting clusters from two folds would be a rarity. Unless the protein is a 
pseudo-gene, a very special case of non-homologous recombination or its primary 
sequence evolved far away from any other protein in the database, we would always 
expect a family of proteins linking the two folds. 
 
PC04 intermediate sequence is a particularly special case since this protein is 
particularly different from any other protein in its family. A usual BLAST search 
finds hits that are sorted by the sequence identity respective to the query. The first hit 
would be 98% identical to the query; the second 90% the tenth hit may be 70% and so 
on.   
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With PC04, the first hit is only 45% identical to the query; it seems that the sequence 
diverged quite a lot. We are still working on getting more structural information on 
this protein.  
 
In the clustering map from figure 15, we observe the B12_like associated with SAM 
radical family of proteins that includes NTM0182. It is located closer to the barrel 
fold group of proteins. This also can be seen in figure 12, which shows a clustering 
map of 1I9C (c.23.6 B12-binding domain) and 1ZFJ  (c.1.5.1: Inosine monophosphate 
dehydrogenase) with NTM0182 highlighted with an arrow.  It is clear that B12_like 
associated with SAM radical family of proteins is indeed clustered closer to (β/α)8-
barrels. NTM0182 was chosen for experimental characterization because it was a 
thermo-stable member of this intermediate family of proteins.  We will discuss the 
structure of NTM0182 in the next section.  
 
Recognizing that CLANS clustering of HHsenser outputs seem to have many 
limitations, I implemented another early idea. Ideally, an intermediate candidate that 
would link two protein structures from different folds may be found by queries from 
both folds. Therefore, it may be present in two HHsenser outputs.  I looked for 
common gene identifiers in flavodoxin-like and (β/α)8-barrel HHsenser outputs. 
However, I never found any common gene identifier.  
 
This idea never really worked out as expected, I assume that hitting the same protein 
starting with two structures from different folds was very unlikely. Now, after having 
assessed the B12-binding domain_like associated with radical SAM domain family of 
proteins is intermediate, I wanted to see whether both folds hit this family.  
 
The B12-binding domain_like family of proteins was clearly more similar to the 
flavodoxin-like fold than to the (β/α)8-barrel. Therefore, it appears in many of the 
flavodoxin-like fold HHsenser outputs (specially the ones that were made using 
queries from the superfamily c.23.6). Thus, finding the same family of proteins in 
(β/α)8-barrel HHsenser outputs would be more interesting.  
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In the HHsenser outputs from the Methanococcus jannaschii synthase (SCOP 
c.1.27.1) and the glycerol uptake operon antiterminator protein from Thermotoga 
maritima (SCOP c.1.29.1) we found the cobalamin B12-binding:Radical SAM from 
Geobacter sp. Moreover, in the output from the dihydropteroate synthetase from 
staphylococcus aureus (SCOP c.1.21.1) the radical B12-binding:Radical SAM protein 
from Methanosaeta thermophile is also found.  
 
The superfamilies c.1.27.1, c.1.29.1 and c.1.21.1 are hitting flavodoxin-like fold 
superfamilies with high probabilities (around 80%). The presence of   the B12-
binding domain_like associated with radical SAM domain proteins in both, the 
flavodoxin-like and (β/α)8-barrel fold HHsenser outputs confirms my assumptions.  
This family is a convergence point for both folds. For future work, we will build 
clustering maps using the HHsenser outputs from both folds where the B12-binding 
domain_like associated with radical SAM family was found.  
 
4.3 Lessons learned from NTM0182 structure 
 
The determination of the NTM0182 structure provided a valuable resource of 
information to better understand the evolution of the  (β/α)8-barrel and flavodoxin-like 
folds. However, from the pure structural analysis, it is not clear yet whether the β-
strand swap has any biological significance or not. The β-strand invasion may be a 
consequence of the construct: without the C-terminal domain partner, the binding of 
the wild type ligand may be abolished. In consequence, the β-strand swaps to shield a 
free hydrophobic pocket. We hypothesized that the wild-type ligand may have a 
phosphate moiety. From some preliminary analysis, performed with the full-length 
construct that includes the C-terminal SAM radical domain, we observe a very strong 
stabilization effect of the protein after dialyzing with phosphate buffer. More 
experiments are needed: test stabilization of NTM0182 (monomer and dimer) upon 
phosphate addition and estimation of the oligomeric arrangement of the full-length 
construct. 
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By comparing the NTM0182 structure with members of the (β/α)8-barrel and 
flavodoxin-like folds it is possible to support homology under classic (70) sequence 
identity thresholds (figure 24). The alignment is structure-based, i.e. superimposable 
residues define the alignment and there is no further optimization to improve the 
sequence identity score. From the classical view of homology inference based on 
protein sequence identity: chance pairwise sequence identity goes up to 12%; if it is 
assumed that all residues can occur at equal frequency in proteins then it drops to 6% 
(10). Also, it has been argued that “above a cut-off roughly corresponding to 30% 
sequence identity, 90% of the pairs are homologous” and that “from 100–35% 
sequence identity, any residue exchange resulting in a stable structure maintains 
structure” (78).  
 
Observing the identities depicted in table 15, the structure of NTM0182 clearly is a 
sequence identity bridge between both folds: in the global alignment it is more than 
20% identical to both folds, while the alignment between the (β/α)8-barrel and the 
flavodoxin-like folds is below 10% sequence identity. The intermediate features of 
NTM0182 are even more evident when looking at the scores of the αβαβ element 
aligned among the three structures: it shares 37% sequence identity, over 40 residues 
aligned, with both folds; while the same fragment between the (β/α)8-barrel and the 
flavodoxin-like folds is only 18% identical.  
 
37% sequence identity over a 40 residues alignment is clearly above the classical 
threshold (70) for supporting homology between pairs of proteins. Moreover, the 
possibility of superimposing this fragment with high scores in multiple homologous 
(β/α)8-barrel superfamilies, and multiple times in the same structures already proven 
to have 2 and 3 fold symmetry are evidences of its intermediate properties. We 
suspect functional reasons for the conservation of the αβαβ element. It is likely that 
the three folds are binding a ligand with a phosphate moiety in the same region. The 
homology is well supported locally; the rest of the sequence between all the folds is 
less identical (aligned only by profile-profile comparisons). Perhaps the regions 
outside of the conserved element diverged by random drift or accommodated to the 
new structural context  
  
 116 
As a summary of this section of our work we conclude that the HMM-HMM 
comparisons provided initial evidences for homology between different folds. The 
initial observations allowed us to focus on a reduced area of the sequence space to 
find a protein that displays intermediate features between the (β/α)8-barrel and the 
flavodoxin-like fold. The structure of NTM0182 revealed a very conserved structural 
motif that is a valuable evidence of common ancestry between the folds. The 
homology is now supported in classical terms (high sequence identity) in addition to 
the HHsearch probability scores. Since we recognized the potential of the HHsearch 
tool, we therefore employed it to compare all the folds classified in the SCOP α/β 
class.   
4.4 Extending the profile-profile comparisons to all SCOP αβ  folds.  
 
As previously stated by Levitt “partitioning the protein structure universe into discrete 
folds does not exclude the similarities between protein domains that occur in different 
folds” (4). Protein classifications may be masking meaningful evolutionary 
relationships. Previously we already recognized the similarities between sub-
structures from different folds; based on this observation we outlined a methodology 
that could be useful in diverse applications (79).  
Subsequently, we explored the structure space using a sequence-based tool. We found 
many well-supported relationships among the most basal folds of the phylogenomic 
tree of architectures. We envisioned that our work could be used as a source of 
combinable fragments related by evolution that can be put together in order to expand 
the functionalities of the fold space. Being aware of the complication that carries the 
generation of chimeric proteins we decided to first build and test a novel chimera to 
see whether the sequence based fragments can be indeed combined in novel structural 
contexts.  
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4.5 Applied lessons from protein evolution: chimera building by 
combination of homologous fold-fragments.  
 
We were able to build a well-folded chimera with native-like properties by combining 
fragments from the proteins LBP and CheY. The periplasmic binding protein I like 
fold resembles a duplication of the flavodoxin-like fold. In fact, the structural 
superposition of CheY on one of the lobes of LBP shows very good scores. It is 
possible to superimpose the same flavodoxin-like fold on the other lobe; however, the 
similarities are not as good. It is likely that the periplasmic binding protein evolved by 
a duplication of the flavodoxin-like fold, since the latter is more close to the base of 
the phylogenetic tree of architectures. We assume that combining related folds 
provides a good starting point for protein design.  
 
The biophysical test performed on the chimera demonstrated that it is well folded. 
However, we did not manage to obtain an atomic model of the construct. Our 
redesign efforts were focused on the loops close to the hinge region. Moreover, we 
tried to use the Rosetta algorithm to evaluate how different designs may produce 
folded proteins. It is not clear whether the relaxation rounds performed with Rosetta 
really provided useful information. We discovered that the starting model we used as 
input to Rosetta has a strong influence on the final outcome. Even generating distinct 
homology models just by small variations in the alignment of template and target, 
already showed random variations in the calculated energies from Rosetta. We only 
observed some indications of problems with very bad energies when we used the 
closed conformation of LBP to build and minimize a homology model. In principle, 
Rosetta would evaluate all the models generated, with an open LBP, in the same way. 
No big differences were observed between the varieties of models used as input for 
the computation.   
 
An atomic resolution model of the chimera would be very valuable since we could 
infer how the fragments from the different folds are fitting together. Especially we 
could observe if the fragments will stay in the same conformation or if they suffer big 
rearrangements to adapt to the novel context.  
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Fig. 43: Structural superposition of LBP (violet) and CheY (green). The 
area where optimization can improve the packing of chimera LBP-CheY 
is highlighted in gray. The red arrow shows where the β-strands from the 
different folds will have to establish interactions to yield a chimeric β-
sheet.  
 
Finally, we observed another area that may be problematic for the proper packing of 
the chimera LBP-CheY. β13 from LBP must establish interactions with β5 of CheY 
in order to build the chimeric β-sheet (figure 43). In the future those areas could be 
improved by protein design or directed evolution to design a better-packed chimera 
that will yield better crystals.  
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5. Final considerations  
 
It is very likely that during the course of evolution modern protein domains were 
assembled by combination of smaller fragments. By comparing the sequences and 
structures of divergent pairs, we discover how nature designed the protein structure 
universe. The organization of protein structures into folds gives meaning to all the 
embellished shapes of the protein domains. Yet, the fold concept being arbitrary, it 
poses certain drawbacks. The protein classifications may obscure similarities in fold 
space and the comparison of sub-structures make the development of a metric of fold 
similarity almost unmanageable.  
 
With our work we demonstrate that protein folds are homologous although they are 
inconsistently classified. Yet, the concept helps to infer evolutionary relationships. 
And since multiple times protein evolution studies have shown that modern protein 
domains evolved by combination of smaller fragments, we could employ the fold 
concept in conjunction with novel homology detection tools to discover previously 
unseen relationships. 
  
Two general strategies can be outlined from our research.  We first compare profiles 
that represent the structure space to find meaningful relationships. These comparisons 
allow us to focus on regions of the sequence space that still lack representative 
structures. Determination of intermediate structures at the boundaries of different fold 
classes will be very informative for our understanding of how sequence defines 
structure. Moreover, by this we can also contribute to map the structure space and 
learn about the evolutionary roads that might have led to fold change during 
evolution. 
 
An enhanced knowledge of sequence-structure relationships will improve our ability 
to predict structures and design novel proteins with extended functionalities. We will 
have to rethink the way protein classifications are constructed to reflect the emergent 
view of a highly related protein fold space. 
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6. Summary of related publications and contributions 
 
6.1 Evolutionary relationships of ancient superfolds. 
 
In the past, common ancestry relationships between very divergent proteins were 
challenging to detect. Therefore, proteins that adopt different folds were classically 
considered to be non-homologous. Using state-of-the-art tools for homology detection 
I was able to find evidence for homology between proteins of two ancestral 
superfolds, the (βα)8-barrel (or TIM-barrel) and the flavodoxin-like fold. Moreover, I 
identified a family of proteins that showed intermediate features between both folds. I 
determined the first crystal structure of one of its members. This atomic model 
provided novel insights into the evolutionary roads followed by two of the earliest 
folds. Our combined insights provide support for an emergent vision where protein 
superfolds share common ancestry.  
Evolutionary relationship of two ancient protein superfolds  
Farías-Rico JA & Höcker B. 
Submitted to Nature, under review.  
 
6.2 Design of chimeric proteins by combination of subdomain-sized 
fragments 
 
As a natural extension of the superfold evolution project, we searched the protein 
structure space to find additional homologous folds. We discovered evidences of 
homology between the periplasmic binding protein-like I and the flavodoxin-like fold. 
To gain insight into how evolution might have occurred, we combined fragments that 
originated from these two folds. Having these experiments as background and 
guidance, but without including the sequence-based novelty approach, we wrote the 
following methods paper.  
Methods Enzymol. 2013;523:389-405 
Design of chimeric proteins by combination of subdomain-sized fragments.  
Farías-Rico JA, Höcker B. 
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6.3 Change in protein-ligand specificity through binding pocket grafting. 
 
The periplasmic binding proteins are promising scaffolds for biosensor engineering. 
In our lab, we are interested in understanding the mechanisms underlying protein- 
binding specificity. PotF and PotD, periplasmic binding proteins, show distinctive 
specificities for putrescine and spermidine. By mutating 7 residues in PotF to the ones 
present in the binding pocket of PotD, the ligand specificity of the protein was 
swapped. Our work shows how it is possible to successfully change the protein-ligand 
specificity through transplanting the binding pocket from PotD onto PotF. Moreover, 
we show how the specificity is encoded in the first shell residues of the PotF binding 
pocket. In this project, I was involved in the determination of the PotF mutant crystal 
structure. 
J Struct Biol. 2013 Jun 17. pii: S1047-8477(13)00157-3. 
Change in protein-ligand specificity through binding pocket grafting. 
Scheib U, Shanmugaratnam S, Farías-Rico JA, Höcker B.  
 
6.4 Detailed description of my contributions to this dissertation.  
 
Under the guidance and support from my advisor Birte Höcker, I performed all the 
work described in this doctoral thesis. I supervised Saacnicteh Toledo Patiño, an 
undergraduate student working in our laboratory, who contributed to this work in the 
following ways: a) cloning, expression and purification of some of the intermediate 
candidates between different folds, b) cloning, expression and purification of some 
chimeric constructs, c) biophysical tests of some of the proteins experimentally tested. 
Saacnicteh Toledo Patiño and Matthias Schwer developed a computational algorithm 
to parse the sequence data that I generated by the HMM-HMM comparisons. This 
algorithm made the detection of the sequence-based connection among the three folds 
addressed in this work possible. Steffen Schmidt contributed with valuable 
bioinformatic support and plotted figures 8 and 9.  
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8. Appendix  
 
8.1 Homology modeling pairwise alignment 
 
Pir format for Modeller input 
 
>P1;LBP-CheY-V5/1-340 
sequence:LBP-CheY-V5:   1: : 340: :: : 0.00: 0.00 
MDDIKVAVVGAMSGPIAQWGDMEFNGARQAIKDINAKGGIKGDKLVGVEYDDACDPKQAVAVANKIVNDGIK 
YVIGHLCSSSTQPASDIYEDEGILMISPGATNPELTQRGYQHIMRTAGLDSSQGPTAAKYILETVKPQRVLI 
VDDAAFM----RMMLKDIITKAGYEVAG------EATNGREAVEKYKELKPDIVTMDITMPEMNGIDAIKEI 
MKIDPNAKIIVGPEGVGNQAMVIEAIKAGAKDLVTMPKRYDQDPANQGIVDALKADKKDPSGPYVWITYAAV 
QSLATALERTGSDEPLALVKDLKANGANTVIGPLNWDEKGDLKGFDFGVFQWHADGSSTKAK* 
>P1;1usk/1-346 
structureX:1usk: :A: :A:c.93.1.1 (A) Leucine-binding protein [Thermotoga 
maritima]:1.53:0.17 
-DDIKVAVVGAMSGPIAQWGDMEFNGARQAIKDINAKGGIKGDKLVGVEYDDACDPKQAVAVANKIVNDGIK 
YVIGHLCSSSTQPASDIYEDEGILMISPGATNPELTQRGYQHIMRTAGLDSSQGPTAAKYILETVKPQRIAI 
IHDKQQYGEGLARSVQDGLKAANANVVFFDGITAGEKDFSALIARLKKENIDFVYY--GGYYPEMGQMLRQA 
RSVGLKTQ-FMGPEGVGNASLSNIAGDAAEGMLVTMPKRYDQDPANQGIVDALKADKKDPSGPYVWITYAAV 
QSLATALERTGSDEPLALVKDLKANGANTVIGPLNWDEKGDLKGFDFGVFQWHADGSSTKAK* 
>P1;1u0s/1-110 
structureX:1u0s: :Y: :Y:c.23.1.1 (Y) CheY protein [Thermotoga 
maritima]:1.90:0.23 
------------------------------------------------------------------------ 
------------------------------------------------------------------GKRVLI 
VDDAAFM----RMMLKDIITKAGYEVAG------EATNGREAVEKYKELKPDIVTMDITMPEMNGIDAIKEI 
MKIDPNAK-IIVCSAMGQQAMVIEAIKAGAKDFIVKPFQPSRV----------------------------- 
--------------------------------------------------------------* 
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8.2 Topology cartoons of chimeras LBP-CheY 2 to 5  
 
 
Fig. 44: LBP-CheY-02 topology cartoon  
 
 
 
 
Fig. 45: LBP-CheY-03 topology cartoon  
 
 
 
 
 
Fig. 46: LBP-CheY-04 topology cartoon 
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Fig. 47: LBP-CheY-05 topology cartoon 
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8.3 Sequences, primers and sources of experimentally tested intermediate 
sequences 
 
Table 22: Sequences of intermediate targets experimentally characterized. 
gi|15642956|ref|NP_227997.1| hypothetical protein TM0182 [Thermotoga maritima MSB8] 
Full sequence MYILFREMKNNWYSLAALLSTIYSRHLDVEARPVKFEEIKKFPPEKTIVAYSF
MSFDLDTVREEVKTLKERGYTLIAGGPHVTADPEGCLRMGFDHVFTGDGEE
NILKFLMGERKKIFDGISKRVNLNHYPPFLPSKGIYMPIEITRGCPFSCAYCQTP
IIAGRRVRHRDVDVVVHYAKLGVKHGRKLARFIAPNSFGYGSKNGVTPNVE
KIEELLYGLKKVGIEEIYFGTFPSEVRPESVTDEVLKVVKKYVNNRSIVIGAQS
GSDRILKIIKRGHTVEQVEEAIEKISLHGFIPHVDFIFGFPFETEEDVEKTFSFIV
KIVERYGAKIHAHTFMPLPGTELFNAGPGRLTEVHYKFLGRLASKGILDGYW
MKQEMLARKVYEIASGGSTDVTSDR 
TM01 MYILFREMKNNWYSLAALLSTIYSRHLDVEARPVKFEEIKKFPPEKTIVAYSF
MSFDLDTVREEVKTLKERGYTLIAGGPHVTADPEGCLRMGFDHVFTGDGEE
NILKFLMGERKKIFDGLEHHHHHH 
Primers >156429561_THERMO_FW  
CGCATATGTATATTCTCTTCAGAGAGATGAAG 
>15642956120_THERMO_RV 
CCTCGAGACCATCGAAGATCTTTTTTCTCTCC 
Gene source Genomic DNA 
TM02 MYILFREMKNNWYSLAALLSTIYSRHLDVEARPVKFEEIKKFPPEKTIVAYSF
MSFDLDTVREEVKTLKERGYTLIAGGPHVTADPEGCLRMGFDHVFTGDGEE
NILKFLMGLEHHHHHH 
Primers >156429561_THERMO_FW  
CGCATATGTATATTCTCTTCAGAGAGATGAAG 
>15642956120_THERMO_RV_MOD 
CCTCGAGCCCCATCAAGAACTTCAAAATATTCTC 
Gene source Plasmid pET-21-TM01 AmpR 
 
  
 130 
gi|254458087|ref|ZP_05071514.1| methylaspartate mutase, S subunit [Campylobacterales bacterium GD 1] 
Full sequence MIELSLNARGFEVFNLGVNTYLEEFFDAVVETGADILLISSLNGEAEGWSR
EIKLLKSKYKNLDNLVMMIGGNLVVGSADAETIIPKYKNYGFDLVFHQV
DLNTGLDTLEEFLKERNK 
CM01 MIELSLNARGFEVFNLGVNTYLEEFFDAVVETGADILLISSLNGEAEGWSR
EIKLLKSKYKNLDNLVMMIGGNLVVGSADAETIIPKYKNYGFDLVFHQV
DLNTGLDTLEEFLKERNKELEHHHHHH 
Sub-cloning  NdeI, XhoI 
Gene source Purchased plasmid 0946287_254458087_M_mutase_pMA AmpR 
CM021 MKVVTGVVGNDIHVVANRLIELSLNARGFEVFNLGVNTYLEEFFDAVVE
TGADILLISSLNGEAEGWSREIKLLKSKYKNLDNLVMMIGGNLVVGSADA
ETIIPKYKNYGFDLVFHQVDLNTGLDTLEEFLKELEHHHHHH 
Primers >fw-camp-Nter  
CGCATATGAAAGTAGTAACAGGCGTAGTCGGAAATGACATTCATGTT
GTAGCAAATAGATTGATCGAGCTGTCGCTGAAT 
>rv-camp-Cter  
CCTCGAGCTCTTTCAGAAACTCCTCCAGTGT 
Gene source Plasmid pET-21-CM01 AmpR 
1 ORF corrected in NCBI database, gi|298283453|gb|EDZ62765.2| methylaspartate mutase, S subunit 
[Campylobacterales bacterium GD 1] Version 2 (cloned) CM02 
 
  
 131 
gi|15897403|ref|NP_342008.1| hypothetical protein SSO0477 [Sulfolobus solfataricus P2] 
Full sequence MNTFYSRKVKYNIMAWEIILTADKGSFTDYGGSSVLGYVACMPSRLIPKFFM
DRFFTPDVPVDSEGRAIVAPYALRKVESTLVHAGFDSVVVIPPHRLEKAINQK
TKVVGLTVHDPFGLNPVSFKLSMIFGGGPTWTAKYFEEFGEKISKLKSKYNF
KVIVGGPGSWELTKENKDWADVIFIGEAEADLPRVVKSIIDGQEVPKVVYGK
NPKVNEIPPIINPARLGEVQITRGCPRGCQFCPITPETFRTIPLDVVKKEVEVNM
RAGVKRVEFITDDVLLYGSQKLRVNHEAITKLFTETMNMGVDGIWFPHISAP
AVRSSPQTVKAMSEIARYDEDRAAAPVVGLESGSEKILSKYMRAKPFPWTPR
EWKDVILDATAIMNDNYIYPCYTMTIGYPEETNEDVDQSIDLVQSIIDHKLKA
WIFPLPVIPMGVSYIRNNPFPVLEKMPTRYWDVLYISWKYDLQITREMIPILTG
GIKNKFAQRTVQYMIDKIFYSIEWVFKQLKETQGKYAYTFASINLNNTTGVIK
AIYWLFRLAFKPL 
SS01 MAWEIILTADKGSFTDYGGSSVLGYVACMPSRLIPKFFMDRFFTPDVPVDSE
GRAIVAPYALRKVESTLVHAGFDSVVVIPPHRLEKAINQKTKVVGLTVHDPF
GLNPVSFKLSMIFGGGPTWTAKYFEEFGEKISKLKSKYNFKVIVGGPGSWELT
KENKDWADVIFIGEAEALEHHHHHH 
Primers >15897403_ss_N-dom14FW 
TGCATATGATGGCATGGGAGAGATCATATTAACC 
>15897403_ss_N-dom187RV 
TCTCGAGTGCTTCAGCTTCTCCTATGAATATAAC 
Gene source Genomic DNA 
SS02 MNTFYSRKVKYNIMMAWEIILTADKGSFTDYGGSSVLGYVACMPSRLIPKFF
MDRFFTPDVPVDSEGRAIVAPYALRKVESTLVHAGFDSVVVIPPHRLEKAINQ
KTKVVGLTVHDPFGLNPVSFKLSMIFGGGPTWTAKYFEEFGEKISKLKSKYN
FKVIVGGPGSWELTKENKDWADVIFIGEAEALEHHHHHH 
Primers >15897403_ss_N-dom14FW_mod 
TGCATATGGCATGGGAGATCATATTAACCGC 
>15897403_ss_N-dom187RV 
TCTCGAGTGCTTCAGCTTCTCCTATGAATATAAC 
Gene source Genomic DNA 
SS03 MNTFYSRKVKYNIMAWEIILTADKGSFTDYGGSSVLGYVACMPSRLIPKFFM
DRFFTPDVPVDSEGRAIVAPYALRKVESTLVHAGFDSVVVIPPHRLEKAINQK
TKVVGLTVHDPFGLNPVSFKLSMIFGGGPTWTAKYFEEFGEKISKLKSKYNF
KVIVGGPGSWELTKENKDWADVIFIGEAEADLPRVVKSIILEHHHHHH 
Primers >fw-15897403-v3.0 
TGCATATGAACACCTTTTATAGCCGT 
>rv-15897403-v3.0 
TCTCGAGAATTATGGATTTTACAACTCGTGGTAGATCTGCTTCAGCTTCTC
CTATGAATATAACATC 
Gene source pET-21-SS02 
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gi|77918738|ref|YP_356553.1| putative Fe-S oxidoreductase [Pelobacter carbinolicus DSM 2380] 
 
Full sequence MNYLFVVPRDNCFGFLTIPPGVVYVATSLKETGRNVYGIHLNYESDTKESLK
KKIIDNNIDVLCIGGLSDQYNEIKRTIDLSKQIKPDLIIVVGGGLITAQPTLIMEN
IGADYAIVGQGEITICELAEALEGKKPIRDVAGIVYFENQALVCNENRPEIREL
DTVTNPDYDIFPYTQVPNDPININGDFKRTVNITASRSCPYNCTFCYHPSGTTY
RQRSIENIFREIDFLLSKYDIEHLLIIDELFAIDENRVSEFCEAIAKYDVTFSVQL
RVDGIDENLLLKLKNAGCTSISYGLESADNSILKSMKKGTDISQIEKALSLTRK
IGFFIQGYFIFGDIEETMGTVNTTIRWWMKHLEYGINLAMIRIFPGSYLYQHAI
EQSIITDQMQYIENGCPLINISKLTDQEFAGLIKKSPILIRNFSV 
 
PC01 MNYLFVVPRDNCFGFLTIPPGVVYVATSLKETGRNVYGIHLNYESDTKESLK
KKIIDNNIDVLCIGGLSDQYNEIKRTIDLSKQIKPDLIIVVGGGLITAQPTLIMEN
IGADYAIVGQGEITICELAEALEGKLEHHHHHH 
Sub-cloning  NdeI, XhoI 
Gene source Plasmid 1 015643.gb FeSoxPelobacter pMA-T AmpR 
PC02 MIPPGVVYVATSLKETGRNVYGIHLNYESDTKESLKKKIIDNNIDVLCIGGLS
DQYNEIKRTIDLSKQIKPDLIIVVGGGLITAQPTLIMENIGADYAIVGQGEITIC
ELAEALEGKLEHHHHHH 
Primers >fw-peloprimer1 
CGCATATGGGCCGTAACGTCTATGGAATTCACCTGAACTATGAG 
>rv-peloprimer 
GCTCGAGTTTGCCTTCCAGAGCTTCAGCCAGTTCACAGAT 
Gene source pET-21-PC01 
PC03 MGRNVYGIHLNYESDTKESLKKKIIDNNIDVLCIGGLSDQYNEIKRTIDLSKQI
KPDLIIVVGGGLITAQPTLIMENIGADYAIVGQGEITICELAEALEGKLEHHHH
HH 
Primers >fw-pelo-primer2 
CGCATATGATTCCGCCTGGAGTAGTGTATGTGGCCACCTCA 
>rv-peloprimer 
GCTCGAGTTTGCCTTCCAGAGCTTCAGCCAGTTCACAGAT 
Gene source pET-21-PC01 
PC04 MNYLFVVPRDNCFGFLTIPPGVVYVATSLKETGRNVYGIHLNYESDTKESLK
KKIIDNNIDVLCIGGLSDQYNEIKRTIDLSKQIKPDLIIVVGGGLITAQPTLIMEN
IGADYAIVGQGEITICELAEALEGKKPIRDVAGIVYFENQALVLEHHHHHH 
Primers >FW-PELO-v1.0 
CGCATATGAACTATCTGTTTGTGGTG 
>Rv-PELO-v1.0 
CCTCGAGGACAAGTGCTTGGTTTTCAAAATACACGATCCCGGCAACATCG
CGGATCGGTTTTTTGCCTTCCAGAGCTTCAGCCAG 
Gene source pET-21-PC01 
PC05 MIPPGVVYVATSLKETGRNVYGIHLNYESDTKESLKKKIIDNNIDVLCIGGLS
DQYNEIKRTIDLSKQIKPDLIIVVGGGLITAQPTLIMENIGADYAIVGQGEITIC
ELAEALEGKKPIRDVAGIVYFENQALVLEHHHHHH 
 
Primers >fw-pelo-primer2 
CGCATATGATTCCGCCTGGAGTAGTGTATGTGGCCACCTCA 
>Rv-PELO-v1.0 
CCTCGAGGACAAGTGCTTGGTTTTCAAAATACACGATCCCGGCAACATCG
CGGATCGGTTTTTTGCCTTCCAGAGCTTCAGCCAG 
Gene source pET-21-PC01 
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PC06 MGRNVYGIHLNYESDTKESLKKKIIDNNIDVLCIGGLSDQYNEIKRTIDLSKQI
KPDLIIVVGGGLITAQPTLIMENIGADYAIVGQGEITICELAEALEGKKPIRDVA
GIVYFENQALVLEHHHHHH 
 
Primers >fw-peloprimer1 
CGCATATGGGCCGTAACGTCTATGGAATTCACCTGAACTATGAG 
>Rv-PELO-v1.0 
CCTCGAGGACAAGTGCTTGGTTTTCAAAATACACGATCCCGGCAACATCG
CGGATCGGTTTTTTGCCTTCCAGAGCTTCAGCCAG 
Gene source pET-21-PC01 
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>gi|16272184|ref|NP_438393.1| inosine-5'-monophosphate dehydrogenase-like protein [Haemophilus 
influenzae Rd KW20] 
Full sequence MTNIHYHKILILDFGSQYTQLIARRVREIGVYCELWAWDVTEQXIREFAPELY
QGRAFKSYRGMGSLGAMAKGSSDRYFQSDNAADKLVPEGIEGRIPYKGYLK
EIIHQQMGGLRSCMGLTGCATIDELRTKAEFVRISGAGIKESHVHDVAITKEA
PNYRMG 
Gene source Gene assembly
1 
HI01 MTNIHYHKILILDFGSQYTQLIARRVREIGVYCELWAWDVTEQXIREFAPELY
QGRAFKSYRGMGSLGAMAKGSSDRYFQSDNAADKLVPEGIEGRIPYKGYLK
EIIHQQMGGLRSCMGLTGCATIDELRTKAEFVRISGAGIKESHVHDVAITKEA
PNYRMGLEHHHHHH 
Primers Internal: 
 >1_h.influenzae_sens 
ATGACCAACATTCATTATCATAAAATTCTGATTCTGGATTTTGGCAGCCA
GTATACCCAG 
>2_h.influenzae_anti 
GTTCGCAATACACGCCAATTTCACGCACACGACGCGCAATCAGCTGGGTA
TACTGGCTGC 
>3_h.influenzae_sens 
TTGGCGTGTATTGCGAACTGTGGGCGTGGGATGTGACCGAACAGCAGATT
CGTGAATTTG 
>4_h.influenzae_anti 
ACGATAGCTTTTAAACGCACGGCCCTGATACAGTTCCGGCGCAAATTCAC
GAATCTGCTG 
>5_h.influenzae_sens 
GTGCGTTTAAAAGCTATCGTGGCATGGGCAGCCTGGGCGCGATGGCGAA
AGGCAGCAGCG 
>6_h.influenzae_anti 
CGGCACCAGTTTATCCGCCGCGTTATCGCTCTGAAAATAACGATCGCTGC
TGCCTTTCGC 
>7_h.influenzae_sens 
CGGATAAACTGGTGCCGGAAGGCATTGAAGGCCGTATTCCGTATAAAGG
CTATCTGAAAG 
>8_h.influenzae_anti 
ATGCAGCTACGCAGGCCGCCCATCTGCTGATGAATAATTTCTTTCAGATA
GCCTTTATAC 
>9_h.influenzae_sens 
GGCCTGCGTAGCTGCATGGGCCTGACCGGCTGCGCGACCATTGATGAACT
GCGTACCAAA 
>10_h.influenzae_anti 
CTTTCTTTAATGCCCGCGCCGCTAATACGCACAAATTCCGCTTTGGTACGC
AGTTCATCA 
>11_h.influenzae_sens 
CGCGGGCATTAAAGAAAGCCATGTGCATGATGTGGCGATTACCAAAGAA
GCGCCGAACTA 
Primers >12_h.influenzae_anti 
GCCCATACGATAGTTCGGCGCTTCTTTG 
External 
>h_in_fw 
CGCATATGACCAACATTCATTATCAT  
>h_in_rv  
CCTCGAGGCCCATACGATAGTTCG 
1 The gene was assembled using 12 internal primers and 2 external primers. The method was adapted from 
(48). 
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>gi|164688057|ref|ZP_02212085.1| hypothetical protein CLOBAR_01702 [Clostridium bartlettii DSM 16795] 
Full sequence MSKRKQVTVPMEKIKEQDKYINEIKNENERYFHLTGKKKSYFIQTFGCQMNE
HDSEKLGAMLNAMGYEPSLMADNADLIIYNTCAVRENAELKVYGNLGHLK
LIKRRNPNLKIAVCGCMMQQPAIVKEIKAKYKHVDLVFGTHNLYKFPELLSE
SMSSDSILIDVWDVDGEVVEGLRSDRKFELKAFVNIMYGCNNFCTYCIVPYT
RGRERSRRPEDIMNEIKELVANGTKEVTLLGQNVDSYGKTLEEEDRMTFAEL
LRAVNEIDGLERIRFMTSHPKDISDEVIYAMRDCDKVCEFLHLPVQCGSTKLL
KKMNRHYSKEDYLRIVEKAKAEVPNIAFSTDIMVGFPGETEEDVEDTLDVIR
QVRYDNAFTFIYSKRTGTPAAKMEDQIPEDVKHKRFNRVLELVNEISKENNT
THQDEVVEILVEGKSKTDDTKFTGRTRQNKLVNFSVKNPDADLIGKLVNVKI
TEAALSFSLNGEMVE 
 
CB01 MKSYFIQTFGCQMNEHDSEKLGAMLNAMGYEPSLMADNADLIIYNTCAVRE
NAELKVYGNLGHLKLIKRRNPNLKIAVCGCMMQQPAIVKEIKAKYKHVDLV
FGTHNLYKFPELLSESMSSLEHHHHHH 
 
Primers Internal 
>164688057-SS-1 
ATGAAAAGCTATTTTATTCAGACCTTTGGCTGCCAGATGAACGAACATGA
TAGCGAAAAA 
>164688057-AS-2 
GGCTCGGTTCATAGCCCATCGCGTTCAGCATCGCGCCCAGTTTTTCGCTAT
CATGTTCGT 
>164688057-SS-3 
GGGCTATGAACCGAGCCTGATGGCGGATAACGCGGATCTGATTATTTATA
ACACCTGCGC 
>164688057-AS-4 
CAGGTTGCCATACACTTTCAGTTCCGCGTTTTCACGCACCGCGCAGGTGTT
ATAAATAAT 
>164688057-SS-5 
GAAAGTGTATGGCAACCTGGGCCATCTGAAACTGATTAAACGTCGTAACC
CGAACCTGAA 
>164688057-AS-6 
ACAATCGCCGGCTGCTGCATCATGCAGCCGCACACCGCAATTTTCAGGTT
CGGGTTACGA 
>164688057-SS-7 
CAGCAGCCGGCGATTGTGAAAGAAATTAAAGCGAAATATAAACATGTGG
ATCTGGTGTTT 
>164688057-AS-8 
TCGCTCAGCAGTTCCGGAAATTTATACAGGTTATGGGTGCCAAACACCAG
ATCCACATGT 
>164688057-SS-9 
CCGGAACTGCTGAGCGAAAGCATGAGCAGCGATAGCATTCTGATTGATGT
GTGGGATGTG 
>164688057-AS-10 
TTCGCCATCCACATCCCACACATCAATC 
 
Primers External 
>164688057FW 
TGCATATGAAAAGCTATTTTATTCAG 
>164688057RV 
ATCTCGAGTTCGCCATCCACATCCCA 
Gene source Gene assembly1 
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CB02 MKSYFIQTFGCQMNEHDSEKLGAMLNAMGYEPSLMADNADLIIYNTCAVRE
NAELKVYGNLGHLKLIKRRNPNLKIAVCGCMMQQPAIVKEIKAKYKHVDLV
FGTHNLYKFPELLSESMSSLEHHHHHH 
 
Primers >164688057FW 
TGCATATGAAAAGCTATTTTATTCAG 
>RV_CB_v2.0 
AT CTCGAG GCT GCT CAT GCT TTC GCT CAG CAG TTC 
Gene source pET-21-CB01 
1 The gene was assembled using 10 internal primers and 2 external primers. The method was adapted 
from (48). 
 
 
>gi|21673629|ref|NP_661694.1| acetyl-CoA carboxylase, carboxyl transferase subunit beta/methylmalonyl-
CoA mutase, C-terminus, partial [Chlorobium tepidum TLS] 
Full sequence MLYSKLLADNFVCATCGHRYVRLSARDYIELILDENAFTEHQETRYIIDRDIL
NFPEYANKLHEERVKNGMTTALITGDGAIDGKEVVLCATSFGFLGGSFCMST
GEKVWRAAKIAIENRRPRILVAKVGQDGHDRGAKVIAAAFADIGFDVDISPL
FQTPEEIVQQALDNDVHIVGISSLAGGHKTLVPQVVEGLKEARRGDILVIAGG
VIPERDYDYLYERGIAGVFGPGTVIAEAAIKLLALLLEHHQ 
CT01 MLYSKLLADNFVCATCGHRYVRLSARDYIELILDENAFTEHQETRYIIDRDIL
NFPEYANKLHEERVKNGMTTALITGDGAIDGKEVVLCATSFGFLGGSFCMST
GEKVWRAAKIAIENRRPRILVAKVGQDGHDRGAKVIAAAFADIGFDVDISPL
FQTPEEIVQQALDNDVHIVGISSLAGGHKTLVPQVVEGLKEARRGDILVIAGG
VIPERDYDYLYERGIAGVFGPGTVIAEAAIKLLALLLEHHQLEHHHHHH 
 
Primers Internal primers 
>21673629-SS-1 
ATGCTGTATAGCAAACTGCTGGCGGATAACTTTGTGTGCGCGACCTGCGG
CCATCGTTAT 
>21673629-AS-2 
CATCCAGAATCAGTTCAATATAATCACGCGCGCTCAGACGCACATAACGA
TGGCCGCAGG 
>21673629-SS-3 
TATTGAACTGATTCTGGATGAAAACGCGTTTACCGAACATCAGGAAACCC
GTTATATTAT 
>21673629-AS-4 
TTTGTTCGCATATTCCGGAAAGTTCAGAATATCACGATCAATAATATAAC
GGGTTTCCTG 
>21673629-SS-5 
TCCGGAATATGCGAACAAACTGCATGAAGAACGTGTGAAAAACGGCATG
ACCACCGCGCT 
>21673629-AS-6 
ACAGCACCACTTCTTTGCCATCAATCGCGCCATCGCCGGTAATCAGCGCG
GTGGTCATGC 
>21673629-SS-7 
GCAAAGAAGTGGTGCTGTGCGCGACCAGCTTTGGCTTTCTGGGCGGCAGC
TTTTGCATGA 
>21673629-AS-8 
CAATCGCAATTTTCGCCGCACGCCACACTTTTTCGCCGGTGCTCATGCAA
AAGCTGCCGC 
 
 
 
Primers >21673629-SS-9 
CGGCGAAAATTGCGATTGAAAACCGTCGTCCGCGTATTCTGGTGGCGAAA
GTGGGCCAGG 
>21673629-AS-10 
CGCAAACGCCGCCGCAATCACTTTCGCGCCACGATCATGGCCATCCTGGC
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CCACTTTCGC 
>21673629-SS-11 
GCGGCGGCGTTTGCGGATATTGGCTTTGATGTGGATATTAGCCCGCTGTTT
CAGACCCCG 
>21673629-AS-12 
CAATATGCAC ATCGTTATCC AGCGCCTGCT GCACAATTTC 
TTCCGGGGTC TGAAACAGCG 
>21673629-SS-13 
GGATAACGAT GTGCATATTG TGGGCATTAG CAGCCTGGCG 
GGCGGCCATA AAACCCTGGT 
>21673629-AS-14 
TCGCCACGAC GCGCTTCTTT CAGGCCTTCC ACCACCTGCG 
GCACCAGGGT TTTATGGCCG 
>21673629-SS-15 
AAGCGCGTCG TGGCGATATT CTGGTGATTG CGGGCGGCGT 
GATTCCGGAA CGTGATTATG 
>21673629-AS-16 
CGGGCCAAAC ACGCCCGCAA TGCCACGTTC ATACAGATAA 
TCATAATCAC GTTCCGGAAT 
>21673629-SS-17 
GGGCGTGTTT GGCCCGGGCA CCGTGATTGC GGAAGCGGCG 
ATTAAACTGC TGGCGCTGCT 
>21673629-AS-18 
CTGATGATGT TCCAGCAGCA GCGCCAGCAG TTT 
External 
>21673629FW 
TGCATATG CTGTATAGCAAACTGCTGGC 
>21673629RV 
ATCTCGAG CTGATGATGTTCCAGCAGCAG 
Gene source Gene assembly
1 
1 The gene was assembled using 18 internal primers and 2 external primers. The method was adapted from 
(48). 
 
>gi|153892102|ref|ZP_02013051.1| Radical SAM  domain protein [Opitutaceae bacterium TAV2]  
 
Full sequence MHTHTDTNRQKPPPLSAFLPTSKKEIEARGWTDGADVILFTGDAYVDHPSFG
AAVIGRVLEAQGWRVAIVPQPNWRDDLRDFRKLGRPRLFFGISGGCMDSMV
NHYTANRRLRSDDAYTAGGMAGQRPDRVVTVYSKILKTLYPDVPLVIGGIE
ASLRRLTHYDYWSDSLRPGLLVESGADLLVYGLGEKPICEIATRLDAGEPVS
ALTDIKQTAWLATSADTAAAAGEGGGGGGETGMAGGGKSFVRHSF 
OB01 MHTHTDTNRQKPPPLSAFLPTSKKEIEARGWTDGADVILFTGDAYVDHPSFG
AAVIGRVLEAQGWRVAIVPQPNWRDDLRDFRKLGRPRLFFGISGGCMDSMV
NHYTANRRLRSDDAYTAGGMAGQRPDRVVTVYSKILKTLYPDVPLVIGGIE
ASLRRLTHYDYWSDSLRPGLLVESGADLLVYGLGEKPICEIATRLDAGEPVS
ALTDIKQTAWLATSADTAAAAGEGGGGGGETGMAGGGKSFVRHSFLEHHH
HHH 
Sub-cloning  NdeI, XhoI 
Gene source Plasmid 0904716_RSAM__domain_opt_pMA AmpR 
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OB02 MHTHTDTNRQKPPPLSAFLPTSKKEIEARGWTDGADVILFTGDAYVDHPSFG
AAVIGRVLEAQGWRVAIVPQPNWRDDLRDFRKLGRPRLFFGISGGCMDSMV
NHYTANRRLRSDDAYTAGGMAGQRPDRVVTVYSKILKTLYPDVPLVIGGIE
ASLRRLTHYDYWSDSLRPGLLVESGADLLVYGLGEKPICEIATRLDAGEPVS
ALTDIKQTAWLATLEHHHHHH 
Primers  >SAMdom22FW  
CGCATATGACGAGTAAAAAAGAGATCGAAGCCCGTGGATGG 
>SAMdom220RV 
GCTCGAGTGTAGCCAGCCACGCTGTTTGTTTGATATCGG 
Gene source pET-21-OB01 
 
>gi|15899035|ref|NP_343640.1| methylmalonyl-CoA mutase, alpha-subunit, chain B (mcmA2) [Sulfolobus 
solfataricus P2] 
Full sequence MMITTKRIKVIVAKLGLDGHDRGAKVVARALKDAGMEVVYTGLRQTPEQIV
RAALQEDADVIGISILSGAHLELIPKVVEIMKQNGLNDVGLIVGGVIPPEDIKK
LKEMGVDEVFLPGSSLKEIVEKVKKVAREKRGISVE 
SM01 MMITTKRIKVIVAKLGLDGHDRGAKVVARALKDAGMEVVYTGLRQTPEQIV
RAALQEDADVIGISILSGAHLELIPKVVEIMKQNGLNDVGLIVGGVIPPEDIKK
LKEMGVDEVFLPGSSLKEIVEKVKKVAREKRGISVELEHHHHHH 
Primers >fwMMcoANdeI 
CGCATATGATTACAACAAAAAGAATTAAGGTT 
>rvMMcoAXhoI 
CTCGAGTTCAACACTTATACCTCTTTT 
Gene source Genomic DNA 
 
>gi|291284796|ref|YP_003501614.1| High-affinity branched-chain amino acid ABC transporter periplasmic 
leucine-specific-binding protein LivK [Escherichia coli O55:H7 str. CB9615] 
Full sequence MLTHKNKATQHHEWGFLTMKRNAKTIIAGMIALAISHTALADDIKVAVVGA
MSGPIAQWGDMEFNGARQAIKDINAKGGIKGDKLVGVEYDDACDPKQAVA
VANKIVNDGIKYVIGHLCSSSTQPASDIYEDEGILMISPGATNPELTQRGYQHI
MRTAGLDSSQGPTAAKYILETVKPQRIAIIHDKQQYGEGLARSVQDGLKAAN
ANVVFFDGITAGEKDFSALIARLKKENIDFVYYGGYYPEMGQMLRQARSVG
LKTQFMGPEGVGNASLSNIAGDAAEGMLVTMPKRYDQDPANQGIVDALKA
DKKDPSGPYVWITYAAVQSLATALERTGSDEPLALVKDLKANGANTVIGPL
NWDEKGDLKGFDFGVFQWHADGSSTKAAK 
>LBP MLTHKNKATQHHEWGFLTMKRNAKTIIAGMIALAISHTALADDIKVAVVGA
MSGPIAQWGDMEFNGARQAIKDINAKGGIKGDKLVGVEYDDACDPKQAVA
VANKIVNDGIKYVIGHLCSSSTQPASDIYEDEGILMISPGATNPELTQRGYQHI
MRTAGLDSSQGPTAAKYILETVKPQRIAIIHDKQQYGEGLARSVQDGLKAAN
ANVVFFDGITAGEKDFSALIARLKKENIDFVYYGGYYPEMGQMLRQARSVG
LKTQFMGPEGVGNASLSNIAGDAAEGMLVTMPKRYDQDPANQGIVDALKA
DKKDPSGPYVWITYAAVQSLATALERTGSDEPLALVKDLKANGANTVIGPL
NWDEKGDLKGFDFGVFQWHADGSSTKAAKELHHHHHH 
Primers >FA_fwd 
ATATCGCATATGGACGATATTAAAGTCGCCGT 
>FC_K_rev 
AATCTCGAGCTTGGCCTTCGTGGATGA 
Source Genomic DNA 
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>gi|351678212|gb|EHA61359.1| response regulator receiver protein [Thermotoga maritima MSB8] 
Full sequence MGKRVLIVDDAAFMRMMLKDIITKAGYEVAGEATNGREAVEKYKELKPDIV
TMDITMPEMNGIDAIKEIMKIDPNAKIIVCSAMGQQAMVIEAIKAGAKDFIVK
PFQPSRVVEALNKVSK 
FB from CheY 
(Fragment B for 
chimera building) 
VLIVDDAAFMRMMLKDIITKAGYEVAGEATNGREAVEKYKELKPDIVT
MDITMPEMNGIDAIKEIMKIDPNAKIIVCSAMGQQAMVIEAIKAGAKDFI
VKP 
Primers >FB_fwd 
TGAAGCCCCAGCGCGTTTTGATAGT 
>FB_rev 
TGGTCATAGCGGGGTTTCACAATGAA 
Gene source Plasmid pET21-CheYWT 
LBP-CheY-01 
(CheY inserted 
region in bold)  
 
MDDIKVAVVGAMSGPIAQWGDMEFNGARQAIKDINAKGGIKGDKLVGVEY
DDACDPKQAVAVANKIVNDGIKYVIGHLCSSSTQPASDIYEDEGILMISPGAT
NPELTQRGYQHIMRTAGLDSSQGPTAAKYILETVKPQRVLIVDDAAFMRM
MLKDIITKAGYEVAGEATNGREAVEKYKELKPDIVTMDITMPEMNGIDA
IKEIMKIDPNAKIIVCSAMGQQAMVIEAIKAGAKDFIVKPRYDQDPANQGI
VDALKADKKDPSGPYVWITYAAVQSLATALERTGSDEPLALVKDLKANGA
NTVIGPLNWDEKGDLKGFDFGVFQWHADGSSTKAKELHHHHHH 
Primers >FA_fwd 
ATATCGCATATGGACGATATTAAAGTCGCCGT 
>FA_rev 
ACTATCAAAACGCGCTGGGGCTTCA 
>FB_fwd 
TGAAGCCCCAGCGCGTTTTGATAGT 
>FB_rev 
TGGTCATAGCGGGGTTTCACAATGAA 
>FC_fwd 
TTCATTGTGAAACCCCGCTATGACCA 
>FC_K_rev 
AATCTCGAGCTTGGCCTTCGTGGATGA 
Gene source Plasmids pET21-CheYWT and  pET21-LBPWT 
LBP-CheY-02 
(CheY inserted 
region in bold)  
 
MDDIKVAVVGAMSGPIAQWGDMEFNGARQAIKDINAKGGIKGDKLVGVEY
DDACDPKQAVAVANKIVNDGIKYVIGHLCSSSTQPASDIYEDEGILMISPGAT
NPELTQRGYQHIMRTAGLDSSQGPTAAKYILETVKPQRVLIVDDAAFMRM
MLKDIITKAGYEVAGEATNGREAVEKYKELKPDIVTMDITMPEMNGIDA
IKEIMKIDPNAKIIVCSAMGQQAMVIEAIKAGAKDFIVKPKRYDQDPANQ
GIVDALKADKKDPSGPYVWITYAAVQSLATALERTGSDEPLALVKDLKANG
ANTVIGPLNWDEKGDLKGFDFGVFQWHADGSSTKAKELHHHHHH 
 >FA_fwd 
ATATCGCATATGGACGATATTAAAGTCGCCGT 
>FA_rev 
ACTATCAAAACGCGCTGGGGCTTCA 
>FB_fwd 
TGAAGCCCCAGCGCGTTTTGATAGT 
>FB_K_rev 
TGGTCATAGCGTTTGGGTTTCACAATGAA 
>FC_K_fwd 
TTCATTGTGAAACCCAAACGCTATGACCA 
>FC_K_rev 
AATCTCGAGCTTGGCCTTCGTGGATGA 
Gene source Plasmids pET21-CheYWT and pET21-LBPWT 
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>gi|351678212|gb|EHA61359.1| response regulator receiver protein [Thermotoga maritima MSB8] 
LBP-CheY-03 
(CheY inserted 
region in bold) 
 
MDDIKVAVVGAMSGPIAQWGDMEFNGARQAIKDINAKGGIKGDKLVGVEY
DDACDPKQAVAVANKIVNDGIKYVIGHLCSSSTQPASDIYEDEGILMISPGAT
NPELTQRGYQHIMRTAGLDSSQGPTAAKYILETVKPQRVLIVDDAAFMRM
MLKDIITKAGYEVAGEATNGREAVEKYKELKPDIVTMDITMPEMNGIDA
IKEIMKIDPNAKIIVCSAMGQQAMVIEAIKAGAKDFIVKPKRYDQDPANQ
GIVDALKADKKDPSGPYVWITYAAVQSLATALERTGSDEPLALVKDLKANG
ANTVIGPLNWDEKGDLKGFDFGVFQWHADGSSTKAK 
Primers >FA_fwd 
ATATCGCATATGGACGATATTAAAGTCGCCGT 
>chimera-lbp-chey-c-ter-A344>K 
AATC TCGA GTCA CTTG GGCT TCGT GGAT GA 
Gene source Plasmid pET21-LBP-CheY-02 
LBP-CheY-04 
(CheY inserted 
region in bold) 
 
MDDIKVAVVGAMSGPIAQWGDMEFNGARQAIKDINAKGGIKGDKLVGVEY
DDACDPKQAVAVANKIVNDGIKYVIGHLCSSSTQPASDIYEDEGILMISPGAT
NPELTQRGYQHIMRTAGLDSSQGPTAAKYILETVKPQRILIVDDAAFMRMM
LKDIITKAGYEVAGEATNGREAVEKYKELKPDIVTMDITMPEMNGIDAI
KEIMKIDPNAKIIVCSAMGQQAMVIEAIKAGAKDFVTMPKRYDQDPANQ
GIVDALKADKKDPSGPYVWITYAAVQSLATALERTGSDEPLALVKDLKANG
ANTVIGPLNWDEKGDLKGFDFGVFQWHADGSSTKAK 
Primers >FA_fwd 
ATATCGCATATGGACGATATTAAAGTCGCCGT 
>OT01_B_I_fwd 
TGAAGCCCCAGCGCAUATTGATAGTcgatga 
>OT01_B_MTV_rev 
TGGTCATAGCGTTTGGGCATCGTAACGAAGTCTTT 
>OT01_A_I_rev  
tcatcgACTATCAAtAtGCGCTGGGGCTTCA 
>OT01_C_MTV_fwd  
AAAGACTTCGTTACGATGCCCAAACGCTATGACCA 
>chimera-lbp-chey-c-ter-A344>K 
AATC TCGA GTCA CTTG GGCT TCGT GGAT GA 
Gene source Plasmid pET21-LBP-CheY-02 
LBP-CheY-04 
(CheY inserted 
region in bold) 
 
MDDIKVAVVGAMSGPIAQWGDMEFNGARQAIKDINAKGGIKGDKLVGVEY
DDACDPKQAVAVANKIVNDGIKYVIGHLCSSSTQPASDIYEDEGILMISPGAT
NPELTQRGYQHIMRTAGLDSSQGPTAAKYILETVKPQRVLIVDDAAFMRM
MLKDIITKAGYEVAGEATNGREAVEKYKELKPDIVTMDITMPEMNGIDA
IKEIMKIDPNAKIIVGPEGVGNASLSNIAGDAAEGMLVTMPKRYDQDPANQ
GIVDALKADKKDPSGPYVWITYAAVQSLATALERTGSDEPLALVKDLKANG
ANTVIGPLNWDEKGDLKGFDFGVFQWHADGSSTKAK 
Primers >FA_fwd 
ATATCGCATATGGACGATATTAAAGTCGCCGT 
>RV_mid-LBPCHEY_version10 
ACC TTC CGG CCC GAC GAT GAT CTT 
>FW_mid-LBPCHEY_version10 
AAG ATC ATC GTC GGG CCG GAA GGT 
>chimera-lbp-chey-c-ter-A344>K_rev_stop _TCA 
AAT CTC GAG TCA CTT GGC CTT CGT GGA TGA 
Gene source Plasmid pET21-LBP-CheY-03 
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8.4 Full table of intermediate sequences.  
 
The headers of the columns designate the following information:  
 
GI:     Gene identifier from intermediate sequence 
Protein name:   Automatic annotation from UniProt database 
Source and  
Taxonomy:    Taxonomy of source organism   
 
c.23:   SCOP and ASTRAL identifiers for flavodoxin-like fold structures 
compared with the intermediate sequence 
cols: Number of HMM-HMM aligned columns between intermediate 
sequence and the structures from flavodoxin-like and (βα)8-barrel 
fold structures  
c.1:  SCOP and ASTRAL identifiers for (βα)8-barrel fold  
structures compared with the intermediate sequence 
Id.%:  Percentage of identity between the intermediate sequence and the 
sequence of the compared structure 
 
Table 23: Full list of intermediate candidates 
GI Protein name Source and taxonomy c.23 cols Id.% c.1 cols Id.% 
150401229 radical SAM domain-containing 
protein 
Methanococcus aeolicus 
Archaea; Euryarchaeota 
d1reqa2   
c.23.6.1  
128 0.17 d1ujpa_   
c.1.2.4 
101 0.18 
117619094 response regulator Aeromonas hydrophila 
Bacteria; Proteobacteria; 
Gammaproteobacteria 
d1p6qa_  
c.23.1 
109 0.17 e2basa1  
c.1.33 
245 0.23 
54026608 putative two-component response 
regulator 
Nocardia farcinica 
Bacteria; Actinobacteria 
d1p6qa_  
c.23.1 
118 0.31 d1o4ua1  
c.1.17 
97 0.14 
46202454 COG2185: Methylmalonyl-CoA 
mutase 
Magnetospirillum 
Bacteria; Proteobacteria; 
Alphaproteobacteria 
d1reqa2   
c.23.6.1  
134 0.27 d1vc4a_  
c.1.2.4 
84 0.21 
116624963 radical SAM domain-containing 
protein 
Solibacter usitatus 
Bacteria; Fibrobacteres 
d1reqa2  
c.23.6.1 
74 0.23 d1vc4a_  
c.1.2.4 
97 0.18 
149914223 cobalamin B12-binding protein Roseobacter sp 
Bacteria; Proteobacteria; 
Alphaproteobacteria 
d1reqa2  
c.23.6.1 
143 0.16 d1y0ea_  
c.1.2.5 
103 0.13 
162453798 hypothetical protein sce5522 Sorangium cellulosum 
Bacteria; Proteobacteria; 
delta/epsilon subdivisions 
d1reqa2   
c.23.6.1 
100 0.19 d1pii_1  
c.1.2.4 
72 0.17 
83746130 Sensory transduction protein kinase Ralstonia solanacearum 
Bacteria; Proteobacteria; 
Betaproteobacteria 
d1p6qa_  
c.23.1.1 
109 0.17 e2basa1  
c.1.33 
245 0.21 
153892102 Radical SAM  domain protein Opitutaceae bacterium 
Verrucomicrobia 
d1reqa2  
c.23.6.1 
110 0.25 d1o94a1   
c.1.4.1 
86 0.1 
83859913 sigma-54 dependent DNA-binding 
response regulator 
Oceanicaulis alexandrii 
Bacteria; Proteobacteria; 
Alphaproteobacteria 
d1ny5a1  
c.23.1.1 
132 0.36 d1o4ua1  
c.1.17.1 
93 0.19 
86740508  radical SAM family protein Frankia sp. CcI3 
Bacteria; Actinobacteria; 
Actinobacteria  
d1reqa2   
c.23.6.1 
135 0.17 d1vyra_   
c.1.4.1 
93 0.14 
137771362  hypothetical protein GOS_6831935 marine metagenome d1reqa2   
c.23.6.1 
88 0.38 e1yxya1  
c.1.2.5 
83 0.19 
140978759 hypothetical protein GOS_3993934 marine metagenome 
 
Rhodopseudomonas palustris 
d1reqa2  
c.23.6.1 
149 0.17 d1twda_  
c.1.30 
223 0.36 
8675109 cobalamin B12-binding Bacteria; Proteobacteria; 
Alphaproteobacteria 
d1reqa2  
c.23.6.1 
147 0.21 d2tpsa_   
c.1.3.1 
96 0.25 
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GI Protein name Taxonomy c.23 cols Id.% c.1 cols Id.% 
156937162 Radical SAM domain-containing 
protein 
Ignicoccus hospitalis 
Archaea; Crenarchaeota; 
Thermoprotei 
e1ys7a2  
c.23.1.1 
111 0.21 d1a53__  
c.1.2.4 
89 0.2 
163753828 Fe-S protein, radical SAM family Kordia algicida OT-1 
Bacteroidetes/Chlorobi group 
d1reqa2  
c.23.6.1 
89 0.16 d1mxsa_  
c.1.10.1 
80 0.13 
33359517 btpA family protein Pyrococcus furiosus 
Archaea; Euryarchaeota; 
Thermococci 
d1ccwa_   
c.23.6.1 
103 0.16 d1geqa_   
c.1.2.4 
177 0.2 
15899035 methylmalonyl-CoA mutase Sulfolobus solfataricus 
Archaea; Crenarchaeota; 
Thermoprotei 
d1reqa2  
c.23.6.1 
132 0.39 e1yxya1  
c.1.2.99 
122 0.26 
20094042 hypothetical protein MK0604  Methanopyrus kandleri 
Archaea; Euryarchaeota; 
Methanopyri 
d1reqa2  
c.23.6.1  
64 0.19 d1vhna_  
c.1.4.1 
211 0.23 
143100560 hypothetical protein GOS_1409136 marine metagenome d1reqa2   
c.23.6.1 
123 0.11 d1twda_   
c.1.30.1 
238 0.38 
134467176  hypothetical protein GOS_220031 marine metagenome d1reqa2   
c.23.6.1 
122 0.16 d1rd5a_   
c.1.2.4 
114 0.15 
168701434 CutC family protein Gemmata obscuriglobus 
Bacteria; Planctomycetes; 
Planctomycetacia 
d1reqa2   
c.23.6.1 
149 0.16 d1twda_   
c.1.30 
234 0.33 
144006038 hypothetical protein GOS_472759 marine metagenome d1reqa2   
c.23.6.1 
89 0.19 d1pii_1   
c.1.2.4 
253 0.37 
149173777 acid aldolase protein Planctomyces maris 
Bacteria; Planctomycetes; 
Planctomycetacia 
d1a04a2  
c.23.1.1 
104 0.12 d1dxea_   
c.1.12 
248 0.32 
146319339 response regulator  Streptococcus suis 
Bacteria; Firmicutes; Bacilli 
d1a04a2  
c.23.1.1 
134 0.31 d1qpoa1  
c.1.17.1  
95 0.15 
134299625 cobalamin B12-binding domain-
containing protein  
Desulfotomaculum reducens 
Bacteria; Firmicutes; 
Clostridia 
d1reqa2   
c.23.6.1 
134 0.33 e1tv5a1  
c.1.4.1 
103 0.19 
119477187 response regulator  marine gamma 
Bacteria; Proteobacteria; 
Gammaproteobacteria 
d1k66a_   
c.23.1.1  
110 0.17 e2basa1  
c.1.33 
246 0.19 
51948340 APRR Response regulator plant-like 
protein 
Ostreococcus tauri 
Eukaryota; Viridiplantae; 
Chlorophyta 
d1i3ca_   
c.23.1.1 
141 0.21 e2basa1  
c.1.33 
122 0.13 
188991972 hypothetical protein xccb100_2577 Xanthomonas campestris 
Bacteria; Proteobacteria; 
Gammaproteobacteria 
d1reqa2   
c.23.6.1 
110 0.16 d1vc4a_   
c.1.2.4  
92 0.21 
51245292  hypothetical protein DP1440 Desulfotalea psychrophila 
Bacteria; Proteobacteria; 
delta/epsilon subdivisions 
d1qkka_  
c.23.1.1 
139 0.17 d1o4ua1  
c.1.17.1 
96 0.15 
114777666 hypothetical protein SPV1_08361 Mariprofundus 
ferrooxydans 
Bacteria; Proteobacteria;  
d1mb3a_   
c.23.1.1 
108 0.15 e2basa1  
c.1.33 
247 0.2 
135504475 hypothetical protein GOS_9154081 marine metagenome d1reqa2   
c.23.6 
108 0.18 d1qopa_   
c.1.2.4 
95 0.12 
135387500 hypothetical protein GOS_9286769 marine metagenome d1reqa2   
c.23.6 
100 0.31 d2tpsa_   
c.1.3.1 
93 0.26 
118050939 response regulator receiver modulated 
diguanylate phosphodiesterase 
Comamonas testosteroni  
Bacteria; Proteobacteria; 
Betaproteobacteria 
d1mb3a_   
c.23.1.1 
114 0.15 e2basa1  
c.1.33 
244 0.18 
136705953 hypothetical protein GOS_7841535  marine metagenome d1reqa2   
c.23.6.1 
167 0.49 e1yxya1  
c.1.2.5 
134 0.12 
39934610 coenzyme B12-binding Rhodopseudomonas 
Bacteria; Proteobacteria; 
Alphaproteobacteria 
d1reqa2  
c.23.6.1 
147 0.2 d1geqa_  
c.1.3.1 
83 0.18 
34495765 hypothetical protein CV_0310 Chromobacterium violaceum  
Betaproteobacteria 
d1reqa2   
c.23.6.1 
118 0.14 e2basa1  
c.1.33 
171 0.11 
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77463853 regulatory protein, PpaA  Rhodobacter sphaeroides 
Bacteria; Proteobacteria; 
Alphaproteobacteria 
d1reqa2   
c.23.6.1 
146 0.16 d1y0ea_   
c.1.2.5 
103 0.12 
23015349 COG1032: Fe-S oxidoreductase  Magnetospirillum 
Bacteria; Proteobacteria; 
Alphaproteobacteria 
d1reqa2   
c.23.6.1 
126 0.15 d1i4na_  
c.1.2.4 
102 0.11 
108800290 cobalamin B12-binding protein Mycobacterium sp. 
Bacteria; Actinobacteria; 
Actinobacteria (class) 
d1reqa2   
c.23.6.1 
148 0.16 d1y0ea_  
c.1.2.5 
102 0.13 
119695507 cobalamin B12-binding domain protein Mycobacterium sp 
Bacteria; Actinobacteria; 
Actinobacteria (class) 
d1reqa2   
c.23.6.1 
148 0.16 d1y0ea_  
c.1.2.5 
102 0.13 
73749252 DNA-binding response regulator  Dehalococcoides sp. 
Bacteria; Chloroflexi; 
Dehalococcoidete 
d1mvoa_   
c.23.1.1 
116 0.35 d1rd5a_   
c.1.2.4 
108 0.18 
116750679  cobalamin B12-binding domain-
containing protein 
Syntrophobacter fumaroxidans 
Bacteria; Proteobacteria;  
d1reqa2   
c.23.6.1 
127 0.18 d1rd5a_  
c.1.2.4  
101 0.17 
18976592  hexulose-6-phosphate synthase Pyrococcus furiosus 
Archaea; Euryarchaeota; 
Thermococci 
d1kgsa2   
c.23.1.1 
112 0.15 d1rd5a_   
c.1.2.4 
246 0.18 
150391225 radical SAM domain-containing 
protein 
Alkaliphilus metalliredigens 
Bacteria; Firmicutes; 
Clostridia; Clostridiales 
d1reqa2  
c.23.6.1 
122 0.16 d1hg3a_   
c.1.1.1 
102 0.15 
163854214 cobalamin B12-binding  Methylobacterium 
Bacteria; Proteobacteria; 
Alphaproteobacteria 
d1bmta2  
c.23.6.1 
129 0.14 d1y0ea_   
c.1.2.5 
118 0.14 
157374162 response regulator receiver modulated 
diguanylate phosphodiesterase 
Shewanella sediminis 
Bacteria; Proteobacteria; 
Gammaproteobacteria 
d1k66a_   
c.23.1.1 
109 0.15 e2basa1  
c.1.33 
246 0.25 
135280051 hypothetical protein GOS_9405829 marine metagenome d1jbea_   
c.23.1.1 
101 0.22 e2c0aa_   
c.1.10.1 
209 0.47 
140452724 hypothetical protein GOS_5212998 marine metagenome d1ccwa_   
c.23.6.1 
94 0.31 e1yxya1  
c.1.2.5 
90 0.16 
116751500 radical SAM domain-containing 
protein 
Syntrophobacter 
Bacteria; Proteobacteria; 
delta/epsilon subdivisions 
d1reqa2  
c.23.6.1 
123 0.21 d1vyra_  
c.1.4.1 
85 0.14 
152964427  response regulator receiver modulated 
FAD-dependent pyridine nucleotide-
disulphide oxidoreductase 
 
Bacteria; Actinobacteria; 
Actinobacteria (class) 
d1k68a_   
c.23.1.1 
135 0.19 e2c0aa_  
c.1.10.1 
87 0.15 
143306820  hypothetical protein GOS_1166505 marine metagenome d1reqa2  
c.23.6.1 
109 0.17 d1mo0a_   
c.1.1.1 
93 0.15 
126180333 radical SAM domain-containing 
protein 
Methanoculleus marisnigri 
Archaea; Euryarchaeota; 
Methanomicrobia 
d1ccwa_   
c.23.6.1 
107 0.15 d1vyra_  
c.1.1.4 
99 0.16 
31335370 glutamate mutase subunit A Actinoplanes friuliensis 
Bacteria; Actinobacteria; 
Actinobacteria (class) 
d1ccwa_  
c.23.6.1 
131 0.22 d1rd5a_   
c.1.2.4 
87 0.23 
163798434 Radical SAM domain protein Methanococcus voltae 
Archaea; Euryarchaeota; 
Methanococci 
d1reqa2  
c.23.6.1 
121 0.13 d1ujpa_  
c.1.2.4 
134 0.14 
152982555  hypothetical protein mma_0744  Janthinobacterium sp 
Bacteria; Proteobacteria; 
Betaproteobacteria 
d1reqa2  
c.23.6.1 
111 0.15 e2basa1  
c.1.33 
203 0.18 
15606339 nicotinate phosphoribosyltransferase 
frag 
Aquifex aeolicus 
Bacteria; Aquificae; Aquificae 
(class) 
d1reqa2   
c.23.6.1 
72 0.32 e1ytka1  
c.1.17 
74 0.43 
33592924 regulatory protein BvgR Bordetella pertussis 
Bacteria; Proteobacteria; 
Betaproteobacteria 
d1i3ca_   
c.23.1.1 
107 0.18 e2basa1  
c.1.33 
230 0.11 
143697032 hypothetical protein GOS_800004 marine metagenome d1ccwa_  
c.23.6.1 
126 0.27 d1gqna_  
c.1.10.1 
0.13 
142146541  hypothetical protein GOS_2809782 marine metagenome d1reqa2  
c.23.6.1 
107 0.3 d1zfja1  
c.1.5.1  
81 0.17 
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135253658 hypothetical protein GOS_9431870 marine metagenome d1reqa2  
c.23.6.1 
157 0.23 e1yxya1  
c.1.2.5 
105 0.17 
163698961 Methylmalonyl-CoA mutase Methylobacterium nodulans 
Bacteria; Proteobacteria; 
Alphaproteobacteria 
d1reqa2  
c.23.6.1 
166 0.33 e1yxya1  
c.1.2.4 
136 0.2 
138518049 hypothetical protein GOS_6026896  marine metagenome d1reqa2  
c.23.6.1 
164 0.29 d1rd5a_  
c.1.2.4 
156 0.19 
138632307 hypothetical protein GOS_6362113 marine metagenome d1reqa2  
c.23.6.1 
89 0.43 e1yxya1  
c.1.2.5 
83 0.17 
136840365 hypothetical protein GOS_7702467 marine metagenome d1reqa2  
c.23.6.1 
125 0.32 d1y0ea_   
c.1.2.5  
120 0.17 
147678754 methylaspartate mutase subunit S  Pelotomaculum 
thermopropionicum 
d1reqa2  
c.23.6.1 
134 0.48 d1y0ea_  c.1.2.5  0.12 
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